var title_f31_8_31872="Initiation of ovarian transposition procedure";
var content_f31_8_31872=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F87821&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F87821&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 532px\">",
"   <div class=\"ttl\">",
"    Initiation of ovarian transposition procedure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 512px; height: 566px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Laparoscopic lateral ovarian transposition. The ovarian ligaments (1-see arrow) and the mesovarium (2) are divided. If mobility is inadequate, a relaxing incision on the peritoneum inferior to the ovary (3) may be needed.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31872=[""].join("\n");
var outline_f31_8_31872=null;
var title_f31_8_31873="Angioid streaks";
var content_f31_8_31873=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F77863&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F77863&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Angioid streaks",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 338px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical angioid streaks in fundus of patient with pseudoxanthoma elasticum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Gold, DH, Weingeist, TA. Color Atlas of the Eye in Systemic Disease. Lippincott Williams &amp; Wilkins, Baltimore 2001. Copyright &copy; 2001 Lippincott Williams &amp; Wilkins.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31873=[""].join("\n");
var outline_f31_8_31873=null;
var title_f31_8_31874="MRI of temporal lobe glioma";
var content_f31_8_31874=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F75509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F75509&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    MRI of temporal lobe glioma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 285px; height: 356px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    T2 MRI (axial view) of focal left temporal lobe hyperintensity (arrow) caused by a glioma in a nine-year-old girl with the new onset of partial complex seizures.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31874=[""].join("\n");
var outline_f31_8_31874=null;
var title_f31_8_31875="Ranula";
var content_f31_8_31875=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F50630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F50630&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Ranula",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 355px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A ranula (arrows) is a pseudocyst associated with the sublingual glands and submandibular ducts. Ranulas appear as blue, fluctuant swellings lateral to the midline in the lower mouth.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Glenn C Isaacson, MD, FAAP, FACS.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31875=[""].join("\n");
var outline_f31_8_31875=null;
var title_f31_8_31876="Fenoterol and ipratropium: Drug information";
var content_f31_8_31876=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Fenoterol and ipratropium: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/47/43764?source=see_link\">",
"    see \"Fenoterol and ipratropium: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F10159248\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Duovent&reg; UDV",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F10193042\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Anticholinergic Agent;",
"     </li>",
"     <li>",
"      Beta",
"      <sub>",
"       2",
"      </sub>",
"      Agonist",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F10193129\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      Asthma:",
"     </b>",
"     Nebulization: Usual dose: 4 mL; may repeat every 6 hours as needed",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      COPD:",
"     </b>",
"     Nebulization: Usual dose: 4 mL; may repeat every 6 hours as needed",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F10193128\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &lt;12 years: Dosage not established",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F10193130\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block foccan drugH1Div\" id=\"F10193164\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: Canada",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Solution for nebulization:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Duovent&reg; UDV: Ipratropium bromide 0.5 mg and fenoterol 1.25 mg per 4 mL (20s)",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11233947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not available in U.S.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F10193136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Inhalation: Nebulization: Wash hands before and after treatment. Wash and dry nebulizer after each treatment. Twist open the top of one unit dose vial and squeeze the contents into the nebulizer reservoir. Connect the nebulizer reservoir to the face mask. Connect nebulizer to compressor. Sit in a comfortable, upright position. Put on the face mask and turn on the compressor. If a face mask is used, avoid leakage around the mask (temporary blurring of vision, worsening of narrow-angle glaucoma, or eye pain may occur if mist gets into eyes). Breathe calmly and deeply until no more mist is formed in the nebulizer (about 5 minutes). At this point, treatment is finished.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F10193043\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of bronchospasm associated with acute severe exacerbation of COPD or bronchial asthma",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F10193028\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Duovent&reg; UDV may be confused with Combivent&reg; UDV, DuoNeb&reg;",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F10193074\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cardiovascular: Arrhythmias, atrial fibrillation, cardiac arrest, hyper-/hypotension, myocardial ischemia, palpitation, QT",
"     <sub>",
"      c",
"     </sub>",
"     prolongation, SVT, tachycardia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Central nervous system: Dizziness, headache, nervousness, psychological alterations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Gastrointestinal: Constipation, diarrhea, nausea, vomiting, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Genitourinary: Urinary retention",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Endocrine &amp; metabolic: Hyperglycemia, hypokalemia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Neuromuscular &amp; skeletal: Muscle cramps, myalgia, tremor, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ophthalmic: Accommodation disturbance, acute angle closure glaucoma, eye pain, intraocular pressure increased, mydriasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Respiratory: Bronchospasm (inhalation induced), cough, pharyngitis, throat irritation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Miscellaneous: Allergic reactions (anaphylaxis, angioedema, bronchospasm, laryngospasm, oropharyngeal edema, skin rash, urticaria); diaphoresis",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F10193066\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to ipratropium, fenoterol, sympathomimetic amines, atropine (and its derivatives), or any component of the formulation; tachyarrhythmias; hypertrophic obstructive cardiomyopathy",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F10193067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Bronchospasm: Rarely, paradoxical bronchospasm may occur with the use of inhaled bronchodilating agents; this should be distinguished from inadequate response.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Cardiovascular: Serious adverse events, including fatalities, have been associated with excessive use of inhaled sympathomimetics. Concomitant use with other sympathomimetic amines is not recommended; closely monitor patients receiving concomitant therapy with other sympathomimetics.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hypersensitivity reactions: Immediate hypersensitivity reactions (urticaria, angioedema, rash, bronchospasm) have been reported.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     &bull; Hypokalemia: Fenoterol may cause hypokalemia; use caution, particularly in severe asthmatic patients receiving concomitant therapy (eg, steroids, xanthine derivatives) capable of potentiating hypokalemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Asthma: Appropriate use: Ipratropium is not indicated for the initial treatment of acute episodes of bronchospasm.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular disease: Use fenoterol with caution in patients with cardiovascular disease (arrhythmia, hypertension, HF); beta-agonists may cause elevation in blood pressure and heart rate and may result in CNS stimulation/excitation. Beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists may also increase the risk of arrhythmias and myocardial ischemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cystic fibrosis: Use with caution in patients with cystic fibrosis; may increase the risk of gastrointestinal motility disturbances.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Diabetes: Use fenoterol with caution in patients with diabetes mellitus; beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonists may increase serum glucose.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Glaucoma: Use ipratropium with caution in patients with narrow-angle glaucoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Hyperthyroidism: Use fenoterol with caution in hyperthyroidism; may stimulate thyroid activity.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Pheochromocytoma: Use fenoterol with caution in patients with pheochromocytoma.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Prostatic hyperplasia/bladder neck obstruction: Use ipratropium with caution in patients with prostatic hyperplasia or bladder neck obstruction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use fenoterol with caution in patients with seizure disorders; beta-agonists may result in CNS stimulation/excitation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Appropriate use: Asthma: Symptom relief of &lt;3 hours following an administered dose or failure of previous dosage regimen to provide relief indicates worsening of asthma and requires therapy adjustment; patients should be instructed to notify healthcare provider immediately and not to exceed recommended dose. Anti-inflammatory therapy should be administered to patients receiving beta",
"     <sub>",
"      2",
"     </sub>",
"     -agonist inhalation therapy on a routine basis.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Intermittent positive-pressure ventilation (IPPV): Use of ipratropium/fenoterol in conjunction with IPPV may be ineffective in severe airway obstruction; fatal episodes of hypoxia and pneumothorax have been associated with the use of ipratropium/fenoterol in conjunction with IPPV in acute asthma attacks.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13299543\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F10327945\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     AbobotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of AbobotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Acetylcholinesterase Inhibitors (Central): Anticholinergics may diminish the therapeutic effect of Acetylcholinesterase Inhibitors (Central). Acetylcholinesterase Inhibitors (Central) may diminish the therapeutic effect of Anticholinergics. If the anticholinergic action is a side effect of the agent, the result may be beneficial.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aclidinium: May enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Anticholinergics: Ipratropium (Oral Inhalation) may enhance the anticholinergic effect of Anticholinergics.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Cannabinoids: Anticholinergic Agents may enhance the tachycardic effect of Cannabinoids.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Mirabegron: Anticholinergic Agents may enhance the therapeutic effect of Mirabegron. This may result in acute urinary retention.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     OnabotulinumtoxinA: Anticholinergic Agents may enhance the anticholinergic effect of OnabotulinumtoxinA.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Potassium Chloride: Anticholinergic Agents may enhance the ulcerogenic effect of Potassium Chloride.  Management: Patients on drugs with substantial anticholinergic effects should avoid using any solid oral dosage form of potassium chloride.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Pramlintide: May enhance the anticholinergic effect of Anticholinergics. These effects are specific to the GI tract.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     RimabotulinumtoxinB: Anticholinergic Agents may enhance the anticholinergic effect of RimabotulinumtoxinB.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Secretin: Anticholinergic Agents may diminish the therapeutic effect of Secretin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tiotropium: Anticholinergics may enhance the anticholinergic effect of Tiotropium.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Topiramate: Anticholinergic Agents may enhance the adverse/toxic effect of Topiramate. Specifically, the risk of oligohidrosis and hyperthermia may be enhanced.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F10193064\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted with this combination. Use with caution prior to delivery due to tocolytic effect of fenoterol.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F10193171\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excretion in breast milk unknown/use caution",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F10193138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Spirometry (FEV, FVC); potassium",
"    </p>",
"   </div>",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F14721647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Aerodual (TH);",
"     </li>",
"     <li>",
"      Atrovent Comp (FI);",
"     </li>",
"     <li>",
"      Berodual (AR, AT, CN, CO, CZ, DE, DK, GR, HN, ID, MY, NL, PH, PL, PT, PY, RU, TH, TW, UY, VE);",
"     </li>",
"     <li>",
"      Berodual HFA (EC, PE);",
"     </li>",
"     <li>",
"      Berodual N (CH, DE, EE, MY, SG);",
"     </li>",
"     <li>",
"      Berodual Solution (SG);",
"     </li>",
"     <li>",
"      Berodualin (AT);",
"     </li>",
"     <li>",
"      Bronchodual (FR);",
"     </li>",
"     <li>",
"      Duovent (BE, BR, DK, IT, MY, NO, NZ, VE, ZA);",
"     </li>",
"     <li>",
"      Duovent N (BR);",
"     </li>",
"     <li>",
"      Duovent UDVS (SG);",
"     </li>",
"     <li>",
"      Iperol (TH);",
"     </li>",
"     <li>",
"      Iperol Forte (TH);",
"     </li>",
"     <li>",
"      Ipradual (AR);",
"     </li>",
"     <li>",
"      Respidual (VE)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F10193140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ipratropium: Blocks the action of acetylcholine at parasympathetic sites in bronchial smooth muscle causing bronchodilation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Fenoterol: Relaxes bronchial smooth muscle by action on beta",
"     <sub>",
"      2",
"     </sub>",
"     -receptors",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F10193079\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Onset of action:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Ipratropium: Bronchodilation: Within 15 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Peak effect: 1-2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Fenoterol: Bronchodilation: 5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;\">",
"     Peak effect: 30-60 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Duration:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Ipratropium: 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Fenoterol: 4-6 hours; In combination with ipratropium: 6-8 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Absorption: Ipratropium: Negligible",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Distribution: Ipratropium: Inhalation: ~3% of dose reaches lower airways",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      <i>",
"       Global Strategy for the Diagnosis, Management and Prevention of COPD",
"      </i>",
"      , Global Initiative for Chronic Obstructive Lung Disease (GOLD), 2013. Available at file://www.goldcopd.com.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 15569 Version 34.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0502-201.77.166.39-CA557B663F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31876=[""].join("\n");
var outline_f31_8_31876=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10159248\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193042\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193129\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193128\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193130\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193164\">",
"      Dosage Forms: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11233947\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193136\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193043\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193028\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193074\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193066\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193067\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13299543\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10327945\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193064\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193171\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193138\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F14721647\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193140\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10193079\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/15569\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/15569|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?42/47/43764?source=related_link\">",
"      Fenoterol and ipratropium: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_8_31877="Olmesartan and hydrochlorothiazide: Patient drug information";
var content_f31_8_31877=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Olmesartan and hydrochlorothiazide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?5/63/6135?source=see_link\">",
"     see \"Olmesartan and hydrochlorothiazide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F203642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Benicar HCT&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F6860153\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Olmetec Plus&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10020642\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10020644\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10020643\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702628",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to olmesartan, hydrochlorothiazide, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10020648\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698463",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697111",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking this drug and have high blood pressure, talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Watch for gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10020649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney function that gets worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10020651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10020646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695872",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause you to pass urine more often. To keep from having sleep problems, try to take before 6 pm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10020647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10020652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10020653\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11199 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-08BE826B45-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31877=[""].join("\n");
var outline_f31_8_31877=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F203642\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F6860153\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020642\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020644\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020643\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020648\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020649\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020651\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020646\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020647\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020652\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10020653\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?5/63/6135?source=related_link\">",
"      Olmesartan and hydrochlorothiazide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_8_31878="Transesophageal echocardiography in traumatic rupture of the aortic isthmus";
var content_f31_8_31878=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Transesophageal echocardiography in traumatic rupture of the aortic isthmus",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/8/31878/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31878/contributors\">",
"     Philippe Vignon, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31878/contributors\">",
"     Roberto M Lang, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/8/31878/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31878/contributors\">",
"     Emile R Mohler III, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/8/31878/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31878/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/8/31878/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 1, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic aortic rupture (TAR) is a life-threatening injury. It usually occurs in the region corresponding to the aortic isthmus (located between the left subclavian and the first intercostal arteries) as a result of shear forces generated by unrestrained frontal collisions [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/1,2\">",
"     1,2",
"    </a>",
"    ] or by side-impact crashes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/3\">",
"     3",
"    </a>",
"    ]. The major risk of TAR is adventitial rupture which usually results in lethal hemorrhage. In a multicenter trial that enrolled 274 patients with TAR, the overall mortality rate reached 31 percent, with 63 percent of deaths attributable to aortic rupture [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/4\">",
"     4",
"    </a>",
"    ]. Despite modern acute care, hemodynamic instability remains a major mortality risk factor in patients with TAR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/5\">",
"     5",
"    </a>",
"    ]. Over the last decade, endovascular treatment of descending thoracic aortic trauma has emerged as an alternative to conventional surgical repair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/6\">",
"     6",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/23/37240?source=see_link\">",
"     \"Thoracic endovascular aneurysm repair\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although aortography was previously considered the clinical gold standard for the diagnosis of TAR, contrast-enhanced computed tomography (CT) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/7\">",
"     7",
"    </a>",
"    ] and transesophageal echocardiography (TEE) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/8,9\">",
"     8,9",
"    </a>",
"    ] are now the predominant imaging modalities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. The main advantage of TEE is its portability and repeatability at the bedside in patients with multiple traumatic injuries consistent with management strategies [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/12\">",
"     12",
"    </a>",
"    ]. Intravascular ultrasound (IVUS) has more recently emerged as a valuable diagnostic tool for the precise characterization of TAR and on-line guidance of endovascular repair [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This review will discuss the specific role of TEE in traumatic rupture of the aortic isthmus. The technical aspects of TEE are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/24/38280?source=see_link\">",
"     \"Transesophageal echocardiography: Indications, complications, and normal views\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     TEE FINDINGS ASSOCIATED WITH SUBADVENTITIAL TRAUMATIC AORTIC RUPTURE",
"    </span>",
"    &nbsp;&mdash;&nbsp;The TEE diagnosis of subadventitial TAR requires the presence of a disruption of the aortic wall with flow on both sides of the lesion that can be identified by color Doppler imaging [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/14\">",
"     14",
"    </a>",
"    ]. TEE findings associated with subadventitial TAR are most frequently observed in the region corresponding to the aortic isthmus (typically about 25 to 35 cm from the incisors, immediately distal to the origin of the left subclavian artery).",
"   </p>",
"   <p>",
"    Typically, a thick and irregular intraluminal flap is seen traversing the lumen of the aortic isthmus in the transverse view (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76283 graphicRef76883 \" href=\"mobipreview.htm?35/8/35971\">",
"     image 1A-B",
"    </a>",
"    ). Since this lesion corresponds to disruption of the entire thickness of both intimal and medial aortic layers, it should be considered a \"medial flap.\" In the longitudinal view, the medial flap is nearly perpendicular to the aortic wall, since traumatic lesions are usually confined to a few centimeters (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63952 graphicRef63464 \" href=\"mobipreview.htm?11/50/12067\">",
"     image 2A-B",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    An abnormal aortic contour is also commonly observed due to the acute formation of a localized false aneurysm (pseudoaneurysm) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/14,15\">",
"     14,15",
"    </a>",
"    ]; the wall of the false aneurysm consists of the adventitial layer under pressure. Depending on the size of this false aneurysm, the thoracic aorta may or may not be enlarged (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76283 graphicRef76883 graphicRef63952 \" href=\"mobipreview.htm?1/41/1687\">",
"     image 2A",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Color Doppler echocardiography typically depicts similar blood flow velocities on both sides of the medial flap (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63464 \" href=\"mobipreview.htm?13/15/13567\">",
"     image 2B",
"    </a>",
"    ). In addition, a mosaic of colors surrounding the disrupted aortic wall may be observed, reflecting local blood flow turbulence (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63464 \" href=\"mobipreview.htm?13/15/13567\">",
"     image 2B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/14\">",
"     14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mediastinal hematomas can be accurately diagnosed using TEE and are observed in most patients sustaining TAR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/16,17\">",
"     16,17",
"    </a>",
"    ]. Diagnosis is based on the presence of an increased distance between TEE probe and the anteromedial aortic wall",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the presence of an ultrasound signal consistent with blood between the posterolateral aortic wall and the left visceral pleura (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61327 \" href=\"mobipreview.htm?11/5/11345\">",
"     image 3",
"    </a>",
"    ). Mediastinal hematomas can also occur in the absence of traumatic aortic injury, (eg, laceration of small mediastinal vessels, vertebrae fractures). However, mediastinal hematomas are usually larger when associated with TAR than those secondary to other traumatic injuries [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Traumatic aortic rupture should be distinguished from acute aortic dissection, which can occasionally be induced by chest trauma. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?25/19/25914?source=see_link\">",
"     \"Clinical manifestations and diagnosis of aortic dissection\"",
"    </a>",
"    .) Several TEE findings help when distinguishing between those two conditions (",
"    <a class=\"graphic graphic_table graphicRef57912 \" href=\"mobipreview.htm?34/10/34987\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef76283 graphicRef76883 \" href=\"mobipreview.htm?35/8/35971\">",
"     image 1A-B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63464 \" href=\"mobipreview.htm?13/15/13567\">",
"     image 2B",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/14\">",
"     14",
"    </a>",
"    ]. Importantly, TAR does not result in two distinct channels as seen in aortic dissection. Thus, blood flow velocities as evidenced by color Doppler imaging appear similar on both sides of the medial flap; in contrast, the false lumen in aortic dissection usually has a slower velocity than the true lumen (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef63464 \" href=\"mobipreview.htm?13/15/13567\">",
"     image 2B",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef61327 \" href=\"mobipreview.htm?11/5/11345\">",
"     image 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    A second potential diagnostic problem is that protuberant atherosclerotic changes of the aorta may be challenging to differentiate from partial TAR and may mask underlying localized subadventitial aortic tears [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/18,19\">",
"     18,19",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Finally, linear artifacts within the aortic lumen may be misdiagnosed as medial flaps. TEE diagnostic criteria have been validated, thus limiting the risk of false positive results [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/20\">",
"     20",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     OTHER TRAUMATIC AORTIC INJURIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;TEE allows accurate diagnosis of other types of aortic injuries.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Superficial traumatic aortic injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;These lesions are too small and superficial to exert an excessive pressure on the adventitial layer. Therefore, both the aortic diameter and contour usually remain unchanged and no or little blood flow turbulence is evidenced using color Doppler mapping. These injuries may be isolated or associated with a subadventitial TAR.",
"   </p>",
"   <p>",
"    Intimal tears appear as thin, mobile, and short (usually &lt;10 mm) intraluminal appendages of the aortic wall, commonly located at or in the immediate vicinity of the aortic isthmus.",
"   </p>",
"   <p>",
"    Wall thrombi within the aortic lumen may also be observed as a result of violent chest trauma. These thrombi may be voluminous and highly mobile, resulting in arterial emboli. They are typically located in the proximal descending thoracic aorta which is otherwise free of atherosclerotic changes.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other traumatic aortic injuries",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic dissections and intramural hematomas have been described using TEE in patients sustaining severe blunt chest trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/15,21\">",
"     15,21",
"    </a>",
"    ]. Intraluminal obstruction caused by the disrupted aortic wall may result in a pseudo-coarctation syndrome and associated ischemia. In this case, TEE depicts usually an intermittent aortic obstruction with a maximal pressure gradient greater than 20 mmHg using continuous wave Doppler [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC ACCURACY OF TEE",
"    </span>",
"    &nbsp;&mdash;&nbsp;No single imaging can identify all cases of traumatic rupture of the thoracic aorta [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/11\">",
"     11",
"    </a>",
"    ]. More than one imaging modality",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    repeated imaging may be required to establish the diagnosis. Computed tomography (CT) and transesophageal echocardiography (TEE) are the major diagnostic modalities that are currently used to evaluate traumatic aortic injury.",
"   </p>",
"   <p>",
"    Transesophageal echocardiography (TEE) is a powerful imaging modality for the diagnosis of TAR located in the region of the aortic isthmus. In experienced hands, the sensitivity and specificity of TEE ranges between 91 and 100 percent and between 98 and 100 percent, respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/8,9,14,18,22-24\">",
"     8,9,14,18,22-24",
"    </a>",
"    ]. The reliability of TEE in the diagnosis of TAR involving the aortic isthmus requires meticulous examination by an experienced echocardiographer. The diagnostic accuracy of TEE for the identification of TAR involving other aortic segments is unknown and traumatic injuries to aortic branches are usually outside the field of view of TEE probes.",
"   </p>",
"   <p>",
"    TEE and CT have similar diagnostic accuracies for the identification of subadventitial injuries of the aortic isthmus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/25\">",
"     25",
"    </a>",
"    ]. Multidetector CT (MDCT) with 3D reconstruction has replaced helical CT in recent series [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/26,27\">",
"     26,27",
"    </a>",
"    ]. TEE is more sensitive than CT for the diagnosis of superficial traumatic thoracic aortic injuries and for the detection of associated cardiac trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/25\">",
"     25",
"    </a>",
"    ]. Given the wide availability of CT in the emergency setting, TEE is mainly indicated in the assessment of hemodynamically unstable ventilated patients.",
"   </p>",
"   <p>",
"    Although contrast aortography was previously considered the clinical gold standard, it may fail to detect a tear until the development of pseudoaneurysm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/11\">",
"     11",
"    </a>",
"    ]. Intravascular ultrasound (IVUS) or TEE can help clarify the diagnosis when thoracic aortography is abnormal or equivocal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Transthoracic echocardiography (TTE) is",
"    <strong>",
"     not",
"    </strong>",
"    adequate for the accurate diagnosis of TAR and therefore should not be used for this indication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     TEE AND THERAPEUTIC MANAGEMENT OF TRAUMATIC AORTIC INJURIES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A gradation of severity of TAR using TEE has been proposed [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/24\">",
"     24",
"    </a>",
"    ], with a potential impact on acute management [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/29\">",
"     29",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Grade 1 TAR correspond to superficial lesions that can be safely and efficiently managed conservatively [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/12,14,23,25,29,30\">",
"       12,14,23,25,29,30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Grade 2 aortic injuries represent subadventitial TAR that require repair [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/14,23\">",
"       14,23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Grade 3 TAR correspond to aortic transsection with blood extravasation or aortic obstruction with ischemia and must be promptly repaired [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/23,29\">",
"       23,29",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Associated injuries (eg, severe head trauma, extensive pulmonary contusion, intra-abdominal bleeding) can be worsened by the use of",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?39/34/40489?source=see_link\">",
"     heparin",
"    </a>",
"    or aortic clamping during aortic repair. Postponed surgery has been successfully proposed in selected, hemodynamically stable patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/31,32\">",
"     31,32",
"    </a>",
"    ]. TEE may help guide the management of these patients.",
"   </p>",
"   <p>",
"    Endovascular stenting constitutes a minimally invasive alternative to open surgery that is increasingly performed in the acute phase of TAR [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. A meta-analysis of retrospective cohort studies suggests that endovascular treatment of descending thoracic aortic rupture as an alternative to open repair is associated with lower postoperative mortality and ischemic spinal cord complication rates [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/6\">",
"     6",
"    </a>",
"    ]. However, no prospective randomized trial is available and long-term results of endovascular stenting remain unknown in this clinical setting. Long-term survival studies are needed to determine the efficacy and durability of endovascular repair in this setting. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?36/23/37240?source=see_link\">",
"     \"Thoracic endovascular aneurysm repair\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?10/7/10361?source=see_link\">",
"     \"Management and outcome of thoracic aortic aneurysm\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    When stent-graft repair of TAR is chosen, IVUS",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    TEE may help guide endovascular stent placement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/26,35,36\">",
"     26,35,36",
"    </a>",
"    ] and enable identification of complications after device deployment [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31878/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The TEE diagnosis of subadventitial TAR involves identification of disruption of the aortic wall (medial flap) with flow on both sides of the flap identified by color Doppler imaging. Other associated findings include abnormal aortic contour due to pseudoaneurysm and evidence of mediastinal hematoma. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'TEE findings associated with subadventitial traumatic aortic rupture'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of TAR includes aortic dissection, protuberant atherosclerotic changes, and linear artifacts. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Differential diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      TEE also enables diagnosis of superficial traumatic aortic injuries as well as traumatic aortic dissection or intramural hematoma. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Other traumatic aortic injuries'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      TEE and CT offer similar diagnostic accuracy for the identification of subadventitial TAR. Given the wide availability of CT in the emergency setting, TEE is mainly indicated in the assessment of hemodynamically unstable ventilated patients. In addition, TEE is highly sensitive for the diagnosis of limited aortic injuries, and allows a gradation of severity of aortic trauma. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnostic accuracy of TEE'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/1\">",
"      PARMLEY LF, MATTINGLY TW, MANION WC, JAHNKE EJ Jr. Nonpenetrating traumatic injury of the aorta. Circulation 1958; 17:1086.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/2\">",
"      Fisher RG, Hadlock F. Laceration of the thoracic aorta and brachiocephalic arteries by blunt trauma. Report of 54 cases and review of the literature. Radiol Clin North Am 1981; 19:91.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/3\">",
"      Fitzharris M, Franklyn M, Frampton R, et al. Thoracic aortic injury in motor vehicle crashes: the effect of impact direction, side of body struck, and seat belt use. J Trauma 2004; 57:582.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/4\">",
"      Fabian TC, Richardson JD, Croce MA, et al. Prospective study of blunt aortic injury: Multicenter Trial of the American Association for the Surgery of Trauma. J Trauma 1997; 42:374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/5\">",
"      Duwayri Y, Abbas J, Cerilli G, et al. Outcome after thoracic aortic injury: experience in a level-1 trauma center. Ann Vasc Surg 2008; 22:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/6\">",
"      Xenos ES, Abedi NN, Davenport DL, et al. Meta-analysis of endovascular vs open repair for traumatic descending thoracic aortic rupture. J Vasc Surg 2008; 48:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/7\">",
"      Collier B, Hughes KM, Mishok K, et al. Is helical computed tomography effective for diagnosis of blunt aortic injury? Am J Emerg Med 2002; 20:558.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/8\">",
"      Cinnella G, Dambrosio M, Brienza N, et al. Transesophageal echocardiography for diagnosis of traumatic aortic injury: an appraisal of the evidence. J Trauma 2004; 57:1246.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/9\">",
"      Vignon P, Lang RM. Use of Transesophageal Echocardiography for the Assessment of Traumatic Aortic Injuries. Echocardiography 1999; 16:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/10\">",
"      Patel NH, Stephens KE Jr, Mirvis SE, et al. Imaging of acute thoracic aortic injury due to blunt trauma: a review. Radiology 1998; 209:335.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/11\">",
"      Hiratzka LF, Bakris GL, Beckman JA, et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121:e266.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/12\">",
"      Hainer C, B&ouml;ckler D, Bernhard M, et al. [Blunt traumatic aortic injury: importance of transesophageal echocardiography]. Anaesthesist 2008; 57:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/13\">",
"      Marty B, Tozzi P, Ruchat P, et al. An IVUS-based approach to traumatic aortic rupture, with a look at the lesion from inside. J Endovasc Ther 2007; 14:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/14\">",
"      Vignon P, Gu&eacute;ret P, Vedrinne JM, et al. Role of transesophageal echocardiography in the diagnosis and management of traumatic aortic disruption. Circulation 1995; 92:2959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/15\">",
"      Goarin JP, Catoire P, Jacquens Y, et al. Use of transesophageal echocardiography for diagnosis of traumatic aortic injury. Chest 1997; 112:71.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/16\">",
"      Le Bret F, Ruel P, Rosier H, et al. Diagnosis of traumatic mediastinal hematoma with transesophageal echocardiography. Chest 1994; 105:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/17\">",
"      Vignon P, Rambaud G, Fran&ccedil;ois B, et al. Quantification of traumatic hemomediastinum using transesophageal echocardiography: impact on patient management. Chest 1998; 113:1475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/18\">",
"      Buckmaster MJ, Kearney PA, Johnson SB, et al. Further experience with transesophageal echocardiography in the evaluation of thoracic aortic injury. J Trauma 1994; 37:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/19\">",
"      Oxorn D, Towers M. Traumatic aortic disruption: false positive diagnosis on transesophageal echocardiography. J Trauma 1995; 39:386.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/20\">",
"      Vignon P, Spencer KT, Rambaud G, et al. Differential transesophageal echocardiographic diagnosis between linear artifacts and intraluminal flap of aortic dissection or disruption. Chest 2001; 119:1778.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/21\">",
"      Vilacosta I, San Rom&aacute;n JA, Ferreir&oacute;s J, et al. Natural history and serial morphology of aortic intramural hematoma: a novel variant of aortic dissection. Am Heart J 1997; 134:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/22\">",
"      Chirillo F, Totis O, Cavarzerani A, et al. Usefulness of transthoracic and transoesophageal echocardiography in recognition and management of cardiovascular injuries after blunt chest trauma. Heart 1996; 75:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/23\">",
"      Smith MD, Cassidy JM, Souther S, et al. Transesophageal echocardiography in the diagnosis of traumatic rupture of the aorta. N Engl J Med 1995; 332:356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/24\">",
"      Goarin JP, Cluzel P, Gosgnach M, et al. Evaluation of transesophageal echocardiography for diagnosis of traumatic aortic injury. Anesthesiology 2000; 93:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/25\">",
"      Vignon P, Boncoeur MP, Fran&ccedil;ois B, et al. Comparison of multiplane transesophageal echocardiography and contrast-enhanced helical CT in the diagnosis of blunt traumatic cardiovascular injuries. Anesthesiology 2001; 94:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/26\">",
"      Astarci P, Lacroix V, Glineur D, et al. Endovascular treatment of acute aortic isthmic rupture: concerning midterm results. Ann Vasc Surg 2009; 23:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/27\">",
"      Bruckner BA, DiBardino DJ, Cumbie TC, et al. Critical evaluation of chest computed tomography scans for blunt descending thoracic aortic injury. Ann Thorac Surg 2006; 81:1339.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/28\">",
"      Patel NH, Hahn D, Comess KA. Blunt chest trauma victims: role of intravascular ultrasound and transesophageal echocardiography in cases of abnormal thoracic aortogram. J Trauma 2003; 55:330.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/29\">",
"      Vignon P, Martaill&eacute; JF, Fran&ccedil;ois B, et al. Transesophageal echocardiography and therapeutic management of patients sustaining blunt aortic injuries. J Trauma 2005; 58:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/30\">",
"      Kepros J, Angood P, Jaffe CC, Rabinovici R. Aortic intimal injuries from blunt trauma: resolution profile in nonoperative management. J Trauma 2002; 52:475.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/31\">",
"      Wahl WL, Michaels AJ, Wang SC, et al. Blunt thoracic aortic injury: delayed or early repair? J Trauma 1999; 47:254.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/32\">",
"      Akins CW, Buckley MJ, Daggett W, et al. Acute traumatic disruption of the thoracic aorta: a ten-year experience. Ann Thorac Surg 1981; 31:305.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/33\">",
"      Agostinelli A, Saccani S, Borrello B, et al. Immediate endovascular treatment of blunt aortic injury: our therapeutic strategy. J Thorac Cardiovasc Surg 2006; 131:1053.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/34\">",
"      Alsac JM, Boura B, Desgranges P, et al. Immediate endovascular repair for acute traumatic injuries of the thoracic aorta: a multicenter analysis of 28 cases. J Vasc Surg 2008; 48:1369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/35\">",
"      Dobson G, Petrasek P, Alvarez N. Images in Anesthesia: transesophageal echocardiography enhances endovascular stent placement in traumatic trans-section of the thoracic aorta. Can J Anaesth 2004; 51:931.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31878/abstract/36\">",
"      van der Starre P, Guta C, Dake M, et al. The value of transesophageal echocardiography for endovascular graft stenting of the ascending aorta. J Cardiothorac Vasc Anesth 2004; 18:466.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8156 Version 6.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-118.195.65.247-FCC50AAECF-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31878=[""].join("\n");
var outline_f31_8_31878=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H9\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      TEE FINDINGS ASSOCIATED WITH SUBADVENTITIAL TRAUMATIC AORTIC RUPTURE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      OTHER TRAUMATIC AORTIC INJURIES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Superficial traumatic aortic injuries",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other traumatic aortic injuries",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSTIC ACCURACY OF TEE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      TEE AND THERAPEUTIC MANAGEMENT OF TRAUMATIC AORTIC INJURIES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8156\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8156|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?19/59/20415\" title=\"diagnostic image 1A\">",
"      TEE transverse view of aortic rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?6/38/6752\" title=\"diagnostic image 1B\">",
"      TEE transverse view aortic rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?36/49/37663\" title=\"diagnostic image 2A\">",
"      TEE longitudinal view aortic rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?13/15/13567\" title=\"diagnostic image 2B\">",
"      Color Doppler TEE aortic rupture",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"mobipreview.htm?11/5/11345\" title=\"diagnostic image 3\">",
"      TEE hemomediastinum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8156|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/10/34987\" title=\"table 1\">",
"      TEE aortic rupture v dissection",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?25/19/25914?source=related_link\">",
"      Clinical manifestations and diagnosis of aortic dissection",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?10/7/10361?source=related_link\">",
"      Management and outcome of thoracic aortic aneurysm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/23/37240?source=related_link\">",
"      Thoracic endovascular aneurysm repair",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/24/38280?source=related_link\">",
"      Transesophageal echocardiography: Indications, complications, and normal views",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_8_31879="Approach to the patient with sensory loss";
var content_f31_8_31879=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Approach to the patient with sensory loss",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/8/31879/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31879/contributors\">",
"     Hannah R Briemberg, MD, FRCPC",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31879/contributors\">",
"     Anthony A Amato, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/8/31879/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31879/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/8/31879/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31879/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/8/31879/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 31, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sensory loss may be due to disorders of the central or peripheral nervous system. As in most of neurology, the initial goal when confronted with a patient with sensory loss is localization of the lesion using information from the history and physical examination. This narrows the differential diagnosis and directs further investigations. Localization requires an understanding of the anatomy of the sensory system.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     ANATOMY OF THE SENSORY SYSTEM",
"    </span>",
"    &nbsp;&mdash;&nbsp;Perception of a somatic sensation depends on detection of a stimulus by specialized receptors in the skin, muscle, or joints. Information from these receptors is then transmitted via peripheral nerves to the central nervous system. With the exception of the mesencephalic nucleus, whose projections carry proprioceptive information from the muscles of mastication [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/1\">",
"     1",
"    </a>",
"    ], the cell bodies of the primary sensory neurons that constitute the peripheral nerves reside in ganglia outside of the central nervous system. Projections from these ganglia then enter the central nervous system to synapse with second order neurons.",
"   </p>",
"   <p>",
"    The peripheral nerves are made up of large myelinated fibers that transmit proprioceptive, vibratory, pressure, and touch stimuli, and small, relatively unmyelinated fibers that transmit pain, temperature, and touch stimuli. (Note that touch is transmitted by both large and small fibers.) Projections from the cell bodies receiving pain, temperature, and touch stimuli enter the spinal cord via the dorsal nerve root. These fibers terminate in the dorsal horns, fanning out over several segments [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/2\">",
"     2",
"    </a>",
"    ]. They synapse with the second order neurons in the dorsal horns. These neurons then cross the midline of the cord in the anterior commissure in front of the central canal, and these second order neurons ascend (now on the opposite side of the spinal cord to the peripheral nerve) in either the anterior spinothalamic tract (touch) or the lateral spinothalamic tract (pain and temperature) to the ventral posterolateral nucleus of the thalamus. Here, they synapse with neurons which ascend to the primary sensory cortex in the parietal lobe (",
"    <a class=\"graphic graphic_figure graphicRef61109 \" href=\"mobipreview.htm?1/58/1959\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Projections from the dorsal root ganglia that carry proprioceptive, vibratory, pressure, and touch stimuli directly enter the dorsal columns from the dorsal roots [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/1\">",
"     1",
"    </a>",
"    ]. The gracile column is medial and carries stimuli from the lumbar and thoracic region; the cuneate column begins laterally in the cervical region, which it subserves. Thus, the dorsal columns consist of first order neurons traveling ipsilateral to the peripheral nerve from which they originate. These neurons synapse with second order neurons in the cuneate and gracile nuclei of the medulla. These second order neurons cross in the dorsal midline of the medulla and ascend through the brainstem as the medial lemniscus to the ventral posterolateral nucleus of the thalamus where they synapse with third order neurons which project through the internal capsule and the centrum semiovale to the primary sensory cortex in the parietal lobe (",
"    <a class=\"graphic graphic_figure graphicRef78866 \" href=\"mobipreview.htm?28/13/28884\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    As with the motor cortex, the primary sensory cortex is arranged somatotopically, with the face represented laterally, close to the Sylvian fissure. The hand and arm are represented just above the region for the face and the leg is represented medially, similar to the layout of the motor homunculus.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     DEFINITIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sensory loss is categorized as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Hypesthesia is the diminished ability to perceive pain, temperature, touch, or vibration.",
"     </li>",
"     <li>",
"      Anesthesia is the complete inability to perceive pain, temperature, touch, or vibration.",
"     </li>",
"     <li>",
"      Hypalgesia is the decreased sensitivity to painful stimuli.",
"     </li>",
"     <li>",
"      Analgesia is the complete insensitivity to painful stimuli.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Hyperpathia, hyperesthesia, and allodynia refer to an increased sensitivity to sensory stimuli.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     SENSORY EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The goal of the sensory examination is to \"localize the lesion.\" This portion of the examination tends to be subjective because it relies on the patient's responses to various stimuli; thus, it is usually done following the motor examination. With the more objective data obtained from the motor examination, the examiner is often able to narrow down a differential and proceed with a more focused sensory examination, resulting in less frustration for both the patient and examiner. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?37/30/38377?source=see_link&amp;anchor=H72#H72\">",
"     \"The detailed neurologic examination in adults\", section on 'Sensory examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The primary sensory modalities usually are examined first. These include touch, proprioception, vibration, temperature, and pain. Abnormalities in these sensations may occur with any sensory syndrome (eg, peripheral nerve injury, radiculopathy, spinal cord syndromes, thalamic and cerebral hemispheric syndromes). A disproportionate loss of vibration sense and proprioception, compared with pain and temperature sensation, tends to occur with diseases of the dorsal columns of the spinal cord (eg, tabes dorsalis, vitamin B12 deficiency, multiple sclerosis) and also with demyelinating neuropathies and sensory neuronopathies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/48/776?source=see_link\">",
"     \"Pathogenesis, clinical manifestations, and treatment of late syphilis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/32/11786?source=see_link\">",
"     \"Etiology and clinical manifestations of vitamin B12 and folate deficiency\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Higher cortical sensation can be examined if touch sensation remains relatively preserved and the patient is suspected of having a cortical lesion. Examination of cortical sensation includes two point discrimination, graphesthesia, stereognosis, and extinction:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Two point discrimination is the ability to recognize two points applied simultaneously to the skin as distinct from a single point. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?37/30/38377?source=see_link&amp;anchor=H79#H79\">",
"       \"The detailed neurologic examination in adults\", section on 'Two-point discrimination'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Graphesthesia is the ability of the patient to identify numbers or letters drawn in the palm of the hand.",
"     </li>",
"     <li>",
"      Stereognosis is the ability to recognize common objects such as keys, coins or paper clips by touching or handling them with one's eyes closed.",
"     </li>",
"     <li>",
"      Extinction is evaluated by simultaneously touching two separate points on either side of the body. The test is abnormal if the patient consistently identifies the stimulus on only one side of the body. Extinction is seen in relatively large parietal lesions.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The Romberg is a test of proprioception. It is positive when the patient is able to stand with feet together and eyes open without losing his balance but is unable to remain steady with the eyes closed. This occurs because patients are using their eyes to compensate for the lack of sensory feedback they are receiving from their lower extremities. A functional correlate of this often comes out in the history when the patient notes that he loses his balance when he gets up at night in a darkened room.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     PATTERNS OF SENSORY LOSS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The history and physical examination are key to determining the cause of sensory loss. Ancillary studies may be helpful in selected circumstances.",
"   </p>",
"   <p>",
"    Sensory loss that is confined to a part of a limb suggests injury to a peripheral nerve, nerve plexus, or spinal root (eg, mononeuropathy or radiculopathy). In contrast, sensory loss involving most of an extremity or the trunk suggests the presence of other disorders, that may be distinguished as follows (",
"    <a class=\"graphic graphic_figure graphicRef72447 \" href=\"mobipreview.htm?35/7/35958\">",
"     figure 3",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Involvement of both sides of the body is consistent with a polyneuropathy or spinal cord disease, while involvement of one side is consistent with contralateral disease of the brainstem, thalamus, or cerebral cortex.",
"     </li>",
"     <li>",
"      A sensory level is consistent with spinal cord disease or, more rarely, lateral medullary infarction.",
"     </li>",
"     <li>",
"      Sensory loss of the face suggests disease above the spinal cord (eg, brainstem, thalamus, or cerebral hemispheres). With lower brainstem disease (eg, lateral medullary syndrome), the sensory loss on the face is typically opposite that of the body, although ipsilateral sensory loss has also been reported [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/3\">",
"       3",
"      </a>",
"      ]; sensory loss is on the same side of the face and body with upper brainstem, thalamic, or hemispheric disease.",
"     </li>",
"     <li>",
"      \"Stocking-glove\" sensory loss is most commonly seen with length dependent axonal neuropathies, although other disorders may also present with this pattern.",
"     </li>",
"     <li>",
"      Disproportionate loss of vibration sense and proprioception, compared with pain and temperature sensation, tends to occur with diseases of the dorsal columns of the spinal cord (eg, tabes dorsalis, vitamin B12 deficiency, multiple sclerosis) and demyelinating polyneuropathy.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A number of these disorders are discussed in more detail below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Neuropathy",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     Mononeuropathy and radiculopathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Mononeuropathies refer to pathology affecting an individual peripheral nerve. One common example is carpal tunnel syndrome; patients with carpal tunnel syndrome frequently complain of numbness and tingling in the median nerve distribution that can be particularly bothersome at night, often awakening them from sleep. This may or may not be accompanied by wrist pain that can radiate up the arm or into the hand. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42230?source=see_link\">",
"     \"Clinical manifestations and diagnosis of carpal tunnel syndrome\"",
"    </a>",
"    .) Mononeuropathies are diagnosed clinically based on signs and symptoms that correlate with an individual nerve distribution (",
"    <a class=\"graphic graphic_figure graphicRef54042 \" href=\"mobipreview.htm?41/32/42505\">",
"     figure 4",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Radiculopathies refer to pathology affecting the nerve root, resulting in signs and symptoms in the corresponding dermatome (",
"    <a class=\"graphic graphic_figure graphicRef53006 \" href=\"mobipreview.htm?21/8/21634\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef50419 \" href=\"mobipreview.htm?10/36/10822\">",
"     figure 6",
"    </a>",
"    ) and myotome. Because of the overlap in nerve root innervation of both individual muscles and dermatomes, weakness and sensory loss can be mild",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    not involve the entire region described on the",
"    <span class=\"nowrap\">",
"     dermatome/myotome",
"    </span>",
"    maps. Instead, smaller \"signature zones\" of sensory loss may define the level of nerve root involvement (",
"    <a class=\"graphic graphic_table graphicRef73889 \" href=\"mobipreview.htm?34/15/35068\">",
"     table 1",
"    </a>",
"    ). Although radiculopathies may not cause significant sensory loss, they characteristically result in paroxysmal severe lancinating pain that may be exacerbated by coughing, sneezing, or straining.",
"   </p>",
"   <p>",
"    Occasionally it is difficult to differentiate a mononeuropathy from a radiculopathy clinically. As an example, both a peroneal nerve palsy and an L5 root lesion can result in a drop foot and numbness over the lateral aspect of the leg and dorsum of the foot. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42233?source=see_link\">",
"     \"Overview of lower extremity peripheral nerve syndromes\"",
"    </a>",
"    .) Electrodiagnostic testing (nerve conduction studies and electromyography) are useful in distinguishing between these conditions. In a peroneal palsy, nerve conduction studies may demonstrate focal slowing in the peroneal nerve at the fibular head, while in an L5 radiculopathy there may be evidence of denervation in L5 muscles outside of the peroneal territory (eg, tibialis posterior or flexor digitorum longus, both of which are innervated by the tibial portion of the sciatic nerve).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Stocking-glove sensory loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Stocking-glove sensory loss is a term used to describe sensory loss affecting the distal lower and upper extremities that is most commonly seen in length dependent axonal neuropathies. Axonal neuropathies are most frequently due to:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Diabetes mellitus",
"     </li>",
"     <li>",
"      Alcohol",
"     </li>",
"     <li>",
"      Vitamin B12 deficiency",
"     </li>",
"     <li>",
"      Syphilis",
"     </li>",
"     <li>",
"      Human immunodeficiency virus",
"     </li>",
"     <li>",
"      Lyme disease",
"     </li>",
"     <li>",
"      Uremia",
"     </li>",
"     <li>",
"      Chemotherapy",
"     </li>",
"     <li>",
"      Vasculitis",
"     </li>",
"     <li>",
"      Paraneoplastic neuropathy",
"     </li>",
"     <li>",
"      Amyloidosis",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    With axonal neuropathies, the longest axons are affected first and the symptoms start distally in these axons and progress proximally. Thus, patients do not start to notice numbness in their hands until the sensory symptoms or signs have progressed to just above the knee.",
"   </p>",
"   <p>",
"    The examination usually reveals a decrease in vibration threshold, pinprick, and temperature distally. Diminished proprioception at the great toe is typically also evident on careful examination, but can be difficult to detect. In combined large and small fiber neuropathies, the ankle jerk is frequently diminished or absent. Patients with pure small fiber neuropathies will primarily demonstrate loss of pinprick and temperature distally, although vibration perception can also be affected. Proprioception and deep tendon reflexes remain intact.",
"   </p>",
"   <p>",
"    Length dependent axonal neuropathies are generally very slowly progressive. Other etiologies need to be considered if the patient presents with a stocking-glove pattern of sensory loss in which symptoms present in the hands and feet simultaneously, or if the symptoms evolve quickly over several days to weeks.",
"   </p>",
"   <p>",
"    Occasionally patients with mononeuritis multiplex due to vasculitis do not seek medical attention unless their symptoms and signs progress to become confluent and resemble a stocking-glove pattern. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/57/22423?source=see_link\">",
"     \"Clinical manifestations of vasculitic neuropathy\"",
"    </a>",
"    .) The history and examination help to differentiate mononeuritis multiplex from a length dependent axonal neuropathy: the patient will give a history of stepwise sensory loss in discrete nerve distributions (eg, ulnar aspect of hand, then peroneal distribution in foot, etc). Furthermore, weakness, which is not usually a significant complaint in length dependent axonal neuropathies, typically accompanies the sensory loss in mononeuritis multiplex.",
"   </p>",
"   <p>",
"    Patients with Guillain-Barr&eacute; syndrome may present with numbness or paresthesias affecting their feet and hands [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/4,5\">",
"     4,5",
"    </a>",
"    ]. In this situation, the symptoms will have been present only a short time before the patient presents to medical attention. There may or may not be a history of an antecedent infection. The patient develops progressive weakness soon after the onset of sensory loss or paresthesias. The examination should reveal areflexia or depressed reflexes. Sensory loss should be minimal in comparison to the weakness and predominantly affects the larger myelinated fibers carrying proprioception and vibration. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/265?source=see_link\">",
"     \"Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Occasionally, patients with a variant of CIDP (chronic inflammatory demyelinating polyneuropathy) present with a history and examination that are most suggestive of a length dependent axonal neuropathy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. In this situation, the symptoms and signs are predominantly distal and sensory as opposed to the more common form of CIDP where symmetric proximal and distal motor weakness is the predominant symptom. EMG and nerve conduction studies are helpful in differentiating this variant of CIDP from an axonal neuropathy.",
"   </p>",
"   <p>",
"    Central lesions affecting the cervical spinal cord can also present with a stocking-glove pattern of sensory loss. In the younger population, this may be the presenting symptom of a demyelinating lesion in the cervical cord. In the older population, this is frequently caused by cervical spondylosis with cord impingement. Imaging studies (eg, magnetic resonance imaging) are required to positively identify the precise etiology. Hyperreflexia, spasticity (clonus, increased tone), and extensor plantar responses are helpful in pointing to a central cause.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Sensory neuronopathies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sensory neuronopathies are very rare causes of sensory loss. They result from degeneration at the level of the dorsal root ganglion and manifest with sensory ataxia, absent reflexes, and dysesthesias, as well as sensory loss [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/8\">",
"     8",
"    </a>",
"    ]. They are differentiated from length-dependent sensory neuropathies in several ways:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sensory neuronopathies do not necessarily follow a length-dependent pattern. In addition, they are frequently asymmetric. As an example, patients may present with initial numbness in a dermatomal distribution in one hand or even in the face.",
"     </li>",
"     <li>",
"      Sensory neuronopathies lack motor involvement. In contrast, patients with length dependent neuropathies may not complain of weakness, but mild motor abnormalities can often be found on detailed clinical examination",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      nerve conduction studies.",
"     </li>",
"     <li>",
"      Sensory neuronopathies tend to be much more disabling than length-dependent axonal neuropathies. As they progress, patients develop profound sensory ataxia, and almost always decline to the point where mobility aids are required (eg, cane, walker",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      wheelchair).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Sensory neuronopathies are most often associated with paraneoplastic phenomenon [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/8\">",
"     8",
"    </a>",
"    ]. The latter is most commonly associated with small cell lung cancer and the presence of anti-Hu antibodies. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?6/27/6583?source=see_link&amp;anchor=H8#H8\">",
"     \"Paraneoplastic syndromes affecting the spinal cord and dorsal root ganglia\", section on 'Subacute sensory neuronopathy'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other causes of sensory neuronopathy include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Sjogren's syndrome (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?26/42/27306?source=see_link\">",
"       \"Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Guillain-Barre syndrome variant (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?5/22/5481?source=see_link&amp;anchor=H9#H9\">",
"       \"Clinical features and diagnosis of Guillain-Barr&eacute; syndrome in adults\", section on 'Other variants'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Chemotherapy-induced, especially the platinum drugs (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/23/37242?source=see_link\">",
"       \"Neurologic complications of platinum-based chemotherapy\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Vitamin B6 toxicity (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/20/33098?source=see_link&amp;anchor=H40#H40\">",
"       \"Overview of acquired peripheral neuropathies in children\", section on 'Vitamin B6 (pyridoxine) toxicity'",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Friedreich ataxia (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?15/4/15432?source=see_link\">",
"       \"Friedreich ataxia\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Investigations",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve conduction studies and electromyography can be helpful in characterizing neuropathies (eg, axonal versus demyelinating, acquired versus hereditary, etc). These studies are also helpful for discriminating whether sensory pathology is proximal or distal to the dorsal root ganglion (DRG). As an example, radiculopathies that are caused by pathology proximal to the DRG result in sensory loss in the corresponding dermatome, but nerve conduction studies reveal normal sensory responses. In contrast, axonal lesions at or distal to the DRG result in low amplitude or absent sensory responses.",
"   </p>",
"   <p>",
"    Laboratory investigations are worthwhile to rule out treatable causes (eg, diabetes mellitus, lymphoproliferative disorders, uremia, vitamin B12 deficiency, syphilis, human immunodeficiency virus, and Lyme disease) if the history, physical examination, and electrophysiologic workup reveal a generalized sensorimotor axonal neuropathy (",
"    <a class=\"graphic graphic_table graphicRef64055 \" href=\"mobipreview.htm?31/20/32076\">",
"     table 2",
"    </a>",
"    ) and (see",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/12/7369?source=see_link\">",
"     \"Overview of polyneuropathy\"",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/9,10\">",
"     9,10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Unfortunately, the etiology is not always identified. In two separate studies of patients referred to tertiary care neuromuscular clinics for evaluation of peripheral neuropathy, approximately one-quarter remained undiagnosed after extensive workup [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/11,12\">",
"     11,12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Spinal cord lesions",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h3\">",
"     Cape distribution sensory loss",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cape distribution sensory loss is an uncommon but well described pattern of sensory loss resulting from lesions of the central cervical cord (",
"    <a class=\"graphic graphic_figure graphicRef72447 \" href=\"mobipreview.htm?35/7/35958\">",
"     figure 3",
"    </a>",
"    ). The classic presentation involves diminution or loss of sensation for pinprick and temperature across the upper back, shoulders, and upper arms resulting from lesions that involve spinothalamic neurons as they cross in the anterior commissure in the cervical cord. The differential diagnosis includes tumor, syrinx, and demyelination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h3\">",
"     Brown-Sequard syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Brown-Sequard syndrome results from a lesion involving only one side of the spinal cord. In this situation, the patient presents with diminished proprioception, vibration, and weakness on the side ipsilateral to the lesion, and decreased pinprick and temperature sensation on the contralateral side (",
"    <a class=\"graphic graphic_figure graphicRef72447 \" href=\"mobipreview.htm?35/7/35958\">",
"     figure 3",
"    </a>",
"    ). Hyperesthesia or pain may also occur ipsilateral to the lesion. Small lesions, such as those caused by demyelination, can result in isolated involvement of dorsal columns or spinothalamic tracts resulting in ipsilateral abnormalities in proprioception and vibration or contralateral abnormalities in pinprick and temperature, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Magnetic resonance imaging (MRI) is the imaging method of choice in suspected spinal cord lesions as it is far more sensitive than CT in this situation. When a spinal cord lesion is suspected it is important to remember that the sensory level found on examination indicates that the lesion itself is at or",
"    <strong>",
"     above",
"    </strong>",
"    that level. The spinal cord levels or dermatomes are presented for the upper and lower extremities (",
"    <a class=\"graphic graphic_figure graphicRef53006 \" href=\"mobipreview.htm?21/8/21634\">",
"     figure 5",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef50419 \" href=\"mobipreview.htm?10/36/10822\">",
"     figure 6",
"    </a>",
"    ). It is not uncommon for patients to present with an ascending pattern of sensory loss from a cervical cord lesion. Depending on when the patient is examined, different sensory levels will be found for the same lesion. Thus, in working up suspected spinal cord lesions, the physician must image the cord from the neck (cervical region) to the sensory level found on examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Brainstem lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are several classic patterns of sensory loss found with lesions at various levels of the brainstem. Most brainstem lesions involve cranial nerves",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    their nuclei. The resultant signs and symptoms tend to be more useful in localizing the lesion than are the sensory findings in isolation.",
"   </p>",
"   <p>",
"    Wallenberg syndrome is probably the most well known brainstem abnormality leading to sensory loss. It results from a lesion of the lateral medulla and was originally described as involving pain and temperature loss on the ipsilateral face and contralateral limbs and trunk. However, several other patterns of pain and temperature loss have been described in association with this syndrome, including contralateral face and bilateral face involvement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/3\">",
"     3",
"    </a>",
"    ]. Accompanying signs and symptoms include loss of vibration and proprioception as well as ataxia in the ipsilateral limbs. An ipsilateral Horner's syndrome, vertigo, nystagmus, hoarseness, and dysphagia are often present. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?38/22/39273?source=see_link&amp;anchor=H8#H8\">",
"     \"Posterior circulation cerebrovascular syndromes\", section on 'Lateral medullary infarction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The optimal initial investigation when the history and examination suggest a brainstem lesion is a brain MRI. Head CT scans are rarely useful as the artifact resulting from the skull base obscures the brainstem images.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Thalamic lesions",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thalamic lesions may cause a contralateral sensory deficit that involves all sensory modalities to varying degrees. Although tumors and abscesses can involve the thalamus, typically the onset of sensory loss in thalamic lesions is acute or subacute and is the result of a lacunar infarct [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?3/59/4026?source=see_link\">",
"     \"Lacunar infarcts\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thalamic pain syndrome, a type of central post-stroke pain, has been well described and is not uncommon in the recovery phase of these infarcts [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31879/abstract/14\">",
"     14",
"    </a>",
"    ]. Often the sensory examination is normal but the patient experiences severe pain that may be paroxysmal and exacerbated by touch over the contralateral hemibody.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Sensory cortex",
"    </span>",
"    &nbsp;&mdash;&nbsp;Discrete lesions of the sensory cortex are unusual. When they occur only a small part of the body is affected (corresponding to the region of the homunculus where the lesion is found). Any lesion large enough to affect a significant area of the body will result in other associated symptoms.",
"   </p>",
"   <p>",
"    Cortical signs and symptoms, including aphasia, neglect,",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    cortical sensory loss (eg, graphesthesia), are useful in placing a lesion in the cortex. However, cortical signs and symptoms can only be assessed in patients who have adequate sensation for primary modalities; profound alteration of the primary sensory modalities, particularly touch, prevents sensory information from reaching the cerebral hemisphere, thereby rendering cortical sensory tests inaccurate.",
"   </p>",
"   <p>",
"    Either a head CT scan or MRI is a useful initial investigation in the workup of cortical or thalamic sensory loss, although MRI is more sensitive in the diagnosis of demyelinating lesions (eg, multiple sclerosis).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following is a simplified approach to the localization of the lesion responsible for sensory loss:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Is disease confined to part of a limb or most of an extremity or trunk?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disease that is confined to part of a limb is consistent with mononeuropathy or radiculopathy.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Mononeuropathies may involve disorders of the upper extremity (eg, median [carpal tunnel syndrome], ulnar, radial nerves or brachial plexopathy) or lower extremity (eg, peroneal, posterior tibial [tarsal tunnel], femoral, or lateral femoral cutaneous nerves [meralgia paresthetica], (",
"      <a class=\"graphic graphic_table graphicRef78221 \" href=\"mobipreview.htm?34/28/35276\">",
"       table 3",
"      </a>",
"      )). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?8/44/8906?source=see_link\">",
"       \"Overview of upper extremity peripheral nerve syndromes\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42233?source=see_link\">",
"       \"Overview of lower extremity peripheral nerve syndromes\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Radiculopathies classically present with sensory loss in the distribution of a dermatome or myotome, and may be caused by structural spine disease (eg, neck or lower back), infection (ie, varicella zoster virus, Lyme disease, cytomegalovirus), leptomeningeal carcinomatosis, or focal extramedullary tumors. Sensory loss may be relatively mild with radiculopathies or may only involve small \"signature zones\" rather than entire dermatomes (",
"      <a class=\"graphic graphic_table graphicRef73889 \" href=\"mobipreview.htm?34/15/35068\">",
"       table 1",
"      </a>",
"      ); paroxysmal severe lancinating pain is common.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Disease that involves most of an extremity or trunk is consistent with polyneuropathy, spinal cord disease, or central nervous system problems.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     For sensory loss that involves most of a limb or trunk, is one or both sides of the body involved?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Polyneuropathy and spinal cord disease present with sensory loss on both sides of the body:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Polyneuropathy may be caused by a variety of systemic diseases, drugs, or toxins. Stocking-glove sensory loss is characteristic of a length dependent axonal polyneuropathy. The work-up of polyneuropathy is summarized in algorithm 1 and discussed in more detail separately (",
"      <a class=\"graphic graphic_algorithm graphicRef77479 \" href=\"mobipreview.htm?42/63/44018\">",
"       algorithm 1",
"      </a>",
"      ) and (see",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?7/12/7369?source=see_link\">",
"       \"Overview of polyneuropathy\"",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Spinal cord disease typically presents with a sensory level. A cape distribution of sensory loss is characteristic of disease of the central cervical spinal cord. The Brown-Sequard syndrome is characterized by diminished proprioception, vibration, and weakness on the side ipsilateral to the lesion, and decreased pinprick and temperature sensation on the contralateral side.",
"     </li>",
"     <li>",
"      Sensory loss confined to one side of the body is characteristic of disorders of the brainstem, thalamus, or cortex.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Brainstem lesions are unique in that cranial nerves are usually also involved, and there may be sensory loss of the face that is opposite that of the body.",
"     </li>",
"     <li>",
"      In contrast, disease of the thalamus or cortex may involve sensory loss of the face that is on the same side as sensory loss of the body.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Cortical signs and symptoms (eg, aphasia, neglect, abnormalities of graphesthesia, stereognosis, two point discrimination, extinction) are useful for placing a lesion in the cerebral cortex.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Gilman, S, Newman, SW. Manter and Gatz's Essentials of Clinical Neuroanatomy and Neurophysiology, 8, FA Davis, Philadelphia 1992..",
"    </li>",
"    <li>",
"     Duus, P. Topical Diagnosis in Neurology, 2nd revised edition, Thieme Medical, New York 1989..",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/3\">",
"      Kim JS, Lee JH, Lee MC. Patterns of sensory dysfunction in lateral medullary infarction. Clinical-MRI correlation. Neurology 1997; 49:1557.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/4\">",
"      Barohn RJ, Saperstein DS. Guillain-Barr&eacute; syndrome and chronic inflammatory demyelinating polyneuropathy. Semin Neurol 1998; 18:49.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/5\">",
"      Ropper AH. The Guillain-Barr&eacute; syndrome. N Engl J Med 1992; 326:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/6\">",
"      Rotta FT, Sussman AT, Bradley WG, et al. The spectrum of chronic inflammatory demyelinating polyneuropathy. J Neurol Sci 2000; 173:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/7\">",
"      Katz JS, Saperstein DS, Gronseth G, et al. Distal acquired demyelinating symmetric neuropathy. Neurology 2000; 54:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/8\">",
"      Kuntzer T, Antoine JC, Steck AJ. Clinical features and pathophysiological basis of sensory neuronopathies (ganglionopathies). Muscle Nerve 2004; 30:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/9\">",
"      England JD, Gronseth GS, Franklin G, et al. Evaluation of distal symmetric polyneuropathy: the role of laboratory and genetic testing (an evidence-based review). Muscle Nerve 2009; 39:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/10\">",
"      England JD, Gronseth GS, Franklin G, et al. Evaluation of distal symmetric polyneuropathy: the role of autonomic testing, nerve biopsy, and skin biopsy (an evidence-based review). Muscle Nerve 2009; 39:106.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/11\">",
"      Dyck PJ, Oviatt KF, Lambert EH. Intensive evaluation of referred unclassified neuropathies yields improved diagnosis. Ann Neurol 1981; 10:222.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/12\">",
"      Barohn RJ. Approach to peripheral neuropathy and neuronopathy. Semin Neurol 1998; 18:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/13\">",
"      Kim JS. Pure sensory stroke. Clinical-radiological correlates of 21 cases. Stroke 1992; 23:983.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31879/abstract/14\">",
"      Nasreddine ZS, Saver JL. Pain after thalamic stroke: right diencephalic predominance and clinical features in 180 patients. Neurology 1997; 48:1196.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5096 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-125.39.66.147-7CC26F0507-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31879=[""].join("\n");
var outline_f31_8_31879=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H18\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      ANATOMY OF THE SENSORY SYSTEM",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      DEFINITIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      SENSORY EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      PATTERNS OF SENSORY LOSS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Neuropathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - Mononeuropathy and radiculopathy",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Stocking-glove sensory loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Sensory neuronopathies",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Investigations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Spinal cord lesions",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      - Cape distribution sensory loss",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      - Brown-Sequard syndrome",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Brainstem lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Thalamic lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Sensory cortex",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Is disease confined to part of a limb or most of an extremity or trunk?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      For sensory loss that involves most of a limb or trunk, is one or both sides of the body involved?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5096\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5096|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?42/63/44018\" title=\"algorithm 1\">",
"      Diagnosis of polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5096|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?1/58/1959\" title=\"figure 1\">",
"      Painful and thermal pathways",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?28/13/28884\" title=\"figure 2\">",
"      Tactile sensibility pathways",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?35/7/35958\" title=\"figure 3\">",
"      Sensory syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?41/32/42505\" title=\"figure 4\">",
"      Peripheral nerve innervation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?21/8/21634\" title=\"figure 5\">",
"      Cervical dermatomes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?10/36/10822\" title=\"figure 6\">",
"      Lumbosacral dermatomes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5096|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/15/35068\" title=\"table 1\">",
"      Spinal cord sensory levels",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?31/20/32076\" title=\"table 2\">",
"      Lab tests in polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?34/28/35276\" title=\"table 3\">",
"      Lower extremity neuropathies",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/22/5481?source=related_link\">",
"      Clinical features and diagnosis of Guillain-Barr&eacute; syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42230?source=related_link\">",
"      Clinical manifestations and diagnosis of carpal tunnel syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?26/42/27306?source=related_link\">",
"      Clinical manifestations of Sj&ouml;gren's syndrome: Extraglandular disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/57/22423?source=related_link\">",
"      Clinical manifestations of vasculitic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/32/11786?source=related_link\">",
"      Etiology and clinical manifestations of vitamin B12 and folate deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?15/4/15432?source=related_link\">",
"      Friedreich ataxia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?3/59/4026?source=related_link\">",
"      Lacunar infarcts",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/23/37242?source=related_link\">",
"      Neurologic complications of platinum-based chemotherapy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/20/33098?source=related_link\">",
"      Overview of acquired peripheral neuropathies in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?41/15/42233?source=related_link\">",
"      Overview of lower extremity peripheral nerve syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/12/7369?source=related_link\">",
"      Overview of polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?8/44/8906?source=related_link\">",
"      Overview of upper extremity peripheral nerve syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?6/27/6583?source=related_link\">",
"      Paraneoplastic syndromes affecting the spinal cord and dorsal root ganglia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/48/776?source=related_link\">",
"      Pathogenesis, clinical manifestations, and treatment of late syphilis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?38/22/39273?source=related_link\">",
"      Posterior circulation cerebrovascular syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?37/30/38377?source=related_link\">",
"      The detailed neurologic examination in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?0/16/265?source=related_link\">",
"      Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_8_31880="Pyoderma gangrenosum - ulcer";
var content_f31_8_31880=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F72260%7EDERM%2F52291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F72260%7EDERM%2F52291&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyoderma gangrenosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAFEAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD2IRdOelBUg8dKjOoWYA/0mL/voUjanYquWuoR/wACFXdD1LKAbaQLlsCqq6vpx4+2Qk+m6kGrWG4gXkPH+0KNO4y4U7d6b5WDmqw1SxbgXUR/4FUqX1qyjFxF/wB9UXQEmwAjFKUyKaLm3J4niz/vCp1eIgYljP8AwKjQCJIucYqfy/lzSZHY+3WpQcrigDPZQJ+B1q3Gi8FqgbBk+hq35ZeMEdRTaJCRVZCR1xVJBhiKkLMppsfJzRYZHMmRUO1SMYwauy48vIqmzjdSGhjoQwIzU8Bbbgmk3KR70qkigCXcFpjc0o5HPWkCH3NAC+YV4HalErH60LHuarKQKhBNAirvfOADThuxyDViQpngc1JCoYUBYihQ4yaXoamkG0YFVJGOcCgBdxLkYoOV55FPhUg5z170+QKMk4zQAyOQEZNElyij3qrNKAcJVeOGSZ8tnaaaVwLEt1uTMYz9Kg2SytnJFXo4EjXp0pCcZOMUhmfJbMW5pjJ5Y5HH0rQds1EygjkUAyllCeV/OgmPPAzT2iyxx0pERe9AhN+fuLzUTK5I61bG0EbAB60PgkY60DRT2NnNOAO4Z6VaMR44pkkeTgc0Axo2k9OKlEY28UiQgDrUygAdaCbEMaZByKmjBxihWH1NOXrxQA9OmKlVRTB1p+cdKQxSvBwKikXg8VLuOKjbkGkBlzJye1VSpBrQmHJ4qoRnr2pgQEZ+lNbg4FTYAqORMnNAAo+Xihcgc06M8YxQ1AHjMLzbVL78sOCKmKykjAY1ZSDK8NjHf1qRLeUjh8jkdcVwc/c9H2aXQzJG8tyuGBPenwuTk7Tj3q+LINlsMzD34p8drIrDKClzhyIpwyOBgDGffFOE8wcAMcdw1aX2XIIZFBNItgjdACAMmjnYuRFSW4dFHL59ATzUltLdA73eUHsNx4q3HaADpkD8afLbq0fI5BqlNoXs0Imp3iDi6mB/3ulSx63q8aDZfSsO+TVcwkfcYcHkGnZC/eOO3NHtGL2SNK38U6shAFyr49UrVsvHOoQjE0MUn4YrlCqM42ke+KeYuxJAq1Vl3F7FHar48SQgT2TKemQeKvWvi3TZ/wC/Gf8AaHA/GvO9mRgsCM4pfLwMgkegFUq8upLoI9Yi1axnQBLmI5H96n7o35jZWHqDXkBcoMspA7EDNTR3lzEMxGYY6c4rT26MnQZ6xtOenNOXIPNeYwa5eoAWuZQe4Y9K0IfE9/Gw3N5g/wBpetUq0SfYyR6EORUgyRwK4uDxlIp2zWX12tjFa9n4s0+QgSeZG2O4zVqcX1JcJLc6GONmpXRwetUoNZs7hQLe4jY+m7Bq7DL5vzggiq0ZKARE9e1OUso6cVOWULkck1GHLZwuD6UrBcR3wKhIJOQKeUYgk1JbREqc9RxQMrAOOuKRkLHrV5ofl5qBowDyaBESRKpzkZpwJ3fLQQF6VIgBU470AL1Iyc0yVQV4FKqMAfSkJCqfWgCJlwvI96gYmpHfc2AOKay88UgGbciozHub29amU89KXr0pgR+SoI5NPAHbFSFMjmmqtIYNjFREYPSpSvNMaHc/BOaYgxxxTHBxUu1kHPNN3ZNAEAVuamjB709MZ5xUh24xQAiYJ61JwO9RqOaeqA/WkA/eNtRSMApNPK4BquzDJoAgkYNxUDAA1YfHXkZqFximBVkGTxTAcZBqdwMfzqAgBuKBBkg0Hk08gYqNhnoaQzzqKwYAlmDEcgZqaCIHChsDuMVYWzGc+Z9cVajhREO3J4wcDNeU3d6HrlVI0ZtiA5pWjkG3CnB9KuRR45RVB68nkVY8veh65oQrGUqt5gUECQ+tLJBukdAeDjkdhV9reNSMqATz9aHQBPu4BphYoCNVADMd3XGKjVUBwGBOeQBzWmId68Ffp1oe2G0MIwzKevQimBQMIJx26jNDRwqmDtweOpq+EgGCWXd2GcmpBCTnYRz3FCQmYXlRtJtxGVI/KpIrSIMdmAG9+tabWSncSN7j+9VS4to0cNkRt34/LNOwyq8Uatt6H25qRF2YAUt1ySKeJFLkYcHPAA+U/jUc0pEpWIc9SN1K6CzYfZ1KBmkAz2Haqk6mLGwlz0AHU1dLBVJYjPp1AqusyKcLw3diOTTGoMrR2cjMJJ5HMnYE8D8Km8wxHDqDx1H9akM6B/lZi3oaTdG53TKSf4Vz0oBwGxTq+Tl/rtqQZY/IQo6fNUKOqgl2woPB74q4jvKF8tI9h+6x6/lT5mQ6ZCVkHBIHbIFXLO+1GwVRbXTlR/CTmhYApJJ3O3B7AUR2480NuyOn0q1UaIdJM3rbxVeoP9JSOVRjDdMV02n+LNPuSglVoJCvVxkV5+QVXAYSD0AxUeHz9xQ3XkkVpGu0ZSw6PWhd28v+olSQH+6c1MJ1ToCCw9OpFeTRSSqwKqY29UbFaNvrt5CyBLkOVblJOa2jWT3MJUmj0USPKpx3ojgLNljmuVsfGBSQR3Vrknk7D+tdHba9pl2o8q4COf4XGDWqkmZuLRaaJQRUbsFPNTrJFICUkVhjsc1GygnOKYkV5JS3ApgQnkmpyq4PrSswEZwOlKwyu21evWomGTxn8KmMeG5bJx0FCxkjOMUWEQhORT+AcUMCW+WnBMe9ADSTjim9OlSheOlMKEnjpmgBqhifap1Qg09VAHvT+9AEDLzg1GYwTVork9KNmTQgKLRlaFBPWrrLngikWMEUCIeM0u4DgYp7x46Uzy8nkUDGu/y9qrumQOeKtuAOO9RkbjQIreWNvT86gKY6mrzJjPpTTGCvGKBmXKuaYq1fkhBXI61UI2vj0osBE4pA2BzzUrnrUe0EmgDmorMvHycH2p0VqYh82ME+tayoAowOfeopGjX77Bfc15KR61yqsUaZ4ycUvk4k3bSPQDpU8rRBcxoZP93monSWRCNnlA/xE7j+VMCKaMypgYX3x19qguLRLmFkk3bMYx7VpcRx/fJ9yOTRtDAk5APehAroz7S3jgiCxhtq8DJzUksaSR53YA96veVGq9Tx15qvIY0UbUyvcjgGnsPcphY88DnOCRUsbCMkdB24p0kwUHC4OM4PeqbX6lSGXbxjBo0Gk2PnnCyg5wxORmqRuAsjO2JGIIwT3PQ5qLUpQsKyI2CxIx6YrJuZ/wDRg6Sbm6smOV980FqndIuz3QQiLyuo3ZY53VnyXUW0k5yv8NJ9nnmhSeFQYj1JOSDVBwVkKBQVLYJ7/Q0M2jBWsWI795IQ3zbailv4IR5kjHGO1UdVfy4VhhDBGXJI6kVykd1c21xlD8ueN6BunPSqS0uWoXdjrY9et55HEG7K9cDNOt9aUucYYjr7VwtzqUxnknSXy2JJPk4UD6VTGrTzQwxQmMyBjkAdR6n3pKN9h1I+yspdT1hL6N/mc7l7gdVq5bTpJKUUcAZznpXC6TqTLEsc/DqNvArd06/UoUVwG3EA57VD0J5UzubZVbbtO49xU8cOyQMNvvxXNQ3V3Gm+KUfQLmrdtczyrmWdxnrjAxTTRjKkzovLGN23n9KglhZ0OFA9+tQWs6O4TczgdmbNT3FxHDHhAS38K1VzLladiFrbacKxGR19aqSQO7HzFzj7uP51INQaeNVkDx7Tn2FUNWvJFUopZ16l1bGKxnXjBXLhQcnYZLfRWBdLmfyznOCMk1fs763uoPNgkWRemR6+lZ+n6TZ62XZpwHXG7A6Vu6fo9vYgJbAxADn5Qdx9TTo1aknd7BVpUoq2tyS0vZYCvkSyRn0Vq0LfxPqcDfvEW4jHTdwapGzUEsGDZ5AAxURQqSOQB/eFdUa0kckqEWdXZ+LrWRQt1BJC578EVtW+oWV5D+6vItx/hzg15mQ5xu2qzdCTwBUT5VCofBB6g8n3raOI7mDw/Y9bVYyoYEEHvSlVIwpH0ryuDU72zZZLeeRWIA27s5P0rctPGN4qqbiNJh3IGDWirRZk6UkdqIxnkEUpjA5rnLbxhaSAmSN4z055rYtNTs7xMxXcTe2atSTIaaLOctgVKEwOcZpyoEQHIYsabNlmAHQdDVWJG43NgVOIwE560kMZPzdj0qXqfekMhCelIVx1qyq88Ugjy3I6UCIAm48DNRuu1hV/YAKiaIk5xxQBV69acUBXgVO0QI4601RtOGoAqvFnPrULrtOK0WUA5Haq8wDnGAKAKz8iowpPFWVi+Xn8qdswOmKAKJUiq80eDkA1pugIqvJHuGDQBlyKaaqc1alTaentTFQZ4pjMdRk/KQDUUREjuHiKkNgu38X09qmjOzqQT6U2VgxzgD2FeQeuJGI97BYwAepoeNivyEY65NSAkkDYOnJHamPJnIAyR0qrAVpJAMrs8wjqBzj8afBJ5ikiLAHykUfczu4z1A4oWcEZBGe49KB7E4Cs2CKr3JWOJ87cg/Kq07ezZOQV7Cs+6IaX5/wyeaBqNzPmud4cHKkDHXgVjyS7UkLZOefX8au38KsWYBm5xwcVXW1kDL5gZUZeuO1TudMUkjDuLhyVPmNktnaeBUtsDdOyl9qnqegxV6S0SGZsQ74TgBiec1YCbJFUQ4bjgduKaRblpoRyxeTAoiYrHnI2jg1Va4jDS5J3kgbmHJx/+um399Bbud2C54AzXNXWoEuZYGGGbBDc8+3tTZmrX1LuoQvLK7BHIxlRmuS1yZ7CxExidGmfC7RkgDrn0FeiaQWnjR3Cse6qf61gX8s95c+RqGnSQPFuQxwws+5Scjnvz3rSLtEmo/aadjgM3askTmBd6nBUY4xnk1HaWQjO/ftJGQc131n4E1jV9UM62T5OAguFwqjjuOB9K6i1+D08bSzatqKJDnKwwKTx3yx9vSq9nN7Gca9Gm/fd7bHlGktJH5xmEkiEYRd2CT9e3NaMWqT2TgXVmoiHBKvg59c1o3Ihi1WX+zIJmhHyxx53FwO49zVO4s1vdZFvPI0CEDEZb7p9Dn39fSokm3Y2hKNm2dbp915kMUsasjEH5G4JFa8UuU+eLHoc9fwrj01Q2s8XnwOF3GESHGCRjqPxHNdBDeK2C657YP8ASsuVo0V2tTWsbiSN0ZR8p4IYYxWnO6YB80lh1AHBrlTfNbzFiQQVwEx1/CoxeyuCJAYkPJJPSonUUdCvYOWpvXNwyJIseWYrng1Ss4Zb0BY5FWM4zGg5x7n1qhDMZBut2B3jBYn+VatpNFBHGiJt2jBKjr+Nc0abnK72NJWgrLc6bQ9Kt7SMmHHmMfn3DJNaskTZIDDBGfpXM6bqKRsgZmwCM+tb1tqEU0zKsoJA43cE+2a74KKVkedUU73ZbK7o1ACDsCG649fSoZIgVOGYIDg5HBNM82QRgMqBfULyfyqza3KOvkSGQxs2SUxu/AVVjOztcreUFdSqhu2BzgVDe2AAUrEgD8j5QP1rSndxcSF4Y1TP7obQCcevrUU/kqdjJPExGQVBYE/Q9vpTaQtdzIngWH5gpBOAo/8Ar1CYmQncAMcZ7E+tbGpxQxRRoj5DL5m0rtZW70GBJIh5qOsy9UyB/nikJrqc/JHIUGeh9uKrgMjYjbax6Hs1bdzpxMJaCUupPTHIqlJYyQgKsu5sZ5XjP1pqVgcEwttX1GFSIrh1X0DZ/nWtZeLb+2IM8ay9t0grmLmCePe5VTsGSN2OKjju94UEMoTkEjpmrVVrYzlh0z0e18bQuoa9hZeOqHIrWtvFGmXB3eeIh23jGK8qJjcAqVwfekjTPIJDA8e9aqs+pjLDroe22l/b3GPKmibPTDdavxR5yRye9eCrczRSDAOQcYVsGtSw8Q3sLERXUy467jmrVZMzlQkj2lo8HmoxHk15pb+NtQiXbKYpQO7DmtPT/HUcg/0qB1XuYyKtVIszdOSO5CCkaDI5rHs/FujzYDTsjHorrj9a17fVrC6A+z3MT544arunsRZoini4qs64b61oyjK5HPuO9QGPcaLAVDj2pG5HSp2gI68imFCrDjj3osBA61FIMD2q6yA9KhmTC5xSAy5RyahiHz81blHNQL8r8DimM5vIbOAX9cDNPXAGQAM+1PjRSu+Pke1NlV1k+UcHtmvJPXG/xFycDGOKrzSMAQmOF61IysSS/wB0DGPWoJmVEYuCR6ClctIq/amDhJZsE9+MUedLuXBWVCeSBgj6etVLaeOeV0RSYxyRj9KmPlQQtsUAnkHsKSlc0sWWkKkkfMFyBnj/APXVKV5ZFDyo2D2xjNMN4gtFEmAxYgdjiopJiUCNnGfvHiqBIjVtkku5XCg5AY8mpvta7DbzghWwAWqKZcQs0wzzkEcVGYDNbbJy0XIAfOQQO2fyoSLdmVNQYOwEBzHEpCktyx7n27VmXV3cSYy6oq/Nuz1wO9aD2cSof3g4HOGrL1NLezgDIHklYgIP7x+lKzLVuhy2v3K30zxiaOMx85Pf/E1iSwGMiSKeaZwMmQArjI6c1oXcZTWNs8XkzE5beSSvNMurZyMscEDI/wD1U3PldjrpYeEoczL/AIU1WLT7qQvjyMjCNJnZ6/Wu/wBJ8ew30Mlpp1jDLcIcpMx35XPI25HT15rxdNkDMrL5rknPoB7Vq2kd1aC2urcfZBE3mLKiBicjpn09q6KdXk06HlYnDvmPo3R9cMkSSXThXABZcYxWT8TfEJhspLOxmUzSriSWNvljUjkBuxNebJ4gbU45kYTSKSAwK9T+H8q5q/8ANvb+KwmlMUYx9w8ZA4OPX1rSeJTWhy0MFKU1cyb6YC5/dtMCCOSx5PsO/wBatJ9rt8vcxlpGYbS3DD/PvXUW3hpYoZfNHnBcEyEcn2pfscPnhVTEZGQN2Bj3/CuCVbW6PoKVOHLZmCXuJruKS7JmtoyG+QEFSR2HfpWj/aytcMtqNqDklhzj1rTnsFkjZxH5UZ4AX+KslYrO0nkRQRdddvGW56Z7VCr+0VkDpRirotNIE3yO+4gcHpU3mRvNE7kkleAp4qheStHCJpIzF5uPLMnAI78fWswu77YZZCUYgkjjHtTp0k37xEqmnunWabJEbqQGWNAP4T3NauRNAzW3zgMwOcDgd8V56Z3s5JIl5kLYjXjb26k/yrYAvLpYTaQKrqmZGiPHqcitZJQMlTnU9421vWiYtkg9cgZFXbG7luZkjhU7nOCw/qK4+N5EnlRpX83ouw8D/eHpW/pWpyuSZrYwpGwQuB8pHqH+p71lzhUi46HZ2Us0O63Z8yJwQW6+v45rRR2kbZcLhsfKH4x78fpXKxXh2yyrG7sH+WQZPHf61bi1CR4QjxyNIf8AloeDx6V0RehySjdm69s4+UsrKp5yx/MGommmQ+WnO1s7dxJI9qqwXpUYViu0k5zyBVqylcSEBkbepVcjJHPrQJRstTUkEF0iLHJtBTLBk3S8env9Krw3YuYgDvtnjB3suWOPc9+KZGHXkSoNrZBGMn6VNFIqxukIUK/L88HPc0yeUITHcyB0nUoflK7CD9eOOaWMxWyMIpFLM4b7vzDHbnmoYoI7WVirLHlf9YzAZJB7Dr14qilzliTHypxljyvtUt2GoJsluEFzJL5kiFVGcBfv1ny2ksZOY1iODnJ5wfSlLEMzhiD3zQJHG5g26NRwG+apuaclhYLVJLUs2zKHk45P0FU5SqqcZyp4yMZq28xuPnb92rEDhcY7ZqW2jjZk+fJ5ByOKq+hHJYzkkkEgLiNSeQcmoXebzAY0Xceo3da37i2t2xwWIqnJaCNd0e5s+lK5PKiiJXO4bCOeWBzinKWwwkGBg4IGRR5Up3szEt6gVcS32wr5smQ3ZeSPrVcxLplYO52hQR05zmpYrmRGcfMp7MKZsEeB5pVQepHA96c4OGXj7uR3zTU2iHRT6GlbeIdQt1xDdyhR0Bat6y8dXMJAmWOfGMnvXFbHLBgQynrxSBFVmOcN3wO1Wq0kZvDRZ6fF47tX4ubeSMf3k+YVoW/iTSbgfJeBSR0cYrx3hgGjk3DJAFPiVwvzEFs9DWqxBjLCHuEF1BLEGjnjfIwNrA5qZ4yYs9j3rw03UsR+ViADnCmtPT/FmrW6BYrotH/ckG7+daLERZk8NM9KuUCsc5pkcYJ+tcUvjW5Zl+1W8bjkErxzWtZ+K7FtolV4m9xkVoqkHszN05x3Qxgc8DG3t2oblt2MCo5WcgkcEdM0x3coD0PTPrXlnqoU5ZhzuJPJx0qvcxlVPqexoeOZeUlJPUggVHcRfMHBIfHUMaRolqVJN+7hUUY6gYqhdSg8bCY8fMfepp5mdmWVdxU5BzVO5xuzGWGeCDkZB7Gg1SsVJp23K3ylQc4/wpXmWWRfmAIXIToR3qLUdq3AxC23djAPHWnNGYGRzEvntnaT1Ao2NLaGwsm62O5kVFHy9yT3+tZt9KYxGEQlSAC38Oc9hVa6DCRSzMwUjIA4B9KdLcXEyZaMoiN8qEYOfbNDlcmMbMjRHUhnVmc+g5/DtVLWrPdHGSPKx6dc+ua0bc55LbFXGSTn8TWbr+oyQwyGNiyuCo2ccH+dKOrNE9dDjtSuCZ3kuoBIxG1ZJMnDdjn/AB4pLe388oY7l3ug3KRMcA+xqO406eZ1mmt5PmzsKjO71q/ZWjWZYImIZD85B5Uev0/GtKitqbUqkX7qIbzw7JbwyyJDhAQJXZcFWPTPf8a565tVUBGGAG6g8CuyurRDPkXCtIO4csSO2ay7yCW/RbW0szLcIxJaJSzODjgj27Y9awVTmkdkKcVC0tS7pV5b2PlrM6eQzY8xfm59SM1ta6dHfT5HW5ga8UZiEQ+eTkDJ7AY598GuWMmnPYWcUumMlzDlZLhZsEncCSVPBwoIA461a06G3KyIAN2SUbaAB69K0lNRXc4o4RKSlqiS31iaO32gvv8A4s9qit7m4YlJkQqzZB3dqtJbrgeUVVSSBu7n1qtFp88cmVKeRkscjr9K5XazO/mjFXLsWpsUzcSMu44AUHoO9anh+aKO3nmdbZyZGf54w7A49fTFYgnSOCXY+GbPG3oMVBDJNBBGlujFpH2525z6dK1wkfedkcmJmlBo22tbfUbxBeQrPGh3qin5T7VR1XTEe4ZII/JQ/MqjsB39qtafaz6eyTPDLG7HLBwTj6eoq/OWu4t0xBMn3gnXH4V1OCv5nFF21icnPpou1wCwkVgCT046mui0f9ykiW/3VU8g8kemKs2WlPi5nkki+xBQqAg4XPcnt19az76BrGcuJCY3GFlCkBuO3TPX+Vcta9ry2Nac9HAybm2gSeQxF0KnLH1NRi52gIskjKPvgjA/+vVxo4SGubmd41EW/BjyS5P3T6cfWsSa5aWXCvGsa4YmTjd7VajokdcPf6bG/psrhyYLplB7ZK4FayXs9sgEkocjoemRWZpkiX1qjtt2dVULxn+orTuYoWgVPJQSA58xODz7VLpyi9GYSnFvVFyy1SOWT5yqse7ACtj7bDbsWRlRXxnbyDXFSO0MDRyIjKPXjiktyk0RVQ4CjoW4oVSaQvYxk7nUXOuWiKQzcd9g6n14rPXxFYyyhGfyOT80i4GPTmuK1aVo7oIuApXHPQE96rTBhMY1feBwDuBz+I60KUmrnbDBU9rnrEV4qruQiSNgCvl8jHrVm2CPKsxlGGzuUcH868+8D3VxFqJtgzGFgSQGAK/SvRIhCdskUjCdD8rk1pHXU4MRRdGXKJM6CY4jBY8KAPyqCO4mLkIgVA2NuOcehqxPPCyqWO18k9O9VI2yWfJB6Djr71TMUrmi0SzqzbkSTO5goyBnsKiR0DqgIAH8WOPrUUKs5fkLxjd6/gamvY7iPypIACWA9t1ISXQmedh+6yGXrkCk8/cyxFSOPlYeh9aihvXkVSAXGeSOAfwq4Rtcb9ykcjGKLicSk8ZRmZm5HQ+tKrOImLlSpGeGp9wpQjCoQeVDHIxRFCzAHMbZA6ilcOUh2rMo2g8gdQc/lSvGxjAG0MBipIy63LZUbem40427SSjACIQTgHJouDiRQqcFeScdTyM0xoSVbbEPNbg9uK0YIEjwHHJ4AFSyL5Xcq3Qn2pktGYIkiG3llI546e9NeNcfKCo/vnvWukACbsFu4B6flVeO2yxWThevHOaBGNLAGIbdszySvWpDbllyuScZPPUVtShBhY4xjv7CqxURFsKcEYXI6+wpCtcxZ42AG0g57ZqNgFXk7STyDWw1v5iKCoRj97dx+VSRwJGpWRApJ4PWnzC5UdTKGwSI/wAA1QJsdDjPB6nrV1w+OEXI689KqCJlmb5+WXJ9Aaexmgcr0HAPas69kJbCjleamupDG6uvOTjFZV1qKxtIJR8xwAfSkawiUL6Ty42PGTwCD0rPlndBHs4RRuyT15qa7ePyVmlYBHzgc4GP89ayzf28izKS2YiApHRs+9RLsdMUh6XiwzmS63MrA7R6/SoLzU0QbgrFiMYHNZmqXMsqu8IGyMbiSMlQO5rIjurqaAzrCXjAyPM+U7fYd6ajbVmyp3OiTWLlEwuyNiOcnBP4etR3F5cP8jOVYkZKnkjv9KbaadfXe2xtAkUV6R+8lTaFYDpuIyAO+PXmoZbO6i0M35WKSNJPJ/12HVsHOFI55HX/ABoaYKMXs9SSz1e4iRreEeaxLbUIzkA88+1aH2RblYiFLznBMcZA2/Wsu1nbUZbZYpYpJSvlxRJFtbdjjL4G7uK17rU7vRo3tr7S2trmRBLh8ZVckAAZ4zjvzVLlTMnCS06mXIs/mtb2jxFLdizxksC6jggN/Sr19qFlDYh3jCM4ZU8pssvGACMYHHfmqEt3FNd3F1p1hcz6fLEGKSShGR8YJU4Oeh4x/Ks6a8DxMtxEqbyAjMCWVR2H17mrqVFFbjw9Fykm1oXGtUntYY4J38oPwxOE57kc4rX8N29k/iSSSUTJa29uT+6kMZMpIVfnH3eTn8KxoI4rfa0TkKRubJ4Pp+tW/DF6v/CTz3F9KIrPJlW2QnYW7DJ5wP6CuSlJOp7z0OjFOSg+Rkmr+DVhsbSNbp7m7aRvPitw0jAZOOCAAPU5PWs3SdI1iw1OCy+ySvFIx27kwPrk8frXp3h2KHXbq4a3vnjCMJHYKFdd2R3PzDHP4mrer2stnb2kC3cN3CSssYeNoxKytlUyeMvjHPFdrpqauebDG1Yy5Hr6nm2v6JeQQpcNayjzE3oAPlKno2fzrFheSWNYzcMCo2nIzmvVfDN/JY3Uo1q2RZtr/wCjzgoUZjwnJ6AfpjFcJqWh21reyxpcA3iTlWWNgUxtBBDA8nnp2xXM6Vlod1HFOV4y6GfBO7WWbtI/s8P7uMRoAxUdiR1z781mQXdzZ2wuIRJAUfMcitgpk9e/rXcaX4YXVrMR/avsqxuMhgCxXnceoHA5561kzaN5EN5CRIzQgMoC484bsZOCR/jWlO6fPYzlyybimZsd7q91EmNTa5CgEgghSf7vP866jTEt9cuFjsbZ47lwdsG/Az7N35rmBayw3KBInjOMAvx+Ndf4Y0KK50i9vzqdtHcxqwS3MhWXjHzD8+lSqr5n2LrKMIJ7djK1MXdusthPPKiRyHzYAeMrwMjuaqWdzGxI8ozyKd22Q4C/T9Kr3oP9rxrNPKgYqHcrknPU8+3PvW2IbLQreWafa9xG2+JGB3Shifmbsu0AdOuamrR+sRUkZOXI7dWUNVja4ujLcYdp13ZLdD6nPU1zV3ZRSLvmdgok2usYG4L6jPU10tvfx3Gol4rkyrsUmR0xtzjOR6A8Z711Emgpqup3VxBrUMV7IhWYxxrtmi4GEUcDjj9aKdKSV0b0K8aTaqHkQjn0lLWSC4kknkcq8IjYeWM8c9Dkelakup3sYQshW4mAMZI6g9DXf6t4YtrFA0VqpvVyVCHJUc45+nUmuL1zTr7T5oUuLURTkh1VWDkHONoIJ/Kuv7Kvuc0JqVVtbGNO2pxssdyx+Y4LEZH0q9ZwS28ExSflhwM559M07UridLVZboGN+mxhgn6Uyzu7cacZ5btFl3BRbYJkb/awBj86505Sg7o7ZKCkrPUzhemSUJeRBlBwcfKVNa1rFaORbQJJJdvjyyMbRzzk/wCe9SW9rNcNMI7FmJwGMinaM9Px9q07DSbfSQX3yiR2AMjDlT6D0FS6WhtLENFCzspdK1+zEsiJ5hG9gdyjJxtPvwa9AkWN13RFQAOmcVyGpR/a5E3RO+xlwwBIBzx+NdFfXCq20oVU8Men4UR0Rz4ibquLe9i3boFTEgDEtuJFWSFWaNSpOQSM81TtCiFiu5YSQpLA4z7n/wCtVia6RJG3xAhehDdau5y21LMbIZEGSqY64zk+/pTDJM0p4ZSCMEHBA/CmQzm4UMIsgcj3HtUkgHmIyAjjuMflQLqV41MYZkR23EkknGDV6K73sFbdvBxtz/ShSU3MPnCjcyleGFLbWu+43RxuPmypDZC/U0rdgbXUrTSR/aJEKkoeQ46qfSkt7OSU7NxZAcA/dwatXkc8QKpHvRz1HJqmszRy7T8vOclu/eltuNPTQ247N4xETzt4YjtUzxBU3oBtAwe2fepLO4823QCTBPvnNWryWFkRGTLMRnAx061enQwcm3qZOckNsP1QEjFSGNXBDbsepq0u0OY88FuKfKCMjAyOg7mkimV+rmOMkgd8Yobytrt2UdupqUEGNmVMYzkZpwiVnwcHjn1+lAilEquCVztJ6mnSxK64RgoXnp1q95YwyDg/wq9QgGOWVXbcO3PIpNC3Kos3IVzHv7cg9fQUlx5ShlVWLcA+aoBB78Vtbo7m0hRLlImjXBR8gA5+8MdazNWIurxShLlEVfMZcbyB96ny21JTbdmbjB0yTjOOw61VmbKAZGCMZ71qSplCDz6/WqTxpEpbAfJ7djVWMosypIsn5sEAce1YmoLE7xkJkDPOPQV0NztZiqDDKO3Ss2CymukD+WBFuKtK3AB60ram8HbU5m8hja2Ebq4jB3LtTr7H2rmNTEkIRIVCl8soRcZB7V6JrKwWkUzNKJHC7QExz7Zrz7WNQk/tUtbJumXhPmwqkjt+NLl1szopS6pDLOz1S9tIpmt3EMmQp25VwOGz78fpXUeKPD8Wj6VAyw3mq6jPbErOJvJW1hAGdqgAnIJHPaohZ+ItM8PpeNe2yHymlEUcmyYow+YqD1Hr79KjtZ7y1hjk8Qy2cUyqsl19smMt3cxZJ/dn+E44wCM1tZK8bGU5yk7pr0LUGkeMLLw8rabdT3ssA8ya0lRJI7eIqQuwnk8ZyAO1JN4B1aXQrKXVtYWC0eWRmjeMpFbHH8XozEAcD8azdV8S3X2fV9R0y8tbm1vmjtm82cma2C/d2rxgHHX2rJsvEviKe6u9RW+dYnnxLGpGxXcHkIc9s84/Ws6koJWZrTjX+JWWvYp63/ZVnZWz6RLI0+Ck0UjFijjncDjGD6dRinwavpmoaLO2ofaRqcVocMmW+0Tbzgk+mDzmsXU9PuIFjkilt5o7glPKD7pFK4yWXsDnr7V3PhvRYdW1trzxRBJZhgu2xtrQxC5wgOAeFRcbST754rGEb9NzqqOMYKTb9evoXPD1x4S0vTdOupb29vVXEk+mxphDNgndk445xt55rm/FWoWmqXU89nZfZQWBhhUYEYz0/wDr1pWGhWUVjNNeXMsDRz/8eqBS7RZ+8p6ZA9fSt2PQvDF9dXEcOp3cAvIm8iSdgUDLj7xABx29z9KpqVTaySMVOnSm3q2eekS2uIms3hkVPm87PGfmBwfYitays7K2dJdUu929kkhNuhG7n0PGPrjpU2qaNdrHdJZ3a+VGg3O7hzI2eFGeW/DoKuaNpEz+HLH7Zp629w7kGQZ3TDPBI7VMIKd2OvNJKz3OotNRiiubuay+ywQzxMZEjkbK8cqpI5B7DtmuofUbI6eVsBc317PHiSIxKd+0hcDB7cYxWbY2NtYrbx3tmbqKVSQLYbWB75U9c+1SxtPZXSaj4d0m4t7YhVkedsxqB6AcEHIJ/Cu6mmkeNU5W7nG634fnvZft0KXE140hEttMx8xWJx3NZ914Qvo72K4vSoM1wNscOE2OTgbiOFX1xXsNk+jWqvdm7W5u8FhG6YDyeuPT2qnqQtppWs0nif8Ad5LkjaWK5Iz6VMsNGTuOni5w0RyXhqJ7XRA2+KWWK7KtBPICEHdh2bn8PmrcttKs4mnluUX7VK3ySStnJzweOvPb3rKj8HtJpt1fWF5bweWc/vxgNgZAB+metQ6U97e29jc2dpFLKsvlIFb5pJB82dvbA6/StFBxVhuspNu5d1jw5BMZ4pVSBrZNxeF93z47p1+bgADua4zVZJ9K8MLo97ZmCR737R5u35mG3HlnHcHnA/GvQbfxBctrlpq0tpEXkBhbC7Gl+baNmc5IPfNcX8WdXuWudO0x1Rb2C4kk2IoAAbufVsc1hUhGCcludNGc6jUHsL4Vt40uEvb1LiVjGAu9PMIUdDgnoAMc+lYGp5u9YneWSR4EjBZJ2GFOei46r6VqzyQxWGnwPb3yXrRF3llcbduDkDAGMnP/ANertvoMKw2085IS4OGYjLIB7dqzleouXY0pzUJOTObt5fLule2VY8oVYjByCMEYrTmuF0qOF7FFFznOWHA/DtW2+gwWtyvllAMZLoNwINV/FGjXIsgVlfyt3mBTjGAOefXHanTpKlDljsW6qnJXM2z8T6hLcFIjJLqj7YIIFQbZVOcgsTkHHT9awPEbXI1mV72zkgv7U7ZlU48thwMkfhzTNbs7E3zR2k7TxpgJI0ZTPAzwen/1qLbT5bOIwXU8kImlXzmfJKjPVh1OOuKcaras9zT2MIvmjsy1ov2fWGuHv4x9qLEhSDhQeeB0rq18EaHN5l3DNEQsZZw/DKf4cEDH51xtmIYrthbzGRVdlE23yx16gHpx2NdTPeodHlt7NGw6h2Z5CAZAMf1olWcFpG7MJxu/degzw0l3pEM0Mdw0to5ZsSfcI77Qf503UbfdcBZDgTSY3SNuUE85Of8APNP0e7kknIYJOSoGHb7vH6D2q1qltKY1a8hDxGKRUO/ZhgM5z3xj8elZYiNWXLKHzRpSai7MxVsJoJQyTYYKcMj8GpLWTeGF1lzuBBPHPcc0uiT3E7NBZi2nuUOxBKflbPQntx0NI1reedcWt7Ai3QOwbB8u727VfI7XRcp+9aRbfU7dbvC+WpTqsnPb0qeJlvILmQFI2iUMqgZZx6KPaseaxsIb+0Etqv7t1EzAs3A75HQeoAqaa8kXU5pLZmESYXKj7g5wpz16Yz3pWstR2TfunQ2SB4IjG7FgBhGBBqbzTJhTs4yCSeh96p2Ek06o80PlyhfuYIz71oOeYyFROBlSvUU1qtDB7gEGFjDiL1Ocr9RT5/NhhHlyFWJA/d9SPWrBgRotpTdKpyG9PU49KfLarbWsMryFmbqQnB+hz0ptCuQpujgKM+8bRjnk8VmXARLgRoodtpPzHkntgd60hbSGbzF+aRAVBHce47VPbIszBLiJCo4XKjco7c+oNS1dBexT0aPbhd8oxwQ2CAf6VrQhDI5Ri2FwNx7+v8qjELx/N/rAOmF+b8fWhs+eskZO3b90/wD16ErCeruOWCRZ/OyGiOBwOAanlkYZRBuLnlVwasW6ErkMSvdR0qUWoQNtUZOScd6dhN33Mr5oGA3FmbJOex/xrSAVRG6Mhk25IIxkUxYQwzj94Rxt5x9amt4w86huVAxjHIosDYoCxjzWIw4yp7j8O9Z15CzsTEBkcZPU++K1rtEYfIi54x9KqRiJJUkfGFPK84/Gm0JdyzbC8WytfsphRNvzgsoO7J5OfbFUNQeWO4drwqZcDoQV/TvVyW7jTcRaW7J1GQQTTEMdy6yiOJFJ2lccD0NOW1kZwTvdo6GVQp2sD9PwrLuiEiUIVLMccVr3bMoUQpv3DnJxtFZT27mQOq+Y5bBbGKpoyizG1EiJuXAOfXFVnlnW3SyS4Hz7ndB3Y9h+HOa057OESRqWAZmIff8AwjI5/OrqQW9jobXyPbySW+4NuIGBjPJ7Y46dc0oxbNHNJI8718QxBRLII0Evlseob5Scg/XH51W0y2s9B0HUNdubKO9IDW6W8pB+Y8bjn0yOnPak1jV7afWNPnnT/RIXRpI1+VVBx19B0yaZq8/2rTtVFxqUEGmR3hWY2ibnuNz8qmTjAUZ5pq1m0brW0H8zkLTWNVuz9is75y9xtgUTsCuN24KC33VyBXoMMXh/XdNm01bhf7Vltkuby7aDMgm3EuBjjAwBgcYPWsia003StF1XVNMheaxvNttbS3kQZ4FK8sflOCSeCB0+tc94K1caNr7zTufslxG0FwI1+fb1+Vj05A6dqxUnTdpvc6p01Wi501bl/P8A4Be8JeE7a2vL7+2tKOqoi5j8i6McaANgs2OT1BA+tWrbwpcQi4a7TyLWa5GGVmKBSeF9yM5ya6fS9c0a9gEomuLe0gCK4WMB/mO0GRs4xup8GtWMkqW1nq8MjxOZj5rYWQj+72zxW3LBpI5p1azk5M878R+FL3SryRYZzqG0kvcWqnao9D3rVjj8SanKA9zIt/co1v5l03CxEAE5/hGABn6V1s2o6gIoYINNuGF/kxAAb5SOWbjkjntxXNm8ubjWZhr7XNugDRPBAPJbaBkJ04ycdaxmoxdkdFOrOcfeS0+8xL6a4i1C7gltw72oW2kjiOEix8u0HJz0OfxqC1gvpmmu4IJRBbKS7xoWVM+voPeqtzb/AGaIyREK2cnqR/8AX+tGg3F/LFciyaaSNk82URuwwqkEkjoenfNRbl3RpKWl47nR+HJ9X0XWLW4CH7VdZeOc7WCL/Qc12V/I+rPHcySy/aI1w0gOAf8AdH49qzNXisorJb+CZZnvLf7SkYcfuRuwFyMAkeg7g1HpUv29YpoJWjilwkmTuwc8k46Dpitoy+wcE3z++drpFwzWghgz9pETYldd7J7D0+neiO6Zb+IXWrOyzBvtUMUYzGMAjOTgDjoOlUtPSO5l8m1lCOpxuEhVlI6Nmuj0bRLKRUgvpUunbcIvtDE8/wAQB7nnv6ZrpjdnJNJas53V4Le4aP7Hdu3nOUjP2ckSE9NpHB6YPpWTPo+yRI7pQssZDPGWwVOe/t347Guxvo7TRr1LW1htrQWse43AP3GJ9+56fjWBrV9JJoZNwJDNGxczcEvk85PU+1EnbcIpvYxvEer22n297ZXkrRtsZAF+b5weFB9Capat4ml8MQXcHh68QoADtbAnJYAZXjk/e54746VZAOu6CLa40e2M8JwbgblYfN97HQH165rJPhGWyjhv79pJi21YpAxGVHb69aTm3sVGlFfEbyaq8Hgy0vtZmlvLlPLa0EYCncRkIzY4wSSe5rzy8Muu+IpZ47SSW6BDJDGzSDOM9Rz35r3rUdO8OXXgZLZf9RJGrK5fMkbZzwT91h/SvFb3wxfaPf2Ukpjv9MnlIjfe0aXGcjaxBGOeSM+lZ1oSbXY6MJVp2d9GX9Bt5fE+oTtfFdL0eKPy0hj/AHro3ULng4zu69BXTwWS+HpotOu5HlsbqETRZwzRS5Bx1+6RySa5Pw3qUWnWmq2d1apbXXmGVU+YFBjGxc9Rjofen6frc1zJ9rkt7lpFfy0jkBzgemeg96yi7ysOcZJvTQ7OBriO5s59PgLW63nlOxADFt2SFXPIx396TxJdSavNqS3VsZIbVXzHbyhWaMDAcr3GcE457Utxr+7TXuo7e3UQFpGt5mJyuMBE44PcmuT8CaxJqGsBtde1jsxuNvtbaYSWJC5xk49Mn6118ia5L7nNzte/bYyLkyJbWtxp17HcrHGHRVTBgYnJUg+/PejSdP1DUbmE3flOjOnLTBS+TyoY8A4z1rrPFFzbpdi00OAQb4SfNQBfNjfr17HFcnqVldrbx72EKnO23Y4OQB8xX3B4PeuWrGNJd9TuoValVb2DxBc3Eut3b4TeZSpjb522gY5Pc8dapWd3FeWk0beelymFwjDYwz0Ix6Y/WmX8c0jxSMGjuZ2z5m3Bf1pxs3Cqo2xuOSc8n61hVm4aX3OulGnNarVHc/DxLPWNH1azt5IoNXEiSpbxjYTGBhtvqTjJroPE4WTRTELQy3kBCzLHhlxgkDHuMHjivINJVYdRaZLiWOaJt2+M7D6HBr1CLRtSuLNpPB2oz3sDYYyKVSaNtuNj9yQOhFb0qya03OXEUVCd3LR9/wDM47SL258NXAvWtLa4tHys1q6DLowwRu6j1HuKZP4hubq3YpaELG7Orc7gvYE+uKr65Z39tNOt8swa24lDjkN7j8agjvZuVS3kkVo2b5Yyeg5/Sud1avRXO2NKlL37akEuuwXN9BEryW0zOyvLKpK4xx09859sVFeXSNelmOxXfBYKdpbvg9x3/Gs8AspuZ7WX7PIWSNtpwWHXB74yKs6dDd3pjs90kkduDIke7KxjuwHbOa0lUurNGU4KD93Y67RNW8uGMsoMyjmRcncPoa6C0v4J5PIWRH2LkgAg4PbJ6/lXLaNAJpJIoXjiWNOZWztJ7L9aW4jEEo+0xvDJjIycEj1B9KzhUla9tCJQjJ26nfWjJGApQkhedxJPXr9MU+OGOWQEBjCv3OcgN3A9DXF2WozxzJcJKZNihPm4+UHpXW2kzK2WRCqjICMDk+p6etbRqKZhODgW1z5wIRgHHJwB+mfaoy6F1ODGTg4cYJ/wqRbnzVBUABflX/65qYSQTIfNZI1xnk8Z9BVWRmJDIyvuyS3tzimy3DtOMIzk56Dofr60sAihdg0qxqpySwwQOP8AGnS6pZRghS00w5UIpOf8+tS5RW7HZvZEtjcGSTZPE8eefmx+fFa0KQyLuEgwOcA4IrAttQ3ufMhJcL868DAHPAPtVtL60JV1Jx/u8j86FUj3CUGX5toYmM8e3AOfesy/1i001TJcTCSRScRoctmkub6Z4Ps8QJZ2xk9xnp7VzmqeHLp71rdNksxGXVD9wnqCa58TiJwjelG5tRpwk7VHYv6T4xgu75IZbcwRy/KGLZHJ71v3QSQmOHceT8wxx/nFc7pnghESJtRupJmQYEScKoznGa6xbcQqFVwqYC88/QGqw6rWftia/s+b90Q21n5hjR23EnC8E9PfvSXcKxsY4UlEwAO4jI+h44rctZoDCmwEMFKjaOF9TmqV45a4VQHY4AYnjtwa6pJJHJGTcrGlLJGCXkG5VwcZ7Gs+eWYM+Amwrn5un1xU+/aAVOcDkH+VUrl3aJuOoPA607kJFK9g8+F5AYgy5AUZy2fb04rD1Le3h57aW+VVZlLqqZZSwGcD0Az9TV6Xej7oidy44FZGogwrncpj6AH9cmobN4xOZmsYoNQkiSZXhYohdujruHUehHX6Vk6jIdGV4btvOhjkaS2iVcLKBjAIIxt6HueMVp34+1agtrZSoFXblwOg7/XFVdc0LU9K8U2UOpI2pWsZM0ZhjZhKvGQSOR05A6U02oXR0QUef3mZWoeLtU8TM0UsEUFuXR/LiyFQqNoODx0HpWx4a0yHUbG9s5zaLKqjyZXY7g2cnAB57DnjmqMEtvd3sstvBM93cu3k28KkhyT788ZqhqaXFlfyRQ4S7hbDzRscE+xxXK3zS55K6OnlVvZwXKV9V0aTTLyRI5Uk2r87J0X2PvTdElvLefdYbo7gKyySHAIVvlP3uCOa0fD9zH9plj1GSL7M8T4eRSwUhTgEAjknv2NZ1kEhvzcS3GVUcrjhlPBXJHXHesedKV3sbOUrODPRLPwnfWUlvf8Ah/VJIZLYBB5sgDAY+baR8uOfu9eanjhRZ7jVtelj1SUqUDT/ACgnoDj+LA/CuPtfEU0NnOsE4SAsfKRjlgvYZPX61malqb3UStNdjH8Ue3r6c12OdOLTRyexrT0k/n1LfjR3aWGOweCOFgdkQAUlBwST9TnrVfQIG0yeCC9it5ndCQqTBy27I2EL0YdfyrmBHPePC8zHEZIX/d696jlb7PNmMnYG4B45odRN2ZssM+XlbPXLUtpUyQ6nCrWJYxypMpDop+bO7HAz6c9ulZXhe9eS2ubu1keKK2ObpCuFRS2FwepJ56DjFc1putPqxjt9RmuLuTG1gXyzpg4GfUVs6BZTSWWqSKrRGOPMib9pmjX+LaOCAcZ9KVS0GnE5bJJxlueiaLcW6wn+zHtZ7uQsV5G1V9SetVNd8b6poWpW1vK2m7DGWDWsYlkiB/iIJxuzx+OcVmeBPCt5NosmoNdwaZZrys88XykngnnHGPwrMv8A4dXEdxDdLrmlaheXLPJHH5/lPKmfvAnjJznaa2jOTgmlqYclJ1HzS0XkYp1x4rn7ZBdyzahNIRP9oQSJKvUE5PXqMYFegSatf+IdKRr+ysrGKGMGBwxAbsRjsPasS3ufCOj6aBpst8mryPJFcXE0al4eM5VOVxkbQc9ya3/D3xBmurOxTUNO06/tixicIFMrbRw7KeB7dutRTXI7ORrWi5RUow276FCHWvPfN3ceQg6rGuTIQMfMPSp38RPJHJBFbxPAyFXR49yjjqOetL4pbS7u1g1G2/cQTyMiKV2hWU8ryPf+dcPr1y2FitHa3tsb3dW654Iz6e1VKfIrtk06Sq2VrGpqsuo6bp8lvp88stlKAzDorGq0/jfUZrS1tb2zt3sISD5JXjIGM/rWbp2qWul3NvLbWctzBLGYrlJ3yNxJwyenbr71tlI4rAXstvbPDuB8tl+YH1q4VOdXRVah7N2kjJgsHu7B7ydPIjLYEqhjs7Dd169q2Z9Ls4pYZlvtSuZAEE1u+6NXbP3VYjIWt3wN4ws7OW+svLfzrzaIoRtAkbdzksflOOnam3Li/tzNaRD5JHNwrNmQYPDehGOMisMRJ0lzRV2zOLblaWiQmqa7barcRWz2y6fPdkRuIx8pwTtbkcjBxxySOamvLTTfDEAh1GO9WSONWsgzJJDIxJ/eBSBnb8pKk46cVQ1nxBcazpz2FzeyLC4ARTCuCOuM4zjPasCbR7mHSovtNwoWLKQxv1wed30zR9Za3Wo40ISSV7eRizSZ1G5vdRvLq6mZjmaYDcw3HaFUcKMY4HFdd4bnm/tCK78to/L3GKV0JVGC9ehzjjj3rn7qCO61SzGnw7Y7tE8mN3yBgDeS3OBkE812enafZWtq0eqT/PES0aFzsZs4zx1/+vWlOftG7rYqrTVJJdWYPiK6trsyf2YknlQpvzKuXLnlnbGQBknjtXMX3y28Mjt++U5+9w4x7dPSuj128stPsrhbS6jKXi7i8EgUhM/cYdjkfd9DXHq1rNGrCaYRKVbYyb9/zcpkHpjqawrQ55LlZ2YdKFO8kamq6g8N2fKS2YzgFNoC8YHy4HSotN1trWfeJxDKvKhGPy9uDUN20cFw6WiGRps5DoowrZ+VQemBx61R1WTR/tFiNJgurcLAFuFCbwZQv38luhY4x2FS6aV7M1i042ktDautQuZ/MmmuZZXkb51fJyPU+vQVBbapdofs9pOISqtl0YghWGGH4jjisuOd3b95woALEdRVy202K4RZ1YqkgzhuprGFR0m2yp0osPEep+ZJZm1toIFt7dYSYR/rGH8bDpuPGfpTNDvdRa31M2oigDYMkuB5jbf4VPYHOTWdq+Ibowxqzu5wDg5FWI/P0uKWIZk3H5js5UHnp27V0QbkuZmFVKNoI7jwNm6RInjVuCzOwzgtx343V1l9aNZacBfyJdWluhUF1x8gzj8eaxPh8v2jSnli83Ep+fcMAkHjiu58qC5spbO9haWKaPylG7leeoPauqMWqZ5tWtapoeWK8NxI32XPkY79jjnp1FX0vZ4YgyTMSAQvyjJ9T/SneIfCFzo482zuGuIAx6HlMdsDn2qfQtPg+W4v42kLANgnCn29681RnzOLVj0nUpuKkndFmLxXIYYo7y1ESsrKGVMBj0zke/WtTS9YtVUy/ZRLLKNpO4NtHXI/yKiTTrBpislntdydhTsPerc+mRGZXW1tolUAKEQqVx3PPJNaKNVdTCUqb0sV9Jthd3k0ly8pywAOcgqRyCT+ArrVs7O3jZTbjHTpyM9c8msu1mnR03Bd3OCAOKv2w8wokvLbuMHGR9K1p04r1Mak3J+RetLKyBLfZIDEo6sCS3fknms5tPt5WnlbUCzSEsiFCNoP+FaNwqINiP8AKDnA5z7GowxiVRLIFVmyAeMCtXFPRozTa1TKkGmKFUm4Dqo2lscfl6Vp2ltFZWzmBGkLnk5+9x/Ko55ERiduyJFwF9B6+9SR3CvaIiMCjYyRweOcZojGMXdCk5SRYLu7qUUKSOd3QflUW0idQdsbEfMMdu1RvKzRsqKxXPBBOKW3S4ab940CQEAjg7gR3NWTtqWLeMESJGUWJQQ6liAWznP4+tEytLfxkH92ANzL3I9aXzH+yJ5Plzqw5fZnJq3ZhZfM3KAy4B2dmI6e9ab6GF7O5nzElVGACeSarTSiRBkYx8pwajcjeHlfBzwuOP8A69RXI+8MkkjuaxuaxRm3WC5UcDmsTWTFdweVKgZS2GAOAfrWrcyqisCASFzwc1iuTIGJQDaSxI7fnWb1OmKOQ1yP7M6SwsyyRqBEVXjAyAD6muo0bxVfXOkm1s/P+2xxbbdkADKzLhu3I9utYfiLLbAo8vJDIdww351zK3mo6feCdn2lWyoVtu0+vtV06ltDaVFTV2bt5FrNhokFwrzHTbSeRWMe1ZYZiMNux8y56c0/XPE95rGn6da2jTwweSkc6SooLsn3WLDlj+VUtN1nUIotXbzLOUXke67Ez/NInXIBwGZTznrzVm8vdNe0s/7PiMM6RbZmLhjI2clgOwxWNS8dmbQjz25o3f8AW5zuvujXcktvZLawkjEauWVeACcnnk/zrPM0ts0YlJZXbapzkKa2JreK9t/3zl0LAbh9e9U9ThUKNhGyM5AHP6VzqSlo0dsWoqxd0K6hsw10U33UMymJZFDREYIO5SOT0xWZcvEb6G5uVkMQlLybMBieo5+tbuqfZWmSPTIWgiYBlWV9xB75NYF/C8UjbyRyDgHpVwdpXJg1NN9Wdn4Q13RYXv7XUrCOV9R2/vnj3PGx4KxjBwTnO4kc/gKzdcPhaxlutMudMu0Y3C/6bHciV4sLgjGACCcZ9Ofaud+0NCqOjGMx4YNnDeo5rGkvhcXrsJJt5beWZsknrnP1rojUctbHPUoRpu6b183udPZWcPljTLrRxbapjEdy0zRFQzAhmU9eOO3BzW4kLW2l2/nyrM+18JDJkrg7dremcZrH0ZF1bU3vL69mmukiDs8rFy5Jxgk+1dFZa8LO3nhjiiGcnDcEt2J9R7VLgqi1OKrNwlruTtY+JdT8OG2tLaQ6d5uzzWZwqgDJcj0B4+tcdNHPbytBd8vG+3JHf1x6V2T+Lr610a4SKWRpDH/r0Izknr0+v0rz/UL9rq4+13Exnlc7nZmyWPSqq2dkjrwDbi1K1masV/brL5cluk9puTzVA+fAPIVu2QaZpd00DsLdBGmSQcc+2T61gwTTkySAfJ0BxnH0rftontnjtwHiSVQ4J43j19x1qORtamtZqKslchuZJXuQZHZlPLDNR3E8k1skCBiqsWyDwK6I2MZt2aNQ0YABb3+tYVxbTQOCELqCcYOMUvYtIzhWUnaxHYNJYTJNdxJcwg5MJYqGGMdRyPwrrodUhvdIjsri2VbXYpyx3OXzyc+nAwO2K5S0nimZorhCPmzkHJoutSePEIhCxqMRsRgk+uaKDlGfLIMQlON1uN1+ye41dUsWw6gE5PP/ANatS31a7023DyswMy4TLHdjpz7cVkW0T6zdLMB9nfdy6fLj8q1bmwjt2ZhK8kYARRJ8xXuSM9M101bPST0OOL1WhJo+p3zRIt/K4toWLQJjKrznkela3i3xRpGqWNnb2oeKUnFwSoO3PUKe/tUtrpVhBY289zqUdwlwocrCrKbdejb8jn0GK891uK2TUZorGQzwI58uQrhm98etJxTskWuWUud9DrdIvtK0PfNC05eSMoQx6Kf4QKpX+vLfXIS3kfDDG5uM/SuTubkCMR3Fpt8olt6k8jgdPXNZkt/vMkccjIe2Bg/nVt8srW0CyqQc2/e6F+SR3neEsrNuIG7p+tbc0P8AZtjD5UzvLIPn3ABRxziqPhu4tbXT5zdW7XF5K6+WGAKbADuBGMntyDxVe4vGvbqJXjFpBGoj2q5YLx978anlg7o0lVry5VJF+S8gMkQUebxgDbg/jV7S7SGTPkrl1IIjwSXz15HTHvWNpio1/DHLMzQmPeBEOTjtn3rqNL82a4AjgMFrn55MhdmO5/z3rlq8lN8r37GksU2rR+8q25RtSWT7JH88flqsxPysTy3BGcDtXVXemG0jWVdogijAGDjp2FVPEWhzWWmRXkN3E5dhlCyhlGMg56GufvdWur+yFtFIHSPAZwOnuampTdRpQ2KVWNlLYZ5Sy3TysSHchtvcqOSKXT5Y5ZLkXKzJEAWO/hicHIx65qokc0LhftUk5YEb1XaqDjoeua27PToLiAou9p2PzsRgKe/WrUWtEYTmnLmOl+G093PdFYZoo4dhmEbccemfX2r1CKS0eZXVnIA++zAnIH8q8us7T7PMI4RIAVyz4yoPf8K1rS9kEG2K4LYypwmBxXXTqKMbM4q1J1JXR3Wo30Lgj93kjb6da5SdDbTtJCqtCuWIzgEn6fjVeNDMC80rksuMcjn6VHb2ztO0bXEktqp3KnGT9ampU5+g6VL2fU14opmhSS4gCOvIwQMCtCJgFIVsr/tDP61iOZSMK2xEwM4ySP8ACrME0katI2WOecNkfl0FZXNmmalqfOXaoKNu52nv+NXiJVKMXVgoywOB+dZMN6CoAXeW5PO3PsatznOdsasQARn+tVcyaLdz5v2cSWu1gozsx96nRPHewLK0YzjkseQPb3psF18pjyqu/RB3ArOuB5DSXQZhtOWX1+o9aG7CSvoWHd0u47Qk42Eox/iTPf3H9atJEqRhQR7fSoGljk8u4Ib5AcBjzzirKDzBGWKlTnIzQkNstqxEQAbIPZqnBCKgzuY92qoXxIAWHljofT2zRmb/AFkLnAPzI/Oaq5DRo2ttEkIX5n3AvjOM/Sp9qWzEw4RWAynv6/WqZlVEieaSQufmBTAC+1Rzv5hLZco/ctzmtOeyMeRyepAQpy5ALHHzKKpzo3znpjpmrMa7IypbOO47VTvQyjcuCp45P8qxLW5jXkS5JwTzzjuPSs03Cqjow+U53D/Z9q2LpHdRkBMjtXPT2e2R/Ndnkfjc3QD0+lQ9zphqrGDqVnc3t3LGJwNPRSdsiBio7BT71gXkIED+bG5JBHocY7V3BUKuxn+XOAQO39a5bXYZHl/0dWeRvukHgfjUr3Tpg29Dk5ZzbuqhiwdRuJGQBUccttcagkU8kccbgQNLCCdmDncQv3jXR2mh3N9JPGkRVjGchpBHuxyQMnnpwO9cxNoUtrLKJoZbfA3KwJ57jI/+vW/L1B1nF2ubF1fDTriazaMySRKY0KdH7g+3r+NUjOlrBMLiP7TdybSoEu0RZ9QB82e3PFZm64tPLmlTBU5U4JDAj+da0Epa086SMb2wuWXp/wDqrKEYpvQupObtysbAlzPdRRQZaZiAit059zwPqak120ubYK99cxvHKoKiPq/JHH5Go7ieZUOzy3Qj51Jzn8KbcSXLzRSS4dsDCtzj6VMZK+xu6U7J3K0Nkz6fcz3AvGiRdsDImYy+f4mPb6c5qTTLiLTrqG9t/Ka4iYPH5iBhkdyDx2raTxxrkdveWMFwkdleHbPAIE2dAMAY+XpnjFYkwieDe6YcHAcDAKnsffNXKcXsOFGo2/aWYQXd8+oyalJHtW6Z8yOmyOQ9SBj3Pb1qfQLR5p3vZ3dp5GOIyM49P1rHeUxahCTE2MkInXcfx7V1WkzLA0UF4u6LkhIjggHnriqtomjgxSXtHFa2JbnT5v7KZpQgiMmc9c+xA+tc7a2qiPBcKEJC+rc9fpXpUdr4amV7jbPFbhx+4lmwQCOenXmuV19dJi1OcaUVhsuil3J+b+LHtU1LpaGuCcfhaMm/Is7ZHgywmGG+TgfQ1atrue8lghmimzbDaFbPHX8hzWRcyvc2nliTzY0clSo6n1NdFoi3U1vFcMwkeVSXcjkY4AP5VGiiufodNT3FddS89yLaLc8u1B1BPANVIruK7GBIrOWKYDdPQ/SoreLTLi4ki1mWSJSw2LbqSWyQCMk4HGTz9K7JvCmm28ynTp5WhIyDMoyOOM4zWtNuaujgnONOykecXlrPa3xCpuD4G8c49q2dTWKbTi0zIzqOFA+6QP51s38MVvO8fmxuF447nvWRfCIhs4IGOQOaicFUa1tY3VaTV2ReG0kXTTEZMea+5gByCBgVLfpHukImGR8rOeKzmaeCdGSUuj5winp7V1On6cXsjLqYRZnX5o2+6B2PuamvThH3r7ijJ35mcrdX05t0s7WeT7KckhGxkkDOfUcVVs8xXy4jV2xnB6ggc/hVswqlzMbdFCKeB2IpjW0iK8qHZJuypz0NRGTpO72NpKNS8SHUm8xVENu0kbn5zn7o9q5u60TULhpjbwpHEqGTLvghR1JrpYGkt4pmlHm8bmbnP/160LWxudSjYRKp2IDtZwCR+PWur20UuZo4a9Fpcqkc/obW0cLRyASywrkvuCZ47EkVGlpJem4aIMkRHzPngZ7VtX2hCC0gLqrsx5WNThD6E9M8Dp2qezju7SzMEkY8sn5MkEr35rKc425ovc7sNOpONpJWKHhDT/7NvJBejey4HzHgBv8A9Veg/ZdMa7uEkYXI2AqI8+Xz1ye2MjHqa4CQ3EF0lz/rGBC5zxitG2v7m2u5YbqRArDcoHGT74rmnRjWqKq3qZ1aHIrRWhqaklnPM7SAqAu1UQ4BOeprMaOK2BWFmQMMOoWr2majbXxjjt4tlztO/e2SmOpOR34xV24lWLHmIk535ZXXkEjuetdiVtnY5m+ljHsjGimOOAsp5BJ5rdsIWnijeRgIs45OM4449apullFCzQSgSKRujcH5vofSrVldLnAhQ46EcisvaRT3NFBtXRspEBbEIxYgkhWOMD3qWybYwGSZcZbBxnmooL1HhleQxhPRQM05bzLCa3KRgg8Hqw+v9apyW9yLPY0EePO4CTAOCxY461PEyq0m1GPUZPT8DiqceqadODulXKjJLghat2k0cyh4AJAwOAOopRlGT0YmmlqgD+apaQgnsqrk1GtyDKYzvMmflQD73/1qvNApADrJ2HT+dFxbh5PlQDHIwetU0K6C2EvmD5WJHG0gAKPWtQTPFMRGfMQcZU4BrJtrpI5jDmRn6Ejt9a1I5NqjoDjoRQiZIfcyvG6MoDEkNwcAfjSOBOMMMnOcY7UZErbQMv2+lPgiKKAp2u3XC5INMm6RPaud7qpYqoAO49FNTR5lBZG9uOP0rPSARuzF8zN949Tj6dqnR4+NrnI4NNbAyZ3wpDKEbI3ehqeGV3wGYADuB0HvVV3+YFfkPr3p0c53ruPmYbO1x1+pouJrQ1i8jQRrBNFECOQ2M9Tzg1VnnCTBZrhJG6Arzn09qJJ4flxZxF88jJ/xqtLcxNISsUYGOgB4NW2ZxTT2JYRhGKOdrcAHtUMqkrwxz29KtBsjAB9jVd1Zs7XAI7VArlWRk8siTG6sC9whYSZ2qTjNbN0kvmZLKR9MVVvI1ltySmSeMdalts2g7HPyD7QMRkDb/e4Arn72b7RIsMRPp0wRXQ3SNJHshk8tgecDPFYl3YC0nDgkvjIP5VlK5102upY024toZo1lkLOOOBwB70Tj7YzW6sWst2WiU7QAerEVQJihLvKY04x85wQTxkVm3cxjfMTMGyBnFbQrNe6KWHU5XRl+I44Le6uFjVgqDCFWyDz156CsmwjnubJiJRLFO2c5+4c9CO1W9XJnhmWRmQOAQeg9jXPQCWyPli4YxO3zhSOR6irtpdCS5ZWfQ2jKAyokQaQLtPIHTk5JpI4nuYIGd+ZQdqA8/WoZ5o53VIlcAKBlxg+9FjC9qxVJG8xlOwbM/jisZJW03O+EpNXaGQotixwy/Kc5cjO7HQUslzIZ9zrgDnkdfeq/2ZmmBZPMSOQeYQccew6nmnarCgWQ207iJnJG77wAA5OBwKHTvqxe1ipcqGyXBuL2B5D/AKpspgdR3zXUC78+MbYUSVeQy9enf2rm9Mi06+m35ul2Lkhscvk4Ax2xjk1tW1va2dopWd5rpyd6ldoQdhnuf0omnFJXscs5Rm7xRajgi1H91cXKwNghvOOF/wA+tchf7rSeNCRMVOB3UgHj8K09Ya4mSKEAL5nA28Zxnr69evtWMxaRikoOchSTwBWkZ82ooUnqr2LYvGuIDFII0uJJSQUiChsnnJH4YFbkV1d2emW8CMWkLkMoPaq32CGCR4PPglaI4keNgwJ7YPce9WLZJGk3xxtgjG3nGPWs684y0RUINq1xbjkxFjukyCOOARU9xrmoeThmXGMbumfqabJbF5xuZAo464p8Vsjo3nbyqnAAHB96xipXsjVxgkrq5nJe3U10kjKCCc7vX8a01ud+EmKqCM9KcY41KrwqjtjNRzRQO2RjceelaODS0InUTsrEMEWZxIZACrZUn29a0NQ1+4jyY9r7Fyw7Cs/+z7kxO8P+qAz8pGR+FYt6t0vBVpTnDA85UHOKpQVRWkjOUlHVams+pSzNNM7LGGGNhXr71ftZbFreNrZmd8H931we5ya5kq82CCY1BO3J5+mO9b2nWCnmaSRGz1UjA9qirGKVp9C07q8eo6WNYYSwJ2ggseqioY7t5SVhlMYTkbe/40us2UhhDvOWgDcjOPzxXL3H2kmUW4dbVDlmUcfnW0XCcbrYyk22otHSyXqiIKJ/3o+bO4kDjrUlvqYuICs3lsQMkjuPXFY2mwGTTt8iuq/ws38VNkDW7L+7wzgpx1APU4rB0oyfKbwl7NXZp39xmFFhZCvoAM1Qmia7iZnOxk+5649RVq1svMxuXYG4Bx1pGcRSbpQ21TgnHPHrTUY017uoSrOpokWLJzcSQ7jFbpEvzyKNrSY5GfU1uwTQmKRGkkkkKAAgdT7msshp41lQbmOSDjFWbaJ9mAcDuaaqvqYezXURfK8wCRiozwSatRxssi+XleeMmiC1USAuMrnjdzir1/ElrDuEnJ7HnNZKOjctjdyV0kQS2N0Y9yqmM/xNj8KswRzR2/8Aq84645q5pzQT25IBcgdSOh+lblpBlN2xioAbtyauNOMleJhKo4vU494Jo7YuwYA9e2Kk0x5nlQWzymQ8ADNd3ESyeWQhH8QYDH0qWCKODdIECE9So6VzvB3e5f1yys0SQtNFEAqlmxkj3pXWSX5cAE99wpsUhdyI+RjJYc1OtxGg2y/KD3xzXdbzOK+pWtrdon+UMAOOufz5rRDeWuRknsGFVPNgKb1BY55qK4uWEZMZAIG5SxzSQ27s0Wl2lcDFTrIrKSSN3Q96yXcmFWJLMRz2x7VMG2LvZdqHHU9ad9RNFyWZUOXwDjjAxVRJRHIXQZY8nJ6+9VTcsZJF4cdQCM8U9l2gOoyDwwI6UMa8yX7SZLhGYgf0q/HMI3QsDJHnJTOM1jylbiEoNrHI+71FShhkKTkkdDwRSTsPc6e2QTKs0WnnYQcMZcfzqneRCK8dRB5fyglA2c/jRa3Mfk2qyiYI0TW5YLw2eQV9Tz0qHU5Qs5RWYGNQmXGCSB1NaNqxzxvzGko+fk8dajmGCArbe54pJ5ArKN/JqpcvwMMdwpEoS7DYLZUduuKypfNEgK/dOcjNXJiXi2dcnrVSUbBwR6kE0mbQ0MPU7gI8Pybmkfy9oIyDTdRjy5mnAK7fmw2dh6Yp95Aq3AkfKSLyrDnB9ayNTmKwxrbyb0YfvcDA3dzWS+J3Oha2sZ1/Ok7rGoyid25aqGrW0QkFwzNgfebn+VRu4+0KZEZSehPGaeLp5U8lF3KDj6e5puPU6U3HYyZUDwyG4h3hk3IwbJ2nPX0rnTmKVXaNdo4jjC9B64rtRJaRXBHVVX5xtxk/4Viaq8MEjCOFtrHJAHQex/pWqkklqZSacnoZcRFzcooVmHTH9K1gggh3SExzhcIUHJ57nvVbTrN1uty5Qr82S2cH0NX7mYvJveIb92Dt+bP4dqwqqbl7ux1KrHlUTPtXmnvJSRJKzNt2quW2gcmrKaTHc2LFruNIVkCFMAODznB9OatWui3V7IZEVVIYKzK2NuRWy3h9NNtS0kkcj7gEQrnPqc9jXSk+U4J1Ep2i7XMuCy8nzEiUyAYVFXAH41twWcKIvmRIzEDknj/61GnQ+Siq55PPJq9FFv2hR8p9eaxbuzVlR7WK5nG+JSYwcBf8e9RSeGoblcf6s5zjFa4spvOUBSXx69v6VoLYvlQ79B27H+tG4/acuzOdtvD9rbqwJ3YPGRw1OlshGgZYzuA5Ge30rrBpkasCGJU/eI4qjqMLsW2ALjhWB4A+tCgkT7Vvqc/9iQnM8a5PTI6VG9sI32kqFPetdYAzKLhyxA9c0S2Tn5/Kwp6ZOcU1oPn7s5qWDzJz5YwB+VUJYzAzkkF8ZyBxXSLp7ElMspY4LdKq3elH/VkkgjO4cGm1cfMr2H6BcQx4ieGOdJCM56j8f6Vj3IHnyb9pyzHj/PNaMOnmAABipOScHp/9ekFlG8ZdCvIySQSQaq+iI5UpNrqc9JaRtIshQnPUCpWlvIIGSC4XB7MMsPxq20Cg7xx2JqVrBX+YrnBxz60e71Hy22MKae7ZEhnaNUXljtOWqCOf/SpIF2zK6gBegBroJNP81H3YGenbNNi0wocHr16ck1S9nayRHvp3uUkhvp7aQJGqQxkA47mmhX8zJjaNsdDzXQwRvFAVb7hOcY4zSyJ51wW8nAHTGcVlJJK0S73fvHMZuJ7pVIkwoxu7Z9quJZs2AUJbqD2/H1roEs1c5CquO2KsRwKSBJtz/EBwPwqeRJWKU0jnYrRx0zxgBfSriSrCBlgD9av39l5uPKRwM5DDrT/sHyJElvuwMbuKwle+hopxtqNSeJozJ5mTjris+533OM73xxwCa6mx0tZEwyLwOQBgVvWdjBEEWNFVeuDTlQnNpt6ELExp7K7OX8L6VNEjz3COqyDaFPXHqa6mKP7NCAw47AVeaPaqbecnnNQ3EJ3KGYspPNdEKfIrI5alZ1JczIFlcMwHCkZB29qhluiiOpO/PBL9vwqSWKR0Ma4CdASeTSW1vGCMBTznLjPbpRqTdFSFZXmVQp2nndjvWoIV2A7upzgnODSPKPLUAbcNkgcA02VvM2lTx656U7aCcrjLmSRUZRDkE/M3c0lmhA3uOvG0jtUxfC4SIsT1OePrU3CKvHbnFK3UOfQoXon+2o0KhVP3s96txk7dsrsU6kH5gPwqTz1xtVSzZ4J5phCllwx3HjA4p2sLmvoSTSW8SjcMrjO7+VRzXCCPiUA9xSMFEe2ZV56ZHSqRVF4VdzD+VDBakv7tn3R5UPkbsmrEPDbpNj4GATyay0yWLsWAB7VoWtwYtrxllkU5DdKTiNuxvl4bu2tVS5W38tNpRlYr1zlcd6g1K4ikuRudtioqBnGC+B1NPjuvsdlaiXVLqJpU3LEkQYKufrUWtWqvvmF29xJEEdjIm35W+6Qe9aa2MFZMsTxb/wB4ZWBHAxVaRpNmIyrH1IwasKx2fM24dciomkVGAPU+gqWUiCDzm/16BT7HINNlVIyWIBJ9s1PvXOSfrTZpFkA2Y24xQh31MDWCW+YdMdDwa5u8lMQMoyFxgDtmuuvoQc5OWIrm7y2O07gRt5x61m1qdVOSaObNvAz/AGi4ubrDEYUdF9cZzmn3lzDjcsTKx5LABeOw4qW4UBiYyGx7d6babjuVoA4PHznt6VdjVrqZsjQhhM+4KvG31+tBMF0uHlIjXlULHLH8K0xaxSW7CQeQVHyq+MtWWLWKFCI1HXOTn9KdkRzOTIZTFs2IjoucFguWJxT1tpRbx7JGYHvjjGalIEczMVVycZyvepLdpJkberIpJ2oRgAewpbFWNLR5fJcI+dvXaOBmp9Xn+0XIBYhF4X1NZ+no2GwCMeorVtId4ViMMfl3Gn7R2sQ4KMuYbaCSRycqFxkluDitS1UuVKK3lgfNtJ6jtU8Glwkh2TcV7Vr2kRAIMYC9QqjipRM5oqWqs5O1BG2eOO3vV20tQqkynv8AdFWVhCAHGfWlRlIw4IweOKpIy5uw5FwMs4CD2qjdWsUhYgAHOfatEvvzzwD2quyMSQ3CHjjrTsSpWM6KFWcIUBA9eKW4hPlkxnIJA9hUtyFgV8SEN1X61TtjcspLSLg8AY4pNFc1yMQsJSdm7pxmnvbxyK7lOc8g1ajkVDgp85OWyOp9qeEllV32fKBzk4GPWmkHOYJtuXLKBnP0xVGSFhHjG1AcbR61qu/znyydpPTGc0s8TN8kP3m7etIv2hgG2G0qAWBP3cZq7b6acZOVXOMk/pV6HT1V1aV9rhtrLjj6ZrTNtbKjmAic5H3jnFHKDqmb/ZBIRQi5OQB3oTSZmXaVJbsPStmOT5FEmN7dx0HtSI5V90koEY7EUWRnzsxJdN2qF5IbjJ6VVgsyGADZ7EV0bwqylmnB3c4xxUeo2MflqIfvg/MT0AocRqp0MSS3AOw8EcZxUcGntIxc4LA/LgY4rRFo6ygsTwM4PerUIX5RxgHtRZD57bFUQBIxv+9ntUscXllQq5yMH2rQEK4JUL70MAqkEDFMjmK0UqjOcg56VaijR2V9zZ7YOKquix/OTuJ7H0p1vOWwQMf7PcUCbNJ2CqdpIPXrTHkUKfmJOMk1W3o7jeGAGe9SMUHH8PtTJI0JADc4zkc0Qswdvlwp7k96imnSM4LcHoaUyxmNfn5oY7kw8xcbsMOo4psLsrNlQAeCVpiXStER6cZPWoUlKM/Uj0A4NKw7mizBYVKknPGM1DvB+U8Hr1qm0rhT0PoMc0xJQz/vRxj0wDQSaHmKrZGMjnOc06R1BLKoy3Q96pxEyNj5doHrTHWEsVDtuHoeaVguXmmVoyjdccd6z1DozoTz2BNEhaMhkbJHvyKBI2QSFIwc8GlYadhkLkBtqvkdc9DTjPIwHIVSPrVOVv4c/fz35BqDzTEhjAPPJOc0+UrmudvpsyJp9t/a0lkUwTbiZGZwuf8AZ7Z9ah1O+uIWngujbnzSr+ZF0ZAPlA/2axrXULKa1tk1K2mkeBPLSSKUKWXJIDAjtnqKXW5ZXuovOihhTyU8qNDuCR4+Xmqb0Mkve1OiVt6qVJC+mKRynUjp+lVVJQsEOTj5vzp2Rt96SGSGTDkNg461FMxRyUwRimTnAwep9KhVyABk/j1osUhHlaQERqVIPU1lX9uWDHcVz1z0/Ktgh1GQmQffkVRmVd4MjdSeD60mioSsctcWYjkY7d2R17VSlBjyOGJ5HPeuqkijkYrwxx8uDWZd2i5A25f6VJ0xmnuc9cGS5cbiVCjrjqaY6GM/eDP2FbH2LeCNpJ7e1IlkfOyRuI/I0IvmRjGJt67k5Jyc8fjVgW8sjhNhKtkZP+NbZshJ8x2hmAGBVyCzABzu3Y59qq1yHVSKdnYbWAdhwOmOorWjsYCmcfNnk5OadFAjrtC8547fjVpIXjUjduUc8ryKLHO6lx9tHjARuB3NXeMHBZT7GqsbAYIYYqVWwvBJJqkQ2RpclZcSkgHox6GpPOSWQBXUr1pxXcnzYyeTmoyQo2qOncUxXLe5DGcHHoc1Xebn7w59OhqMsWGwce9RMVQgA8dOaQkJNMS+CQAf0qDJSXco4PanTBCyktyDUc2SjFDuIHT0pJlDlla4l8sqNg5PNSyMsUYGflxnHrVS2fbIc43EetLO2RyefcU7CvdkeQTkAD+7UzySRozGTYzjAAA3Y789qrPIMqDggdKgaYTSkK5APUP3oQ73Lyyr5CIEfcWPJ6mrEUUIidxnI6bscVlrJtA2nJIzuxwKVpnRG82MtzyM00hF6GY5IkJK5woqcN1BKqvYlqyfOMxwo28cf7NM3yA7CwJJwGA/nRYRrO8SoF37iDkH0oZwsW5XJJ9eayzKF+8Rn2qRD8uXHPpnrQkBMLl3lJYhFqbzBjqrD2PSqRQMD8vXtSxIQSpXCEfwnvRyhzGiZw0QwdmOA1BlZiVbacD86ogkkBhjHY0ocq3y9e1PlFzEwZATuY5B4HaljYBxgEHqT61H5hI+YDdSqwwMfmaagS6hYdsjuO5qq00ikngD6dKhlZ3BCHPv6UJG5GHJJxVchPtAdfPbc/OOnt71ICI02gdvSkQFVJPVfWmO6K43ugA6Zan7MTq2LGQ3zIMD2prOoG0DnNVDf2kbHzLqIL3AYVUl1vTVYZvExz05p+ybJddGrvYqSePcUwu5yoztx0rHfxJpg5FyTgdlNV/+Eu0xdwPnfgvWn7Fk/WIrqdGgkxktjPYcUbjt4AJ+nWuaPjLTDyEuCR2AxUEnjew522s+Meop+xZLxUe51SvxkjBPpSSEEAEnP865A+OLTHy2MuOuNwFKfHVvkFNPcn3ej2IvrUe51XlhzudcN70yBIVuIxdGQW+fm8sDfj2zxXJyePGKjy9OQY7l6k0rxPfarqltZ2lhAZ52CLukIA9yewHWn7EPrSO7jHh1lwjawAvGQI+ag1u6hvL2NrMSiCOFIl80Dcdoxk4rKbxB4fUeRJrEfmKcForORo8+xzkj3xWdrWtzaZdi1e3hlVkWWKeFztljYZVhx39Kfsb6C+sre53z7om+Xle9KJDleec88VGZGdQcYHv1o80DAOPxrksdw9kffvbBx2pxn3YKgZxzmoZbj5tignjmq8gI+cLz/OgC/G28He3BqKdQi/J8yk5NRpKrKMZJ96lQoy4YkCgT0KN1FAUJKbc984qoyvFwql1Hqf61qTxiT5VXK+tUy3lHYRlR3zRYpSKEsYAPYdgBT4Y+Q2BgenpVlnVznC+gUUkKspKsMZ557fhSsHOwVBJ95Sqjp71aiRFACt+dA27hjmovPQPtc9fb+tNITlcsqVznGfpUnm552/gahaVc/uyOlRiUnI4z6mnYnmJmjDZIABJ54qRVVeEA49KpGY79uSfoacWIxzj196aQuYmllAGM4b+lMEoGdvzH09ahcq4yDg1Gz4IVMZ6k0WC4+4uZFjYhMP8ApUSTq6fOfn9KZ8xYlm+UfpTXjjZ9360WHzFhVhCLuJJHPJprTbgdqBV9e9Qp8icgtn+KnqgzjBIx69KaiLnI3k2EFiQTUTO7MTldo7nnNOdSXOeAPelZVx1wKrlJ5yI4I+Yj8BTXdMcOB607yirA8MD0xViKPAyYximoA6liK0uRGVYFTjkbgMU9yZG3HLbu9Eoh3nOFb3NQvcwxvh7iIDr16VSptmbrIUowYiMkN796TdkkuD8p5x3NQtq9lE2fMMhPHA4qpca/bhSsMLk+ucVapNkPEJdTS2K5Lj14pyuS23B4PXFYLeIpQP3dsgx6nNVptd1CUYBRB7LVKiQ8SjrEyc8fpzT9oVTlgo9zXCTXupSH5rhx9OKqTG7kzvmlYd8tVKgZyxXY9CMtvGC0k8eOn3hVGbWtMhJDXKkgdF5rgJLeQ5zk596IrFyc7T+VV7FGbxUnsjrW8U2K7tokdh3AxVaTxbI4AhtRjuWasMac2/7pJ+lW4tOkI4X9Kv2cUZ+3m2SzeItQLfuxFEPYVUk1fVHPNyy+uBirq6TMeqmpBo82PucUcsSXOb6mLLdXkw/eXEpz1+aoHWRlyXcn3Y10X9jTY+5T10OZuCh59qq6IfMzlRAc5x+NBt/bpXYJ4enPRDn6U9/Dk39w/lRzIOR2OOWA9hSPaknkV2S+HJgM7aVvD0xH3D+VJy7DUHbU4lrYr0HvVV4DuOBXeP4dnPRKrP4dn5/dk0rhyHDmNgeQcUqxksMiutn8O3C/8sziof7BuP8Anm2PpRcFF31OaaHC+4q1pM93YanbXVgG+1QuHjwu7JHbHf6VrzaJcBeI2H4Uy2s76yuobi0MsVxGwZHjyGU9sUBZ3NMXVnIxkl8DDzjySkk6Rk/7vYe2azdavLvUNSM17ALdwixpCsZRYowMKqg84Art9RXx1qFwLuCHVrVXRd8cczBS2OWVTyoPXFcrexahdXckmpvcS3a/IxnJLjHY55oi7FOJ6Wsi7Bj7x5qN3y3JyevNUxJhSoIHbNMZsR8ktmvMse3cutJ85wMg9hTgw4IBIHqaz1mBGAMdsHrS7yCPTr1osK5eEy7+mMelOkmz06VmNcHJyRj9ajacHOT+Ap2Fc1Tdrjv9RUDTbmAOSPXFUUlGPlH51G91IvQAj0Bp2Yrl4yKr5LAe56UjyLvLCQEniqSSiUHKkY7Gh8joF2nsRmhRYORpRzZVlAGfWoBJubbvO6qMVy0RKxwdepBFEM5bcxyPUelUok3LTPhtrbR74wakju0X5RggccmqpkyBkgE9KazEfeZMU+UTkXjKjk7R+ANL5g9fwqgjkt8oXHrUmw5JyAKpQJ5y55gAOGHtxUZkJUjjGetVSyrHlpQAOoY1Qn1e3h4VgfpVqmyXVS3NHLnG/OPbpUwIAUjJA79q54+ISrHy4Sw7ZqnJrF9LkKAi54ABq/YsyeIR2AdACSTj+VQy30EKMWmQMevNcVK95OTmSTJ9KiXTbp2yA5+uatUTJ4nsjq5tdsYxhXL/AEFUZvEmQVit8+hNUoNEuGIxHjNaMHhud8bhV8kER7ab2KDa5eNxGsaj6VBLf30/DTMB6LxXUW/hZ+A2fetK38JDAG08ULlXQV5s4OJJZGy7OxPuasJZFsfLnnriu/i8LKp4XNaVt4bRQMqM/Sm5dhckmebxaY7nGz9KtR6LI/8ABivTodBRcfLz9Kvw6NEo+4PyqW2UqZ5Unh+Rgfkq1B4Zduq/pXqaabGD90flVuKyiUfdouP2aR5anhY4wUOfpUv/AAinynKmvTvs0YJOBTGiVsgCgOVHmKeElZvuE/hWhD4RjAGUrv47VAOlOdVHAAxRcfIjiE8LxA8IPyq7B4aiUcoK62ONepFPJXHSkNJI5f8AsGIYASpBocWPu81uSECgEMOKB6GEdEiB5UVOmiwgA7RmtoICO1MJ6igNDMGmwgY2ChtNi/uitMD160EcZphcy/7OixjA/KlXTYiOFBq6Bk+1WrcKMEigLmYmjRnqgqUaFDnlBWyJAvAFDMTzSGmY7eH7d+Ngz9KZ/wAI1B/cWt6MnHWpFagTsc03heBv4B+VJaeGoLW8hnEQJjbd0rq05z3qZVXIJHFNiOGu/B9vJMZTeNuJzubduqjrWhR3V4JCGfbGsZdx8z4GNx+tehTYfKy4z2PpWdqMYaQdOFHNJDdjxMyrzwM1GZ3PQgCqbSbW5Yt9KR5Rx8rYrJYeRr9Zj3LMsjM3MgUe1N85j0YkVWWTJ4jPPJ5pTKVHCD86f1dk/WY9y0JBjGck0m/qQT171VDycHYKk3SHsM0/YMX1hFnf0HTNMMgzheDUW6UtyBTGEu4PnBo9iJ4hFyPIB4yalG444wKyDNc5I3H04qREuZR1f8Kr2JP1lPY0GIQZyvsM4qAzhcebtB9QaqjTLh25Dmr9v4fnlPKnn1FHs0gdZvZFeS6txHkyufTHaq5v48YWN5CO5NdLD4TdgNy8CtCDwqiD7n50+WInKbOGa9u3GIUEYqExajcnDO+D6cV6db+HIk5KCrkOjRKfuiqVl0JcZPdnlkeiXUh+fcfxq7B4Zlbqpr1OHTI8/dFWxYRqOFX8qfMxey7nmdt4UJI3rwa2rbwjGAMoD9a7JYFRhwKuRhSvA5qW2XGmjj4vCsK4yg49qsx6BCmBsH5V05zngUqqNuSDmi41FIwotIiX+EVbjsYkB+UflV9iN2MU/ClaB2KaWyE4CirK26gDAqRAo6CnbyBjAApDGrCoxnrTwi54FNB5pynHNAFhIwOccUsmBxjFMRiRxmlbOM9aBDduD607HP4U9R7Y+tOZc9qYMiC54oKBeeKlOF60xhnnvTEMAJNI8RyKc7hemSaaHOaQDhGxFRlCDg81aiPHzUPjGTikBmzp6VCGK5C1oS4I7c1UeLk0wGCXORnmkDEn+KnrDjqaULhqAFAJAzQSB1zUmDUbx7uhoAdGQT04NWFAAHFMhg9eas7ABjtQBDzmpBuxUiKB2qUjA5oC5CpOKA9SKo55pHjweOtAiW3yTirGO1U4gQ2atRsDxnn3oYDZFyDyBWfOpDEEVfkba3f6Y61TuW+YD0FA2eDADI4p5iUgUUV0HGhEjUdqd5akkY4FFFQNCmNducdKfFGpbHrRRQNFlYEx0q0lrEQMrRRUdC0XLfT7cnJTJrTtrC3z/qxRRS6GkEaFvY24wdgrQt4IlHCCiikaIuCNBgbRSBFLYxRRQikK6gDgVEAM0UUxMkQ07PIoopCIZRip7YAjNFFAE9NbgYFFFAyup5ocnKiiigRPCOtSOBgD1oooERD7xqVVG0UUUwJ0UYFP2gmiipGIvJ5p0h2qcUUUxEDMfWkBOKKKp7AKVBIp4UUUVIDz8uMU1+etFFIBoUYzQyjAoopsCBhzimYGaKKQEo4TPemH79FFMC1GBzTm5xRRSAkiHIHrUxQUUUxCIoJqRkXaeKKKABFGTgYob5ckdaKKAK8zN03ED0qtjJJNFFA2f//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This purulent ulcer with a ragged and violaceous border is consistent with pyoderma gangrenosum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pyoderma gangrenosum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This purulent ulcer with a ragged and violaceous border is consistent with pyoderma gangrenosum.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31880=[""].join("\n");
var outline_f31_8_31880=null;
var title_f31_8_31881="Indications for valve replacement in aortic stenosis in adults";
var content_f31_8_31881=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Indications for valve replacement in aortic stenosis in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/8/31881/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31881/contributors\">",
"     William H Gaasch, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/8/31881/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31881/contributors\">",
"     Catherine M Otto, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31881/contributors\">",
"     Gabriel S Aldea, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31881/contributors\">",
"     Edward Verrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?31/8/31881/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?31/8/31881/contributors\">",
"     Susan B Yeon, MD, JD, FACC",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?31/8/31881/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jun 18, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;In individuals with normal aortic valves, the valve area is 3.0 to 4.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    . As aortic stenosis (AS) develops, a minimal transvalvular pressure gradient is present until the orifice area falls by more than 50 percent. In general, symptoms in patients with AS and normal left ventricular systolic function rarely occur until aortic stenosis is severe (generally defined as a valve area &lt;1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    , usually accompanied by an aortic jet velocity &gt;4.0",
"    <span class=\"nowrap\">",
"     m/sec",
"    </span>",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    mean transvalvular gradient &gt;40 mmHg) (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"mobipreview.htm?17/33/17948\">",
"     table 1",
"    </a>",
"    ). However, many patients do not develop symptoms until obstruction is even more severe, while some become symptomatic with lesser obstruction, particularly if there is coexisting aortic regurgitation.",
"   </p>",
"   <p>",
"    Surgical replacement of the aortic valve and transcatheter aortic valve replacement (TAVR) are the only effective treatments for severe AS. Although there is some lack of agreement about the optimal timing of surgery, it is still possible to develop rational guidelines for the evaluation and management of most patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Particular consideration must be given to the natural history of symptomatic and asymptomatic patients and to the operative risk and the outcome after surgery (",
"    <a class=\"graphic graphic_figure graphicRef81124 \" href=\"mobipreview.htm?3/63/4094\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/53/30551?source=see_link\">",
"     \"Natural history of aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The factors determining the optimal time for valve replacement in AS are discussed here. The recommendations are generally in accord with the 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    valvular heart disease guidelines with 2008 focused update (",
"    <a class=\"graphic graphic_table graphicRef68344 \" href=\"mobipreview.htm?29/2/29740\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]. Recommendations in the 2007 European Society of Cardiology (ESC) guidelines are similar but differ somewhat in their recommendations for asymptomatic patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/4\">",
"     4",
"    </a>",
"    ]&nbsp;(",
"    <a class=\"graphic graphic_table graphicRef57704 \" href=\"mobipreview.htm?25/63/26620\">",
"     table 3",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Issues relating to the methods of valve replacement (eg, mechanical versus bioprosthetic valves), the medical management of asymptomatic AS, and valve surgery in elderly adults are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/37/11865?source=see_link\">",
"     \"Surgical valve replacement in aortic stenosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/62/2025?source=see_link\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/36/34377?source=see_link\">",
"     \"Valvular heart disease in elderly adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CAUSES AND IDENTIFICATION OF SEVERE AS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Causes",
"    </span>",
"    &nbsp;&mdash;&nbsp;The two major causes of true nonrheumatic AS requiring valve replacement are a bicuspid aortic valve and degenerative disease in a tricuspid valve.",
"   </p>",
"   <p>",
"    The relative frequency of the different lesions varies with age. This was illustrated in a report of 932 adults with isolated nonrheumatic AS who underwent operative excision of the stenotic valve; none underwent mitral valve replacement, none had mitral stenosis, and none had undergone previous aortic valvulotomy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/5\">",
"     5",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21706?source=see_link&amp;anchor=H4#H4\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\", section on 'Etiology of valvular AS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The causes according to age at the time of aortic valve replacement were as follows:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Among the 7 percent of patients who underwent surgery at &le;50 years of age, approximately two-thirds had a bicuspid valve and one-third had a unicuspid valve.",
"     </li>",
"     <li>",
"      Among the 40 percent of patients who underwent surgery between the ages of 50 and 70, approximately two-thirds had a bicuspid valve and one-third a tricuspid valve; a unicuspid valve was rare.",
"     </li>",
"     <li>",
"      Among the remaining patients over age 70, approximately 60 percent had a tricuspid valve and 40 percent had a bicuspid valve.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Identification of severe AS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Severe AS is generally defined as an aortic valve area &lt;1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"mobipreview.htm?17/33/17948\">",
"     table 1",
"    </a>",
"    ). The aortic jet velocity is generally over 4.0",
"    <span class=\"nowrap\">",
"     m/sec",
"    </span>",
"    and the mean transvalvular gradient usually exceeds 40 mmHg (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"mobipreview.htm?17/33/17948\">",
"     table 1",
"    </a>",
"    ). However, many patients do not develop symptoms until even more severe valve obstruction is present, while some patients become symptomatic when the stenosis is less severe, particularly if there is coexisting aortic regurgitation. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/11/1208?source=see_link\">",
"     \"Aortic valve area in aortic stenosis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21706?source=see_link&amp;anchor=H21#H21\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\", section on 'Other clinical manifestations'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Occasional patients who appear to have severe AS (eg, aortic valve area &lt;1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    ) have a low gradient (mean gradient &lt;30 mmHg) across the aortic valve that can reflect one of two different abnormalities:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      True stenosis with secondary left ventricular dysfunction induced by a severe stenotic lesion that reduces the stroke volume and the transvalvular pressure gradient.",
"     </li>",
"     <li>",
"      Pseudostenosis in which there is both moderate AS and a low cardiac output due to myocardial disease that is unrelated to the valvular lesion. The calculated valve area may mistakenly suggest severe stenosis in this setting because of valve area equation limitations when applied to low flow rate conditions",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Distinguishing between these disorders is important because surgical correction of the valve lesion in pseudostenosis is associated with a high mortality rate and is unlikely to be beneficial. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/14/35047?source=see_link\">",
"     \"Low gradient aortic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     SYMPTOMATIC PATIENTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Indications for surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Angina, dizziness or syncope, and heart failure (eg, cardiac dyspnea) are the primary manifestations of severe AS, usually occurring with exertion. Average survival after the onset of these symptoms is only two to three years, with a high risk of sudden death (",
"    <a class=\"graphic graphic_figure graphicRef81124 \" href=\"mobipreview.htm?3/63/4094\">",
"     figure 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]. As a result, symptomatic AS is an indication for valve replacement (",
"    <a class=\"graphic graphic_table graphicRef68344 \" href=\"mobipreview.htm?29/2/29740\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21706?source=see_link&amp;anchor=H13#H13\">",
"     \"Clinical features and evaluation of aortic stenosis in adults\", section on 'Symptoms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Although randomized trials comparing surgery to continued medical therapy have not been performed, observational studies have found that corrective surgery in this setting is almost always followed by symptomatic improvement and a substantial increase in survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/1,6-11\">",
"     1,6-11",
"    </a>",
"    ]. The potential magnitude of these benefits can be illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective review of 99 elderly patients with AS and, in almost all, New York Heart Association class III or IV, follow-up at 55 months revealed that 91 percent of survivors were in NYHA class I or II (",
"      <a class=\"graphic graphic_table graphicRef52683 \" href=\"mobipreview.htm?3/2/3117\">",
"       table 4",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a retrospective study of 144 symptomatic patients, survival at three years was 87 percent in 125 who underwent valve replacement compared to 21 percent in 19 nonoperated patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/8\">",
"       8",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A problem with such retrospective observational studies is that the better outcomes with surgery in symptomatic AS could represent selection bias (ie, healthier patients are chosen for surgery). Nevertheless, it is generally recommended that",
"    <strong>",
"     virtually all",
"    </strong>",
"    symptomatic patients with severe AS should undergo aortic valve replacement. A possible exception is the rare patient with end-stage left ventricular dysfunction that is usually due to coexisting coronary disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Survival after aortic valve replacement",
"    </span>",
"    &nbsp;&mdash;&nbsp;Operative mortality (in-hospital regardless of timing and 30-day regardless of location) for aortic valve replacement (for any indication) with or without coronary artery bypass graft surgery (CABG) was reported for 2002 to 2006 data from the Society of Thoracic Surgeons (STS) National Cardiac Surgery Database [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/12\">",
"     12",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For isolated aortic valve replacement, the operative mortality rate was 3.2 percent. Adverse event rates ranged from 1.5 percent for stroke to 10.9 percent for prolonged ventilations.",
"     </li>",
"     <li>",
"      Combined aortic valve replacement and coronary artery bypass graft surgery (CABG) is associated with higher operative mortality and adverse event rates than isolated aortic valve replacement. Mortality was 5.6 percent and adverse event rates ranged from 2.7 percent for stroke to 17.6 percent for prolonged ventilation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A variety of factors affect survival after aortic valve replacement for AS. These include patient age, left ventricular function and New York Heart Association (NYHA) functional class, the presence of low gradient disease, and the volume of procedures performed at the hospital [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/12-14\">",
"     12-14",
"    </a>",
"    ]. In addition, the in-hospital outcome is worse in patients with",
"    <span class=\"nowrap\">",
"     emergency/salvage",
"    </span>",
"    procedures, recent infarction, reoperations, or renal failure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/12,13\">",
"     12,13",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H12\">",
"     'Risk stratification models'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Age",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic valve replacement is performed in patients with a wide age range, but the proportion of elderly patients undergoing this procedure is increasing. Age is NOT a critical factor for outcome, as older patients generally tolerate valve replacement surgery well. As an example, a retrospective review of 1100 patients &ge;80 years of age reported a 30-day and all-cause mortality of 4.0 and 6.6 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/15\">",
"     15",
"    </a>",
"    ]. After the first 30 postoperative days, 70 percent of deaths were due to noncardiac causes. Actuarial survival at one and five years was 89 and 69 percent, respectively. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/36/34377?source=see_link&amp;anchor=H2#H2\">",
"     \"Valvular heart disease in elderly adults\", section on 'Aortic stenosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The impact of age and other risk factors on survival after aortic valve replacement was analyzed in another study of 2359 patients who underwent a first valve replacement, 39 percent of whom had concomitant coronary artery bypass graft (CABG) surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/16\">",
"     16",
"    </a>",
"    ]. Mortality within 30 days of surgery was 5.6 percent. The observed survival at 5, 10, and 15 years was 83, 63, and 46 percent, respectively. During each of the first 12 years of follow-up, the mortality was higher than expected in a reference age- and gender-matched cohort in the general population (",
"    <a class=\"graphic graphic_figure graphicRef57742 \" href=\"mobipreview.htm?23/32/24077\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Factors associated with mortality included advanced NYHA functional class (III or IV) (",
"    <a class=\"graphic graphic_table graphicRef52683 \" href=\"mobipreview.htm?3/2/3117\">",
"     table 4",
"    </a>",
"    ) and preoperative atrial fibrillation. Patients in the oldest age group had a decreased observed survival, but an excellent relative survival, suggesting that age was not a risk factor.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Left ventricular function",
"    </span>",
"    &nbsp;&mdash;&nbsp;The outcome of surgery is in part dependent upon the state of left ventricular (LV) function. Both systolic and diastolic dysfunction are independent risk factors for early and late mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/17\">",
"     17",
"    </a>",
"    ]. The results of valve replacement are similar in patients with normal ventricular function and those with modest depression of contractility (ie, left ventricular ejection fraction [LVEF] between 40 and 50 percent). The depressed ejection fraction in many, if not most, patients is caused by excessive afterload that is immediately corrected by valve replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/18\">",
"     18",
"    </a>",
"    ]. Diastolic asynchrony is normalized later when hypertrophy and fibrosis regress [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In comparison, patients with severely depressed ventricular function (ie, LVEF of 20 to 35 percent) may not experience complete resolution of symptoms after valve replacement. However, survival is still improved in this setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/6,19\">",
"     6,19",
"    </a>",
"    ]. This was illustrated in a report of 154 patients with an LVEF &le;35 percent who underwent aortic valve replacement; simultaneous CABG was performed in 51 percent. The following results were noted (",
"    <a class=\"graphic graphic_figure graphicRef77139 \" href=\"mobipreview.htm?24/47/25341\">",
"     figure 3",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/19\">",
"     19",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Thirty day mortality was 9 percent; multivariate analysis identified significant coronary disease (&ge;two vessel or left main) as the only predictor of mortality.",
"     </li>",
"     <li>",
"      Five year survival was 58 percent; multivariate analysis indicated that the only predictors of mortality were significant coronary disease and a lower preoperative cardiac output.",
"     </li>",
"     <li>",
"      NYHA functional classification improved by at least one class in 88 percent of patients and by two or more classes in 66 percent; an improvement in LVEF occurred in 76 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h3\">",
"     Low gradient aortic stenosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with AS and left ventricular dysfunction may have a low transvalvular pressure gradient despite significant valve narrowing. Such patients are said to have low gradient AS, which is defined as a transaortic pressure gradient of less than 30 mmHg and a calculated aortic valve area &lt;1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    in association with low flow [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/14/35047?source=see_link\">",
"     \"Low gradient aortic stenosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some patients with low gradient AS have true severe AS, whereas others have \"pseudostenosis,\" with a low transvalvular pressure gradient because of the combination of moderate AS and low stroke volume. The distinction between true stenosis and pseudostenosis is made by evaluation of characteristic changes in hemodynamic and structural measurements in response to pharmacologic interventions that augment stroke volume. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/14/35047?source=see_link&amp;anchor=H6#H6\">",
"     \"Low gradient aortic stenosis\", section on 'Differentiating true stenosis from pseudostenosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Patients with low gradient true AS have a high perioperative and postoperative mortality. Nonetheless, surgery is still recommended in most patients because valve replacement is associated with better outcomes than continued medical therapy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/20\">",
"     20",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?24/57/25494?source=see_link\">",
"     Dobutamine",
"    </a>",
"    echocardiography is helpful in risk stratifying patients with severe true AS and in determining the appropriate therapy. Patients with contractile reserve in response to dobutamine have a better outcome after surgery. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?34/14/35047?source=see_link&amp;anchor=H11#H11\">",
"     \"Low gradient aortic stenosis\", section on 'Predictors of outcome from surgery'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h3\">",
"     Hospital volume",
"    </span>",
"    &nbsp;&mdash;&nbsp;An important consideration with regard to the short-term outcome after aortic valve replacement is the volume of procedures performed at the hospital. The magnitude of this effect was illustrated in a review of the Medicare database [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/14\">",
"     14",
"    </a>",
"    ]. The adjusted in-hospital and 30-day mortality were inversely related to hospital volume, ranging from 7 percent in hospitals performing &gt;199 procedures per year to 9.3 percent in those performing &lt;43 per year.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Risk stratification models",
"    </span>",
"    &nbsp;&mdash;&nbsp;The most effective way of stratifying operative risk is by using one of the available validated risk stratification models. As noted above, a variety of factors affect the risk of mortality after aortic valve replacement. The risk models are helpful in the evaluation and counseling of individual patients and planning perioperative care. Models have been developed to estimate risk of in-hospital mortality and complications following aortic or mitral valve surgery with or without coronary artery bypass graft surgery (CABG). These are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/5/7252?source=see_link\">",
"     \"Estimating the mortality risk of valvular surgery\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h1\">",
"     ASYMPTOMATIC SEVERE AORTIC STENOSIS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Role of careful monitoring",
"    </span>",
"    &nbsp;&mdash;&nbsp;With infrequent exceptions, such as patients undergoing coronary artery bypass graft surgery or surgery on the aorta or other heart valves, the 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines on the management of valvular heart disease concluded that valve replacement should not be routinely performed for isolated severe AS in asymptomatic patients (",
"    <a class=\"graphic graphic_table graphicRef68344 \" href=\"mobipreview.htm?29/2/29740\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On the other hand, careful monitoring is required since asymptomatic patients with severe AS have a low rate of survival free from valve replacement (56 to 63 percent at two years and 25 to 33 percent at four to five years in two studies) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. This is associated with a progressive reduction in aortic valve area that averages 0.1",
"    <span class=\"nowrap\">",
"     cm",
"     <sup>",
"      2",
"     </sup>",
"     /year",
"    </span>",
"    and a progressive increase in aortic jet velocity that averages 0.3",
"    <span class=\"nowrap\">",
"     m/sec",
"    </span>",
"    per year. Risk factors for progression include small valve area, left ventricular hypertrophy, and moderate to severe valve calcification. Outcomes worsen as AS progresses and a markedly elevated peak aortic jet velocity (&gt;5.0 or 5.5",
"    <span class=\"nowrap\">",
"     m/s)",
"    </span>",
"    is an independent predictor of cardiac mortality [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/53/30551?source=see_link&amp;anchor=H21857697#H21857697\">",
"     \"Natural history of aortic stenosis in adults\", section on 'Risk factors for progression'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Surgical versus medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Consideration of surgery in an asymptomatic patient with severe AS requires an appreciation of the relative risks of surgical and medical therapy. The surgical mortality of aortic valve replacement varies widely. If it is not well under 2 to 3 percent, then the operative risk clearly exceeds the risk (less than 1 percent) of sudden death in an asymptomatic patient who does not undergo surgery. Furthermore, valve replacement does not abolish the risk of sudden death. In one report that retrospectively analyzed the postoperative course of 599 patients, the late annual mortality was 3.6 percent; sudden death accounted for 24 percent of these deaths [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Insertion of a prosthetic heart valve is also associated with appreciable morbidity. Among the complications of prosthetic heart valves are prosthesis dysfunction, paravalvular leak, thrombus formation, arterial embolism, endocarditis, and the problems associated with anticoagulation. The incidence of serious complications depends upon the type of valve and a number of clinical variables, but significant complications occur at a frequency of at least 3 percent per year, and death due directly to the valve occurs at the rate of approximately 1 percent per year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/25-28\">",
"     25-28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thus, even if surgical mortality can be minimized, the combined risk of valve replacement and the late complications of a prosthetic valve exceed the possibility of preventing sudden death in a truly asymptomatic patient. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?24/57/25497?source=see_link\">",
"     \"Complications of prosthetic heart valves\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Very severe AS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Improved outcomes with aortic valve replacement in patients with asymptomatic very severe AS were suggested by an observational study [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/24\">",
"     24",
"    </a>",
"    ]. Very severe AS was defined as an aortic valve area of &le;0.75 cm",
"    <sup>",
"     2",
"    </sup>",
"    (critical AS) accompanied by a peak aortic jet velocity &ge;4.5",
"    <span class=\"nowrap\">",
"     m/sec",
"    </span>",
"    or a mean transaortic pressure gradient &ge;50 mmHg. Early surgery was performed on 102 patients and a conventional treatment strategy (surgery for symptomatic AS) was followed in 95 patients.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During a median four year follow-up, the operated group had no operative mortalities, no cardiac deaths, and three noncardiac deaths while the conventional treatment group had 18 cardiac and 10 noncardiac deaths.",
"     </li>",
"     <li>",
"      For 57 propensity score-matched pairs, the risk of all-cause mortality was significantly lower in the operated group than in the conventional treatment group (HR, 0.135, 95% CI, 0.030 to 0.597).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The results suggest that surgery can be beneficial in patients with very severe AS with low operative risk. However, the study was limited by nonrandomized assignment to early surgery or conventional therapy.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Possible role of exercise testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Exercise tolerance testing has been proposed as a possible method of risk stratification in patients with severe AS who are asymptomatic with routine activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/2,29-32\">",
"     2,29-32",
"    </a>",
"    ]. The ability of exercise testing to identify asymptomatic patients with severe AS who are likely to develop adverse events was assessed in a meta-analysis of data from seven studies with a total of 491 patients (mean age 50 to 66 years) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An abnormal stress test result was defined as development of symptoms such as dyspnea, angina, syncope or near syncope during exercise; a decrease in blood pressure or a &lt;20 mmHg increase in systolic blood pressure during exercise; &lt;80 percent of normal exercise tolerance; OR &ge;2 mm horizontal or downsloping ST segment depression during exercise.",
"     </li>",
"     <li>",
"      In patients with normal stress test results, no sudden deaths were observed after one year of follow-up. In patients with abnormal stress test results, 5 percent had sudden cardiac death.",
"     </li>",
"     <li>",
"      Adverse cardiac events were observed in 21 percent with normal stress test results and in 66 percent of those with abnormal stress test results.",
"     </li>",
"     <li>",
"      No complications from stress testing were observed.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    On the other hand, exercise parameters did not add predictive value to a multivariate model in an earlier prospective study of 123 asymptomatic patients with mild to severe valvular AS in whom yearly echocardiography and exercise testing were performed for a mean of 2.5 years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Based upon the available evidence, we do not recommend routine exercise testing to estimate prognosis in asymptomatic patients with AS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/2\">",
"     2",
"    </a>",
"    ]. However, observations made during exercise may be of some value in providing an exercise prescription in patients who might otherwise excessively limit their activity [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/34\">",
"     34",
"    </a>",
"    ]. It may also be helpful when the history is equivocal as to whether the patient does or does not have symptoms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines concluded that the evidence was less well established but that exercise testing may be considered in asymptomatic patients with AS to elicit exercise-induced symptoms or an abnormal blood pressure response [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]. Exercise testing should not be performed in symptomatic patients.",
"   </p>",
"   <p>",
"    If exercise testing is performed, the blood pressure should be carefully monitored and the test stopped if the systolic blood pressure falls more than 10 mmHg or if the patient develops symptoms or complex ventricular arrhythmias (",
"    <a class=\"graphic graphic_table graphicRef62494 \" href=\"mobipreview.htm?12/7/12411\">",
"     table 5",
"    </a>",
"    ). Patients with reduced exercise tolerance (inability to reach 80 percent of the predicted normal level of exercise), a blunted blood pressure rise (&lt;20 mmHg), or symptoms that might represent an inadequate exercise-induced increase in cardiac output may be candidates for valve surgery because these findings suggest that the patient is symptomatic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Due to the combination of left ventricular hypertrophy and diminished coronary flow reserve, the development of ST depression during exercise is a common finding in adults with asymptomatic AS and has no apparent prognostic significance unless the patient has evidence of coronary heart disease [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Possible role of brain natriuretic peptide",
"    </span>",
"    &nbsp;&mdash;&nbsp;Plasma concentrations of brain natriuretic peptide (BNP) and N-terminal pro-BNP are increased in patients with heart failure and have value in both diagnosis and prognosis. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19818?source=see_link\">",
"     \"Natriuretic peptide measurement in heart failure\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?7/23/7544?source=see_link\">",
"     \"Evaluation of acute decompensated heart failure\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among patients with severe AS, plasma BNP and N-terminal pro-BNP concentrations are higher in symptomatic than asymptomatic patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/35,36\">",
"     35,36",
"    </a>",
"    ], come down after aortic valve replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/37\">",
"     37",
"    </a>",
"    ], and, among asymptomatic patients, higher values are independently predictive of symptom-free survival [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/38\">",
"     38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The predictive value was illustrated in a report that evaluated 130 asymptomatic patients with severe AS (mean aortic valve area 0.64 cm",
"    <sup>",
"     2",
"    </sup>",
"    and mean transvalvular gradient 64 mmHg) who were followed for one year (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"mobipreview.htm?17/33/17948\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/38\">",
"     38",
"    </a>",
"    ]. Patients with a plasma N-terminal pro-BNP &lt;80",
"    <span class=\"nowrap\">",
"     pmol/L",
"    </span>",
"    (normal approximately 10",
"    <span class=\"nowrap\">",
"     pmol/L)",
"    </span>",
"    had, when compared to those with higher values, a much higher rate of symptom-free survival at six (88 versus 58 percent) and twelve months (69 versus 18 percent).",
"   </p>",
"   <p>",
"    At present, it is premature to recommend routine measurement of plasma BNP or N-terminal pro-BNP in asymptomatic patients with AS. However, in a patient with equivocal symptoms and severe valve obstruction, an elevated value suggests that close follow-up is needed.",
"   </p>",
"   <p>",
"    One potential limitation to BNP measurement in patients with AS is that exercise limitation in the setting of left ventricular hypertrophy may correlate more closely with cardiac output than with pulmonary venous pressure and BNP [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/39\">",
"     39",
"    </a>",
"    ]. More data are needed to define the values that correlate with severity and progression to symptoms and the values that might promote consideration of valve replacement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Major society guidelines and summary",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic valve replacement is indicated for symptoms due to severe AS, but should not be based solely upon the calculation of a severely stenotic valve (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"mobipreview.htm?17/33/17948\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/1,3\">",
"     1,3",
"    </a>",
"    ]. However, there are some settings in which valve surgery is recommended in asymptomatic patients, such as severe AS with an LVEF less than 50 percent or in patients undergoing coronary artery bypass graft surgery or surgery on the aorta or other heart valves and severe (",
"    <a class=\"graphic graphic_table graphicRef68344 \" href=\"mobipreview.htm?29/2/29740\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]. Aortic valve replacement is reasonable for moderate AS in patients undergoing coronary artery bypass graft surgery or surgery on the aorta or other heart valves.",
"   </p>",
"   <p>",
"    Both the",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    and European Society of Cardiology guidelines have attempted to identify other asymptomatic patients with severe AS who might be at high risk without surgery [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. The",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines concluded that the evidence was not well established for aortic valve replacement in certain other settings including the following (",
"    <a class=\"graphic graphic_table graphicRef68344 \" href=\"mobipreview.htm?29/2/29740\">",
"     table 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with an abnormal response to exercise, including development of symptoms, blood pressure fall, inadequate blood pressure rise, or markedly impaired exercise tolerance. Exercise testing should be performed cautiously in patients with severe AS [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/30\">",
"       30",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Possible role of exercise testing'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Patients with a high likelihood of rapid progression, as determined by moderate to severe valvular calcification, age, and coronary heart disease. Another possible indicator is a rapid increase in the aortic jet velocity (&ge;0.3",
"      <span class=\"nowrap\">",
"       m/sec",
"      </span>",
"      within one year) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/22\">",
"       22",
"      </a>",
"      ]. We suggest that evidence of rapid progression might be particularly important in patients who live in a remote area, far from medical care (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/53/30551?source=see_link&amp;anchor=H21857697#H21857697\">",
"       \"Natural history of aortic stenosis in adults\", section on 'Risk factors for progression'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Patients with extremely severe AS (aortic valve area less than 0.6 cm",
"      <sup>",
"       2",
"      </sup>",
"      ), mean gradient &gt;60 mmHg, and aortic jet velocity &gt;5.0",
"      <span class=\"nowrap\">",
"       m/s",
"      </span>",
"      in whom the expected operative mortality is &le;1 percent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Patients in these subgroups almost always have symptoms or develop symptoms after a brief period. Thus, careful monitoring is required if aortic valve replacement is not performed.",
"   </p>",
"   <p>",
"    Once the decision has been made to replace the aortic valve, the choice of valve varies with patient age and other factors (",
"    <a class=\"graphic graphic_table graphicRef63902 \" href=\"mobipreview.htm?9/61/10204\">",
"     table 6",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?11/37/11865?source=see_link&amp;anchor=H3#H3\">",
"     \"Surgical valve replacement in aortic stenosis in adults\", section on 'Mechanical versus bioprosthetic valve'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h1\">",
"     AORTIC VALVE REPLACEMENT AND CABG",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are two settings in which aortic valve replacement and coronary artery bypass graft surgery (CABG) intersect:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients who are candidates for aortic valve replacement in whom coronary angiography demonstrates significant coronary artery disease that could be corrected at the time of valve replacement. The role of coronary angiography prior to surgery and the indications for concurrent CABG at the time of aortic valve replacement issue are reviewed here. (See",
"      <a class=\"local\" href=\"#H2055876\">",
"       'Candidates for AVR who may require CABG'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Patients who are candidates for CABG who also have AS that might be corrected at the same surgery. This issue is discussed below. (See",
"      <a class=\"local\" href=\"#H2055709\">",
"       'Candidates for CABG who may require AVR'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2055876\">",
"    <span class=\"h2\">",
"     Candidates for AVR who may require CABG",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h3\">",
"     Coronary angiography prior to valve surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Some patients require cardiac catheterization to assess the severity of valve disease for decision making about the timing of aortic valve surgery. As an example, catheterization is appropriate if there is a discrepancy between clinical and echocardiographic examinations with regard to the severity of the stenosis or if echocardiographic data are nondiagnostic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Despite the limited indications for cardiac catheterization to assess the valve disease, most patients require coronary angiography before aortic valve replacement because significant coronary disease is common in these patients, and about 40 percent of those undergoing valve replacement require concurrent coronary bypass grafting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Most of these patients have angina, but this symptom can also be induced by AS alone. Thus, symptoms do not predict the presence or absence of concurrent coronary disease and the ECG and noninvasive stress testing may be nondiagnostic in patients with left ventricular hypertrophy [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]. The likelihood of coronary disease increases with age. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?1/62/2025?source=see_link&amp;anchor=H11#H11\">",
"     \"Medical management of asymptomatic aortic stenosis in adults\", section on 'Coronary artery disease'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/36/34377?source=see_link\">",
"     \"Valvular heart disease in elderly adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    and the 2007 ESC guidelines on the management of valvular heart disease recommended coronary angiography before aortic valve surgery in three settings if they are not severely hemodynamically unstable (",
"    <a class=\"graphic graphic_table graphicRef66360 \" href=\"mobipreview.htm?29/4/29772\">",
"     table 7",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Patients with chest pain, other objective evidence of ischemia or a history of coronary disease.",
"     </li>",
"     <li>",
"      In patients at risk for coronary disease, which was defined as men &ge;35 years of age, premenopausal women &ge;35 years of age who have coronary risk factors, and postmenopausal women.",
"     </li>",
"     <li>",
"      When a pulmonary autograft (Ross procedure) is considered in patients in whom the origin of the coronary arteries was not identified by noninvasive testing.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The evidence was considered less well established for performing coronary angiography in the absence of these indications when cardiac catheterization is considered necessary to confirm the severity of AS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h4\">",
"     Noninvasive coronary angiography",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon these guidelines, many patients without significant coronary disease will undergo coronary angiography. Better methods are needed to identify patients at low and moderate risk.",
"   </p>",
"   <p>",
"    A possible alternative is noninvasive coronary angiography, which may be accomplished using computed tomography (CT) or magnetic resonance imaging. The current utility of these tests as an alternative to conventional selective coronary angiography is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?20/26/20906?source=see_link\">",
"     \"Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Data are limited in patients with AS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/40,41\">",
"     40,41",
"    </a>",
"    ]. The ability of CCTA to exclude significant coronary artery disease using a 64-slice scanner was investigated in 70 patients referred for cardiac valve surgery, 31 of whom had AS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/41\">",
"     41",
"    </a>",
"    ]. The prevalence of significant coronary artery disease, defined as the presence of at least one lesion with stenosis diameter of &ge;50 percent, was 26 percent. The sensitivity of CCTA was 100 percent.",
"   </p>",
"   <p>",
"    Further study is required before this approach can be recommended.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h3\">",
"     CABG at the time of surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines reached the following conclusions about CABG at the time of aortic valve replacement [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      CABG was recommended in patients with &ge;70 percent stenosis of major coronary arteries.",
"     </li>",
"     <li>",
"      Among patients undergoing CABG, the weight of evidence favored use of a left internal mammary artery graft for &ge;50 to 70 percent stenosis left anterior descending coronary artery.",
"     </li>",
"     <li>",
"      CABG was considered reasonable in patients with 50 to 70 percent stenosis of major coronary arteries.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2055709\">",
"    <span class=\"h2\">",
"     Candidates for CABG who may require AVR",
"    </span>",
"    &nbsp;&mdash;&nbsp;Among patients with AS who require CABG, hemodynamic assessment of the severity of stenosis can help determine if a combined procedure with aortic valve replacement should be performed. The 2006 American College of",
"    <span class=\"nowrap\">",
"     Cardiology/American",
"    </span>",
"    Heart Association",
"    <span class=\"nowrap\">",
"     (ACC/AHA)",
"    </span>",
"    guidelines on the management of valvular heart disease recommended concurrent aortic valve replacement in patients with severe AS (eg, aortic valve area &lt;1.0 cm",
"    <sup>",
"     2",
"    </sup>",
"    or aortic jet velocity &gt;4.0",
"    <span class=\"nowrap\">",
"     m/sec)",
"    </span>",
"    (",
"    <a class=\"graphic graphic_table graphicRef65280 \" href=\"mobipreview.htm?17/33/17948\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The decision in patients with moderate AS (aortic valve area 1.0 to 1.5 cm",
"    <sup>",
"     2",
"    </sup>",
"    or aortic jet velocity 3.0 to 4.0",
"    <span class=\"nowrap\">",
"     m/sec)",
"    </span>",
"    must take into consideration the natural history of the disease. Studies in which serial testing was performed have identified two groups of patients: one in which there is a decrease in effective valve area of 0.1 to as much as 0.3 cm",
"    <sup>",
"     2",
"    </sup>",
"    per year; and one comprising more than one-half of patients in which there is little or no progression over a three- to nine year-period. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?29/53/30551?source=see_link&amp;anchor=H2893326#H2893326\">",
"     \"Natural history of aortic stenosis in adults\", section on 'Progression of asymptomatic AS'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Thus, some patients with moderate AS who undergo only CABG will progress to severe disease. Valve replacement at this later time is usually associated with a higher risk of mortality than initially combined surgery. In two series with a total of 229 patients who underwent aortic valve replacement after prior CABG, the early mortality rate was 13 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. In one of these series, postoperative complications included worsening heart failure in 35 percent and perioperative myocardial infarction in 13 percent but long-term outcome in survivors was favorable [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/42\">",
"     42",
"    </a>",
"    ]. However, some centers have not noted an increase in early risk with combined surgery (7.4 versus 6.3 percent) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/44\">",
"     44",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Because of this usual increase in risk, some surgeons recommend valve replacement at the time of CABG in any patient with moderate AS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/43,45\">",
"     43,45",
"    </a>",
"    ]. The possible efficacy of combined surgery was addressed in a retrospective study from the Cleveland Clinic of 207 patients who underwent CABG and, on preoperative echocardiography, had mild to moderate AS [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/46\">",
"     46",
"    </a>",
"    ]. Moderate stenosis, defined as a mean transvalvular gradient of 30 to 40 mmHg or a valve area of 1.0 to 1.5 cm",
"    <sup>",
"     2",
"    </sup>",
"    , was present in 71 patients (23 percent). The following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Perioperative mortality was similar in the 129 who underwent CABG alone (3.9 percent) and the 78 patients who underwent combined CABG and valve replacement (3.9 versus 3.8 percent).",
"     </li>",
"     <li>",
"      Among the 129 patients who underwent CABG alone, 21 (16 percent) subsequently underwent aortic valve replacement at a mean of 6.2 years after the initial surgery. The rate was higher in the 23 patients who had moderate stenosis at the time of the initial operation (30 versus 13 percent in those with initially mild stenosis).",
"     </li>",
"     <li>",
"      Among the 71 patients who initially had moderate AS, there was a significantly higher rate of survival compared to CABG alone (42 versus 78 percent at a mean follow-up of about six years, propensity adjusted relative risk 0.43, 95% CI 0.20-0.96). There was no survival benefit from combined surgery in the patients with mild AS.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The 2006",
"    <span class=\"nowrap\">",
"     ACC/AHA",
"    </span>",
"    guidelines reached the following conclusions, according to the severity of the stenosis [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The weight of evidence was in favor of concurrent aortic valve replacement in patients with moderate AS.",
"     </li>",
"     <li>",
"      The evidence was less well established in patients with mild AS who had findings, such as moderate to severe valve calcification, suggesting possible rapid progression of the stenosis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    We suggest that, among asymptomatic patients with moderate AS, valve replacement at the time of CABG should be considered in those in whom rapid progression seems likely due, for example, to moderate to severe valve calcification or preexisting evidence of a rapid increase in aortic jet velocity of &ge;0.3",
"    <span class=\"nowrap\">",
"     m/sec",
"    </span>",
"    within one year [",
"    <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/22\">",
"     22",
"    </a>",
"    ]. There are no prospective studies addressing this issue.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h1\">",
"     MEDICAL MANAGEMENT IN PATIENTS AWAITING SURGERY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The limited role of medical management in patients awaiting surgery is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/43/41654?source=see_link&amp;anchor=H22998847#H22998847\">",
"     \"Medical management of symptomatic aortic stenosis\", section on 'Medical management in patients awaiting surgery'",
"    </a>",
"    .).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/53/36690?source=see_link\">",
"       \"Patient information: Aortic stenosis (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Aortic valve replacement should be performed in essentially all patients with symptomatic AS. Surgery in such patients is associated with marked reductions in symptoms and subsequent mortality. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Symptomatic patients'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      With certain exceptions, valve replacement should not be performed for isolated severe AS in asymptomatic patients. Certain high-risk features have been noted above (",
"      <a class=\"graphic graphic_table graphicRef68344 \" href=\"mobipreview.htm?29/2/29740\">",
"       table 2",
"      </a>",
"      )&nbsp;[",
"      <a class=\"abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"       3",
"      </a>",
"      ]. The threshold for surgery may be lower in such \"high-risk\" patients with critical valve areas of &lt;0.75 cm",
"      <sup>",
"       2",
"      </sup>",
"      than in those with valve areas of &lt;1.0 cm",
"      <sup>",
"       2",
"      </sup>",
"      but &ge;0.75. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Asymptomatic severe aortic stenosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      High risk patients require careful monitoring and almost always develop symptoms after a relatively brief period. (See",
"      <a class=\"local\" href=\"#H19\">",
"       'Major society guidelines and summary'",
"      </a>",
"      above and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?29/53/30551?source=see_link\">",
"       \"Natural history of aortic stenosis in adults\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/1\">",
"      Freeman RV, Otto CM. Spectrum of calcific aortic valve disease: pathogenesis, disease progression, and treatment strategies. Circulation 2005; 111:3316.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/2\">",
"      Otto CM. Valvular aortic stenosis: disease severity and timing of intervention. J Am Coll Cardiol 2006; 47:2141.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/3\">",
"      Bonow RO, Carabello BA, Chatterjee K, et al. 2008 Focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. Circulation 2008; 118:e523.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/4\">",
"      Vahanian A, Baumgartner H, Bax J, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology. Eur Heart J 2007; 28:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/5\">",
"      Roberts WC, Ko JM. Frequency by decades of unicuspid, bicuspid, and tricuspid aortic valves in adults having isolated aortic valve replacement for aortic stenosis, with or without associated aortic regurgitation. Circulation 2005; 111:920.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/6\">",
"      Smith N, McAnulty JH, Rahimtoola SH. Severe aortic stenosis with impaired left ventricular function and clinical heart failure: results of valve replacement. Circulation 1978; 58:255.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/7\">",
"      Murphy ES, Lawson RM, Starr A, Rahimtoola SH. Severe aortic stenosis in patients 60 years of age or older: left ventricular function and 10-year survival after valve replacement. Circulation 1981; 64:II184.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/8\">",
"      Schwarz F, Baumann P, Manthey J, et al. The effect of aortic valve replacement on survival. Circulation 1982; 66:1105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/9\">",
"      Lund O. Preoperative risk evaluation and stratification of long-term survival after valve replacement for aortic stenosis. Reasons for earlier operative intervention. Circulation 1990; 82:124.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/10\">",
"      Kouchoukos NT, D&aacute;vila-Rom&aacute;n VG, Spray TL, et al. Replacement of the aortic root with a pulmonary autograft in children and young adults with aortic-valve disease. N Engl J Med 1994; 330:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/11\">",
"      Horstkotte D, Loogen F. The natural history of aortic valve stenosis. Eur Heart J 1988; 9 Suppl E:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/12\">",
"      O'Brien SM, Shahian DM, Filardo G, et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2--isolated valve surgery. Ann Thorac Surg 2009; 88:S23.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/13\">",
"      Ambler G, Omar RZ, Royston P, et al. Generic, simple risk stratification model for heart valve surgery. Circulation 2005; 112:224.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/14\">",
"      Birkmeyer JD, Siewers AE, Finlayson EV, et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346:1128.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/15\">",
"      Asimakopoulos G, Edwards MB, Taylor KM. Aortic valve replacement in patients 80 years of age and older: survival and cause of death based on 1100 cases: collective results from the UK Heart Valve Registry. Circulation 1997; 96:3403.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/16\">",
"      Kvidal P, Bergstr&ouml;m R, H&ouml;rte LG, St&aring;hle E. Observed and relative survival after aortic valve replacement. J Am Coll Cardiol 2000; 35:747.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/17\">",
"      Lund O, Fl&oslash; C, Jensen FT, et al. Left ventricular systolic and diastolic function in aortic stenosis. Prognostic value after valve replacement and underlying mechanisms. Eur Heart J 1997; 18:1977.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/18\">",
"      Villari B, Vassalli G, Betocchi S, et al. Normalization of left ventricular nonuniformity late after valve replacement for aortic stenosis. Am J Cardiol 1996; 78:66.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/19\">",
"      Connolly HM, Oh JK, Orszulak TA, et al. Aortic valve replacement for aortic stenosis with severe left ventricular dysfunction. Prognostic indicators. Circulation 1997; 95:2395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/20\">",
"      Pereira JJ, Lauer MS, Bashir M, et al. Survival after aortic valve replacement for severe aortic stenosis with low transvalvular gradients and severe left ventricular dysfunction. J Am Coll Cardiol 2002; 39:1356.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/21\">",
"      Pellikka PA, Sarano ME, Nishimura RA, et al. Outcome of 622 adults with asymptomatic, hemodynamically significant aortic stenosis during prolonged follow-up. Circulation 2005; 111:3290.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/22\">",
"      Rosenhek R, Binder T, Porenta G, et al. Predictors of outcome in severe, asymptomatic aortic stenosis. N Engl J Med 2000; 343:611.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/23\">",
"      Rosenhek R, Zilberszac R, Schemper M, et al. Natural history of very severe aortic stenosis. Circulation 2010; 121:151.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/24\">",
"      Kang DH, Park SJ, Rim JH, et al. Early surgery versus conventional treatment in asymptomatic very severe aortic stenosis. Circulation 2010; 121:1502.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/25\">",
"      F&ouml;ppl M, Hoffmann A, Amann FW, et al. Sudden cardiac death after aortic valve surgery: incidence and concomitant factors. Clin Cardiol 1989; 12:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/26\">",
"      Murphy ES, Kloster FE. Late results of valve replacement surgery. II. Complications of prosthetic heart valves. Mod Concepts Cardiovasc Dis 1979; 48:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/27\">",
"      Bloomfield P, Kitchin AH, Wheatley DJ, et al. A prospective evaluation of the Bj&ouml;rk-Shiley, Hancock, and Carpentier-Edwards heart valve prostheses. Circulation 1986; 73:1213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/28\">",
"      Hammermeister KE, Henderson WG, Burchfiel CM, et al. Comparison of outcome after valve replacement with a bioprosthesis versus a mechanical prosthesis: initial 5 year results of a randomized trial. J Am Coll Cardiol 1987; 10:719.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/29\">",
"      Das P, Rimington H, Chambers J. Exercise testing to stratify risk in aortic stenosis. Eur Heart J 2005; 26:1309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/30\">",
"      Amato MC, Moffa PJ, Werner KE, Ramires JA. Treatment decision in asymptomatic aortic valve stenosis: role of exercise testing. Heart 2001; 86:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/31\">",
"      McCann GP, Hillis WS. Surgery in asymptomatic aortic stenosis. BMJ 2004; 328:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/32\">",
"      Otto CM, Burwash IG, Legget ME, et al. Prospective study of asymptomatic valvular aortic stenosis. Clinical, echocardiographic, and exercise predictors of outcome. Circulation 1997; 95:2262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/33\">",
"      Rafique AM, Biner S, Ray I, et al. Meta-analysis of prognostic value of stress testing in patients with asymptomatic severe aortic stenosis. Am J Cardiol 2009; 104:972.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/34\">",
"      Chung EH, Gaasch WH. Exercise testing in aortic stenosis. Curr Cardiol Rep 2005; 7:105.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/35\">",
"      Gerber IL, Stewart RA, Legget ME, et al. Increased plasma natriuretic peptide levels reflect symptom onset in aortic stenosis. Circulation 2003; 107:1884.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/36\">",
"      Lim P, Monin JL, Monchi M, et al. Predictors of outcome in patients with severe aortic stenosis and normal left ventricular function: role of B-type natriuretic peptide. Eur Heart J 2004; 25:2048.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/37\">",
"      Weber M, Arnold R, Rau M, et al. Relation of N-terminal pro B-type natriuretic peptide to progression of aortic valve disease. Eur Heart J 2005; 26:1023.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/38\">",
"      Bergler-Klein J, Klaar U, Heger M, et al. Natriuretic peptides predict symptom-free survival and postoperative outcome in severe aortic stenosis. Circulation 2004; 109:2302.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/39\">",
"      Frenneaux MP, Porter A, Caforio AL, et al. Determinants of exercise capacity in hypertrophic cardiomyopathy. J Am Coll Cardiol 1989; 13:1521.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/40\">",
"      Gilard M, Cornily JC, Pennec PY, et al. Accuracy of multislice computed tomography in the preoperative assessment of coronary disease in patients with aortic valve stenosis. J Am Coll Cardiol 2006; 47:2020.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/41\">",
"      Meijboom WB, Mollet NR, Van Mieghem CA, et al. Pre-operative computed tomography coronary angiography to detect significant coronary artery disease in patients referred for cardiac valve surgery. J Am Coll Cardiol 2006; 48:1658.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/42\">",
"      Fighali SF, Avenda&ntilde;o A, Elayda MA, et al. Early and late mortality of patients undergoing aortic valve replacement after previous coronary artery bypass graft surgery. Circulation 1995; 92:II163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/43\">",
"      Odell JA, Mullany CJ, Schaff HV, et al. Aortic valve replacement after previous coronary artery bypass grafting. Ann Thorac Surg 1996; 62:1424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/44\">",
"      Sundt TM 3rd, Murphy SF, Barzilai B, et al. Previous coronary artery bypass grafting is not a risk factor for aortic valve replacement. Ann Thorac Surg 1997; 64:651.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/45\">",
"      Collins JJ Jr, Aranki SF. Management of mild aortic stenosis during coronary artery bypass graft surgery. J Card Surg 1994; 9:145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?31/8/31881/abstract/46\">",
"      Pereira JJ, Balaban K, Lauer MS, et al. Aortic valve replacement in patients with mild or moderate aortic stenosis and coronary bypass surgery. Am J Med 2005; 118:735.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8154 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1104-122.72.76.133-956556EC73-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31881=[""].join("\n");
var outline_f31_8_31881=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CAUSES AND IDENTIFICATION OF SEVERE AS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Causes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Identification of severe AS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      SYMPTOMATIC PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Indications for surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Survival after aortic valve replacement",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Age",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Left ventricular function",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      - Low gradient aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      - Hospital volume",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Risk stratification models",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      ASYMPTOMATIC SEVERE AORTIC STENOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Role of careful monitoring",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Surgical versus medical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Very severe AS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Possible role of exercise testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Possible role of brain natriuretic peptide",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Major society guidelines and summary",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      AORTIC VALVE REPLACEMENT AND CABG",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2055876\">",
"      Candidates for AVR who may require CABG",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      - Coronary angiography prior to valve surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem2\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      Noninvasive coronary angiography",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      - CABG at the time of surgery",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H2055709\">",
"      Candidates for CABG who may require AVR",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      MEDICAL MANAGEMENT IN PATIENTS AWAITING SURGERY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"CARD/8154\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8154|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?3/63/4094\" title=\"figure 1\">",
"      Natural history of AS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?23/32/24077\" title=\"figure 2\">",
"      Survival after AVR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?24/47/25341\" title=\"figure 3\">",
"      AVR survival and CAD",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"CARD/8154|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?17/33/17948\" title=\"table 1\">",
"      Severity of AS in adults",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/2/29740\" title=\"table 2\">",
"      ACC AHA AVR in aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?25/63/26620\" title=\"table 3\">",
"      Indic aortic valve replace",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?3/2/3117\" title=\"table 4\">",
"      Methods to assess cardiovascular disability",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?12/7/12411\" title=\"table 5\">",
"      Exercise ECG in aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?9/61/10204\" title=\"table 6\">",
"      ACC AHA selection aortic valve",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?29/4/29772\" title=\"table 7\">",
"      Coronary angio valve disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/11/1208?source=related_link\">",
"      Aortic valve area in aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?21/12/21706?source=related_link\">",
"      Clinical features and evaluation of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/57/25497?source=related_link\">",
"      Complications of prosthetic heart valves",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/5/7252?source=related_link\">",
"      Estimating the mortality risk of valvular surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/23/7544?source=related_link\">",
"      Evaluation of acute decompensated heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?34/14/35047?source=related_link\">",
"      Low gradient aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?1/62/2025?source=related_link\">",
"      Medical management of asymptomatic aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/43/41654?source=related_link\">",
"      Medical management of symptomatic aortic stenosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?19/22/19818?source=related_link\">",
"      Natriuretic peptide measurement in heart failure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/53/30551?source=related_link\">",
"      Natural history of aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/26/20906?source=related_link\">",
"      Noninvasive coronary imaging with cardiac computed tomography and cardiovascular magnetic resonance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?35/53/36690?source=related_link\">",
"      Patient information: Aortic stenosis (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?11/37/11865?source=related_link\">",
"      Surgical valve replacement in aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/36/34377?source=related_link\">",
"      Valvular heart disease in elderly adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f31_8_31882="Biologic lung volume reduction";
var content_f31_8_31882=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F57927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F57927&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 575px\">",
"   <div class=\"ttl\">",
"    CT images of biologic lung volume reduction",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 555px; height: 629px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Coronal computer tomography images obtained in the supine position at full lung inflation showing treatment site at baseline (pretreatment) and 6 weeks after low-dose (patients 1-4) and high-dose (patients 5-8) biologic lung volume reduction therapy. Numbering on the scans corresponds to treated sites showing evidence of scarring reactions.",
"    <div class=\"footnotes\">",
"     BioLVR: biologic lung volume reduction; HD: high dose; LD: low dose.",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission of the American Thoracic Society. Copyright &copy; 2009 American Thoracic Society. Criner GJ, Pint-Olata V, Strange C, et al. Biologic lung volume reduction in advanced upper lobe emphysema: Phase 2 results. Am J Respir Crit Care Med 2009; 179:791. Official journal of the American Thoracic Society. Diane Gern, Publisher.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31882=[""].join("\n");
var outline_f31_8_31882=null;
var title_f31_8_31883="Approved ARV agents";
var content_f31_8_31883=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F55550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F55550&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Currently approved antiretroviral agents",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        NRTI",
"       </td>",
"       <td class=\"subtitle1\">",
"        NNRTI",
"       </td>",
"       <td class=\"subtitle1\">",
"        PI",
"       </td>",
"       <td class=\"subtitle1\">",
"        Entry inhibitor",
"       </td>",
"       <td class=\"subtitle1\">",
"        Integrase inhibitor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <p>",
"         Zidovudine",
"        </p>",
"        <p>",
"         Didanosine",
"        </p>",
"        <p>",
"         Zalcitabine",
"        </p>",
"        <p>",
"         Stavudine",
"        </p>",
"        <p>",
"         Lamivudine",
"        </p>",
"        <p>",
"         Abacavir",
"        </p>",
"        <p>",
"         Emtricitabine",
"        </p>",
"        <p>",
"         Tenofovir DF",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Efavirenz",
"        </p>",
"        <p>",
"         Nevirapine",
"        </p>",
"        <p>",
"         Delavirdine",
"        </p>",
"        <p>",
"         Etravirine",
"        </p>",
"        <p>",
"         Rilpivirine",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Saquinavir",
"        </p>",
"        <p>",
"         Ritonavir",
"        </p>",
"        <p>",
"         Indinavir",
"        </p>",
"        <p>",
"         Nelfinavir",
"        </p>",
"        <p>",
"         Fos-Amprenavir",
"        </p>",
"        <p>",
"         Lopinavir/Ritonavir",
"        </p>",
"        <p>",
"         Atazanavir",
"        </p>",
"        <p>",
"         Tipranavir",
"        </p>",
"        <p>",
"         Darunavir",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Enfuvirtide",
"        </p>",
"        <p>",
"         Maraviroc",
"        </p>",
"       </td>",
"       <td>",
"        <p>",
"         Raltegravir",
"        </p>",
"        <p>",
"         Elvitegravir",
"        </p>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     NRTI: nucleoside reverse transcriptase inhibitor; NNRTI: nonnucleoside reverse transcriptase inhibitor; PI: protease inhibitor.",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Dr. Eric Daar.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31883=[""].join("\n");
var outline_f31_8_31883=null;
var title_f31_8_31884="Non antimicrobial sulf";
var content_f31_8_31884=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ALLRG%2F57629&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ALLRG%2F57629&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Selected non-antimicrobial sulfonamides (non-sulfonylarylamines and related drugs)",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Loop diuretics",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Bumetanide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Furosemide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Torsemide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Thiazide and related diuretics",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Hydrochlorothiazide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chlorothiazide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chlorthalidone*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Indapamide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Methyclothiazide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Metolazone*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Sulfonylurea hypoglycemics",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Glyburide",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Glipizide",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Glimepiride",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Chlorpropamide",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tolazamide",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Carbonic anhydrase inhibitors",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Acetazolamide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Brinzolamide ophthalmic*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Dorzolamide ophthalmic*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Methazolamide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Other",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Celecoxib*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Diazoxide*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Fosamprenavir*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Ibutilide",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Probenecid&bull;",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Sotalol",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       <span class=\"red\">",
"        Sulfasalazine&Delta; (salazosulfapyridine, salazopyrin)",
"       </span>",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Sumatriptan",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Tipranavir*",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Topiramate",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Zonisamide*",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * US FDA product insert for this drug contains a cautionary statement regarding use in patients with allergy to any other sulfonamide drug, although clear evidence of cross-reactivity between the sulfonamide antimicrobials and the non-antimicrobials listed in this table is lacking. See text for detail.",
"     <br>",
"      &bull; High risk in G6PD deficiency. See: file://www.g6pd.org/favism.",
"      <br>",
"       &Delta; Releases sulfapyridine (arylamine sulfonamide) in contact with gut flora and therefore should be avoided in patients with significant allergy to sulfonamide antimicrobials.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Data from: US FDA-approved product information file://dailymed.nlm.nih.gov/dailymed/about.cfm accessed 11/23/2009.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31884=[""].join("\n");
var outline_f31_8_31884=null;
var title_f31_8_31885="Posttranslantional processing";
var content_f31_8_31885=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F58292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F58292&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 554px\">",
"   <div class=\"ttl\">",
"    Posttranslational processing",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 534px; height: 192px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic representation of glucagon posttranslational processing that occurs in the pancreas and small intestine. The gene transcript is translated into a preprohormone capable of producing glucagon, glucagon-like peptide (GLP)-I and GLP-II. Only glucagon is produced in the pancreas by tissue specific processing. In the small intestine GLP-I and GLP-II are the primary products.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31885=[""].join("\n");
var outline_f31_8_31885=null;
var title_f31_8_31886="Summary of management strategy for patients with acromegaly";
var content_f31_8_31886=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F61609&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F61609&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 507px\">",
"   <div class=\"ttl\">",
"    Summary of management strategy for patients with acromegaly",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 487px; height: 440px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Summary of management strategy for patients with acromegaly. Control is defined by GH and IGF-I measurements.",
"    <div class=\"footnotes\">",
"     SRL: somatostatin receptor ligands.",
"    </div>",
"    <div class=\"reference\">",
"     Adapted with permission from: Melmed S, Colao A, Barkan M, et al. Guidelines for acromegaly management: An update. J Clin Endocrinol Metab 2009; 94:1509. Copyright &copy; 2009 The Endocrine Society.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31886=[""].join("\n");
var outline_f31_8_31886=null;
var title_f31_8_31887="SCFE Kleins line";
var content_f31_8_31887=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82443&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=0\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 488px\">",
"   <div class=\"ttl\">",
"    Klein's line",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 468px; height: 238px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    In the normal AP view, a line drawn along the superior femoral neck (Klein's line) intersects the lateral portion of the femoral head. In a patient with SCFE, the line passes outside of the epiphysis or just at its superior edge.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f31_8_31887=[""].join("\n");
var outline_f31_8_31887=null;
